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ABSTRACT 
The kidneys are important organs that regulate the level of water and salts 
in the blood, produce hormones that help to control blood pressure, and 
maintain homeostasis of the organism by filtering waste products. Kidney 
disease can either be acute or chronic, the latter progressively worsening 
over time to become end stage renal disease (ESRD) – a stage when 
kidneys are non-functional. At present, the only treatment options for 
ESRD are transplantation or dialysis, which both have severe drawbacks 
in terms of morbidity, mortality and economic cost. Moreover, the 
incidence of ESRD is rising annually and an alternative therapy is 
needed. Therefore, in order to regenerate kidney tissue or prevent 
worsening of the kidney condition, a new therapy should be developed. 
One approach is to use embryonic stem cells.   
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GLOSSARY 
ADH – antidiuretic hormone 
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EB / EBs – embryoid body / embryoid bodies 
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iPSC – induced pluripotent stem cells 
KSC – kidney stem cells 
LIF – leukemia inhibitory factor 
LM – lateral plate mesoderm 
LTA – lotus tetragonolobus lectin 
mESC – mouse embryonic stem cells  
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 14 
UB – ureteric bud 
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Chapter 1: Introduction 
The incidence of end stage renal disease (ESRD) continues to rise 
annually, causing an ever increasing burden on society in terms of both 
human suffering and economic costs. One of the major challenges of the 
21
st
 century will be to devise medical interventions that prevent the onset 
of ESRD. In most cases, ESRD develops from progressive worsening of 
chronic renal disease and available treatment options are dialysis and 
transplantations, although both have severe limitations in quality of life. 
However, there is usually a time-window of several years from the onset of 
mild/moderate kidney disease to the development of ESRD, which presents 
an opportunity to design therapies aimed at preventing disease progression 
by repairing or replacing damaged renal tissue. Such therapy could be 
directed with the use of stem cells. These cells are known to be pluri- or 
multipotent and can either differentiate into all cell types of the body or 
their differentiation potential is limited to a narrow range of cell types, 
respectively. However, in order to replace damaged kidney cells, the stem 
cells should be able to differentiate into at least 10 types of highly 
specialized cells present in the kidney, including the major cell types 
within the glomerulus and nephron tubules. Moreover, following 
transplantation, such cells should be competent to respond appropriately to 
the kidney environment and be able to function normally. Furthermore, 
following cell transplantation, the migration and incorporation of injected 
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cells into the host tissue should be easy to monitor. In other words, prior to 
transplantation, cells should be labelled with a marker that will allow 
distinguishing them from the host cells, without affecting cell behaviour.  
Therefore, in this chapter, kidney development, kidney anatomy and the 
normal physiological functions of the kidney will be described; following 
which, the characteristics of different stem cell types with regard to their 
contribution to kidney regeneration, and the different methods of cell 
labelling will be introduced. 
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1.1 Kidney development 
 
1.1.1 Overview of mammalian urogenital systems: pronephros, 
mesonephros and metanephros 
During gastrulation of the mouse embryo, which occurs at embryonic day 
(E) 6.0-7.5, the three embryonic germ layers are generated; the ectoderm, 
mesoderm and endoderm (Rivera-Perez, 2005). Following migration 
through the primitive streak, the mesoderm forms three sub-populations, 
the lateral plate mesoderm, the paraxial mesoderm and the intermediate 
mesoderm. Each sub-population gives rise to a specific set of differentiated 
cell types. The lateral plate mesoderm gives rise to some of the extra-
embryonic tissues and the somatic and splanchnic mesoderm. The somatic 
mesoderm, together with the ectoderm, forms somatopleura, while the 
splanchnic mesoderm, together with the endoderm, forms the 
splanchnopleura. The somatopleura give rise to the head musculature, 
pericardium, and the bones and muscles of limbs and outer body wall, 
while the splanchnopleura give rise to visceral smooth muscle, cardiac 
muscle, endocardium, vasculature and blood cells.  The paraxial mesoderm 
gives rise to the remaining head tissues (bones and muscles) and the 
somites which develop into: 1) the sclerotome, which gives rise to the axial 
skeleton; 2) the myotome, which gives rise to the musculature of the back 
and ribs, and limbs; 3) the dermatome, which gives rise to the dermis.  The 
 18 
intermediate mesoderm gives rise to the urogenital system – the kidney and 
the gonads and their accompanying duct systems (Gilbert, 2006) 
All three types of mesoderm, i.e., the lateral plate, the paraxial and the 
intermediate mesoderm, are present along the entire cranio-caudal axis of 
the embryo. The intermediate mesoderm gives rise to three separate 
excretory organs which develop from cranial to caudal end as follows: the 
pronephros, the mesonephros, and the metanephros. The first two stages 
(pro- and mesonephros) are simple temporary organs in mammalian 
development, while the metanephros is the permanent kidney (Fig.1.1).  
       
Figure 1.1 Schematic localization of the stages of kidney development in the mouse 
embryo. Mammalian kidneys develop through three stages: pronephros, mesonephros and 
metanephros (the permanent kidney), in cranio-caudal direction. Drawing prepared on the 
basis of Vize 2003 and Gilbert 2006. 
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The pronephric nephrotomes (single nephrons) are located between the 
lateral plate mesoderm and paraxial mesoderm. Nephrotomes open into the 
coelom with the rostrodorsal end equipped with cilia, and the caudal end 
opens into the cloaca. This is a very important organ for aquatic larvae. 
Fully-developed pronephroi are found in primitive fish, such as lampreys 
and hagfish. The pronephric kidney is present during the early 
development of the embryo, and is a temporary organ for teleost fish, 
amphibians, reptiles, birds and mammals (Saxen, 1987; Vize, 2003)As 
soon as the mesonephros develops, the pronephros disintegrates.  
The mesonephros is the second stage of kidney development. It is the last 
stage of kidney organization in teleost fish and amphibians. It consists, 
therefore, of a large number of nephrons, each having an internal 
glomerulus, and excretory tubules divided into two kinds: proximal and 
distal tubules. The mesonephric kidney develops caudal to the pronephros 
(Vize, 2003). 
The metanephros, also called the permanent kidney, is the third stage of 
kidney development for all amniotes. The elementary unit of the kidney is 
the nephron and each human kidney contains about 4x10
5
 to 1.2x10
6
 
nephrons whereas in the rat kidney there are about 3-4x10
4
 nephrons 
(Brenner, 2000). The proximal end of the nephron begins with the 
renal corpuscle (the Bowman‟s capsule which surrounds the glomerulus) 
and continues with the proximal convoluted tubule, proximal straight 
tubule and thin descending limb, thin ascending limb and thick ascending 
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limb, all of which form the loop of Henle, and then the distal straight and 
convoluted tubule, the latter connecting to the collecting (Saxen, 1987; 
Vize, 1997) 
 
               
Figure 1.2 Diagram showing the structure of the nephron of the metanephric kidney. 
Drawing prepared on the basis of Brenner (2000). 
 
 
1.1.2 Development of the metanephros 
Metanephros development comprises of the following stages: development 
of metanephric mesenchyme, ureteric bud outgrowth and invasion into 
metanephric mesenchyme, metanephric mesenchyme induction and 
nephron formation.  
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Metanephric kidney development begins at E9.5 with the formation of the 
metanephric mesenchyme, an aggregate of cells derived from the caudal 
region of the intermediate mesoderm. Specification of the intermediate 
mesoderm is triggered by signals from the paraxial mesoderm and lateral 
plate mesoderm; most notably, mediolateral axis gradients of morphogens 
such as bone morphogenetic protein 4 (BMP4) with its higher 
concentration in lateral plate mesoderm, and the BMP antagonist, Noggin, 
with its higher concentration in paraxial mesoderm (Tonegawa, 1998).  
Later experiments on chicken gastrulae led by Mauch and co-workers 
(2000) showed that differentiation of intermediate mesoderm depends on 
signals from paraxial mesoderm (Mauch, 2000). It was also demonstrated 
that expression of Foxc1 and Foxc2 (fork-head/wing-helix transcription 
factors) in the paraxial mesoderm is important for somite formation and 
when they are down-regulated (i.e. in Foxc1-/- and Foxc2-/- mutants), the 
paraxial mesoderm is converted to an intermediate mesoderm fate (Wilm, 
2004). Therefore, intermediate mesoderm differentiation is regulated by 
morphogens, especially by the BMP4 (James, 2005b) and other paraxial 
mesoderm-derived signals, and it is characterized by expression of Lim1, 
Osr1 and Pax2 genes (Boyle, 2006; Kobayashi, 2005a; Wang, 2005a). The 
intermediate mesoderm gives rise to the nephric duct and the metanephric 
mesoderm, the initial development of which is dependent upon the 
expression of Wilms’ tumour suppressor gene-1 (Wt1, a zinc finger 
transcription factor). In the absence of Wt1, metanephric mesenchyme cells 
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undergo apoptosis (Bouchard, 2002; Kreidberg, 1993; Pritchard-Jones, 
1999; Vize, 2003) causing renal agenesis. However, some studies reported 
that Wt1-/- embryos can generate metanephric mesenchyme-derived renal 
cells in the presence of Pax2, Six2 and GDNF RNAs (Donovan, 1999), 
suggesting that the main function of Wt1 in the early stages of kidney 
development may be to induce expression of Pax2, Six2 and GDNF, Fig. 
1.3. 
The metanephric mesenchyme induces the nephric duct to form the ureteric 
bud (UB). One of the signalling molecule required for ureteric bud 
outgrowth is GDNF (glial cell line derived neurotrophic factor), a member 
of the TGF β (transforming growth factor) family, which is secreted by the 
metanephric mesenchyme and binds to the receptor tyrosine kinase, c-Ret, 
which is expressed by the nephric duct epithelium and is required for the 
induction of ureteric bud outgrowth. GDNF expression by the metanephric 
mesenchyme requires combinatorial action of several transcriptional 
factors, such as Osr1, Eya1, Pax2, Six1, Six2, Sall1, Hox11 genes, all of 
which cause kidney agenesis when not expressed. The genes network 
mentioned above and described in details below is presented on Fig. 1.3.  
The Osr1 (Odd skipped related 1) is a mouse homologue of Odd1 in 
Drosophila melanogaster. Osr1 is a zinc finger containing transcriptional 
factor which plays an essential role during mouse embryogenesis. It is first 
expressed in the intermediate mesoderm at E8.5, and later during kidney 
and limb development. Osr1-/- mutants show kidney agenesis at an early 
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stage of development and several heart defects (Stricker, 2006; Wang, 
2005a). Osr1 has a strong influence on kidney development, and was 
reported to up-regulate expression of other metanephric mesenchyme 
specific genes; for instance, Osr1-/- mutants do not show any expression 
of: Eya1, Pax2, Six1, Sall1 and  GDNF, and have a lower level of 
expression of Lim1 (James, 2006).  
The first gene to be down-stream of Osr1 is Eya1.  Eya1 is a homologue of 
Drosophila melanogaster eyes absent (eya) gene and lack of its expression 
causes the syndromes, BOR (Branchio-oto-renal syndrome) and BO 
(Branchio-oto syndrome) with features of craniofacial abnormalities, 
hearing loss (BO) and kidney defects (BOR) (Xu, 1999). Eya1 is expressed 
in the intermediate mesoderm at E8.5, in the uninduced metanephric 
mesenchyme (E10.5), and also in the condensed metanephric mesenchyme 
(E11.0) (Boyle, 2006). Eya1-/- mutants have no kidney rudiments or ureter 
and there is no outgrowth of the ureteric bud. Furthermore, in the Eya1-/- 
mutants the expression of Six1 and Pax2 genes was found to be decreased, 
suggesting that the expression of these genes is regulated by Eya1 
(Sajithlal, 2005).  
The Six1 gene is a homolog of Drosophila melanogaster sine oculi (so) 
gene. It is expressed in the uninduced metanephric mesenchyme (E10.5), 
in the induced metanephric mesenchyme (E11) and in the ureteric bud 
(E11.5) (Boyle, 2006; Xu, 1999; Xu, 2003).  Six1-/- mutants show kidney  
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Figure 1.3 Schematic presenting a genes interaction network during metanephric 
mesenchyme induction. PM – paraxial mesoderm, IM – intermediate mesoderm, LM – 
lateral plate mesoderm 
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Table 1 Master regulators of kidney development. 
E – embryonic day; I – Shawlot 1999, II – Kobayashi 2003, III – Bouchard 2002,  
IV – Boyle 2006, V – Bouchard 2004. 
 
 
agenesis and a lower level of Pax2 and Sall1 expression. In other words, 
Six1 up-regulates Pax2 and Sall1 expression, but it is itself up-regulated by 
Eya1 which did not show any changes in its expression level in the Six1-/- 
embryo. Another gene in the Six gene family, Six2, is up-regulated by Six1 
(Xu, 2003), but it is playing a similar role to Six1, although its expression 
is limited to the condensed metanephric mesenchyme (Kobayashi, 2008). 
Xu (2003) demonstrated that in Six1-/- mutants the Six2 expression level is 
decreased.  
Pax2 expression in the metanephric mesenchyme is upregulated by a few 
transcription factors but it is first detected in the intermediate mesoderm at 
E8.5, then in the uninduced metanephric mesenchyme at E10.5 and is 
strongly expressed in induced metanephric mesenchyme at E11.0, and also 
in the ureteric bud from E9.5 onwards (Boyle, 2006). Embryonic Pax2-/- 
mutants extend the nephric duct normally, but no ureteric bud formation 
occurs and no metanephroi form. Another member of the Pax gene family 
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– Pax8, also plays a role in kidney development. Pax8 embryonic mutants 
seem to have a normal fully-developed excretory system but die because of 
a defect in thyroid gland development. Interestingly, in double mutants 
(Pax2-/- Pax8-/-), kidney development fails at the pronephros stage 
(Bouchard, 2002).   Therefore, Pax2 and Pax8 have an important role in 
directing intermediate mesoderm cells to a renal cell fate. Pax2 and Pax8 
are also important for Gata3 expression as Pax2-/-; Pax8-/- mutants do not 
show any Gata3 expression. Thus, Gata3 seems to have a specific 
influence on kidney development, especially in terms of CACUT 
(congenital anomalies of the kidney and the urinary tract) diseases. It was 
reported by Grote (2005), that in Gata3-/- mutants, the c-Ret receptor 
(tyrosine kinase) and Wnt11 expression is lost, which leads to defects in 
nephric duct development such as ectopia of the ureteric bud and/or 
multiple disorganized ducts (Grote, 2005).   
The Sall1 (Sal-like1) gene is a mouse homologue of Drosophila 
melanogaster Sal1 gene. Sall1 gene is expressed in the nephric duct and in 
the mesonephros at E9.5, in the uninduced metanephric mesenchyme at 
E10.5 and in the induced metanephric mesenchyme at E11.0 (Boyle, 
2006). It is upregulated by Six1 (Yu, 2004). Sall1 +/- mutants shows 
Townes-Brocks syndrome which is characterized by dysplastic ears, 
preaxial polydactyly and kidney and heart anomalies (Takasato, 2004).  
Sall1-/- deficient mutants die due to kidney agenesis in the perinatal period. 
These mutants fail in the ureteric bud outgrowth and as a consequence, the 
 27 
metanephric mesenchyme remains uninduced and undergoes apoptosis 
(Nishinakamura, 2001; Takasato, 2004). Thus, Sall1 is important for 
ureteric bud formation in kidney development.  
The paralogous group of Hox11 genes contains Hoxa11, Hoxc11 and 
Hoxd11 and play an important role during kidney development through the 
regulation of GDNF expression. These genes are expressed at E10.5 in 
uninduced metanephric mesenchyme and at E11.0 in metanephric 
mesenchymal stromal cells (Boyle, 2006). Single mutations in Hox11 
genes (Hoxa11-/- or Hoxd11-/-) show discernible kidney abnormalities; 
double mutants (Hoxa11-/- Hoxd11-/-) show kidney hypoplasia; removal 
of the Hoxc11 gene results in complete loss of metanephric kidney 
induction. Furthermore, although Pax2 expression is normal in triple 
mutants (Hoxa11-/- Hoxd11-/- Hoxc11-/-) there is no GDNF expression 
and the ureteric bud does not form (Wellik, 2002). 
Therefore, this large complicated GDNF stimulation network of at least 7 
groups of genes is playing an important role in inducing renal development 
by stimulating GDNF secretion and therefore preventing renal agenesis. 
However, apart from positive inducers of GDNF expression, several 
transcription factors are present to repress overexpression and/or 
oversecretion of GDNF. These factors are: Foxc1, Foxc2, Slit2 and its 
receptor Robo2, and BMP4. Foxc1 and Foxc2 are expressed in the paraxial 
mesoderm at E8.5 and in uninduced metanephric mesenchyme at E10.5, 
while Slit2/Robo2 are expressed in the nephric duct and in the metanephric 
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mesenchyme, respectively. These proteins negatively regulate GDNF 
secretion, probably by affecting Eya1 and/or Pax2 translation or their 
activity in the anterior part of the metanephric mesenchyme as suggested 
by Grieshammer and co-workers (Grieshammer, 2004; Kume, 2000b). On 
the other hand, BMP4 acts indirectly as an inhibitor of budding after 
GDNF has bound to the c-Ret receptor (Ichikawa, 2002), and therefore 
blocks further signalling by Wnt11 expression (Fig.1.3) (Vize, 2003). 
Moreover, reduced expression of BMP4 in BMP4+/- heterozygous mice 
results in polycystic kidneys (Vize, 2003). Therefore, all these signals are 
preventing overexpression or oversecretion of GDNF are playing an 
important role in avoiding ectopic ureteric bud outgrowth, thus helping to 
avoid the formation of a double ureter as well as polycystic kidney 
development. 
Once the UB is induced by GDNF to grow out from the Wolfian duct in an 
appropriate site, it extends to reach metanephric mesenchyme (MM). 
When the UB invades the MM, the cells at the bud tip start to secrete FGF2 
and BMP7 to prevent the metanephric mesenchyme from undergoing 
apoptosis (Dudley, 1999). GDNF also induces the cells at the tip of the 
ureteric bud to express Wnt11, which is required for ureteric bud branching 
(Vize, 2003). In Wnt11-/- mutants, kidney hypoplasia was observed, with 
the kidneys appearing much smaller in the mutants compared to the wild 
type (Majumdar, 2003). Other signals from the tips of the branching 
ureteric bud induce the areas of adjacent metanephric mesenchyme to 
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aggregate and undergo a mesenchymal–to–epithelial transition. The first 
signal that makes metanephric mesenchymal cells to condense around the 
tip of the UB is LIF (leukaemia inhibitory factor) (Barasch, 1999). Under 
LIF action, cells up-regulate E-cadherin, Pax2, Wnt9B and Wnt4, 
triggering nephron formation (Barasch, 1999; Park, 2007). Wnt4 plays a 
crucial role in nephron formation; in Wnt4-/- mutants the mesenchyme 
condenses but does not form an epithelium (Stark, 1994). Although many 
transcriptional factors involved in the initial differentiation of the 
metanephric mesenchyme have been identified, it is as yet unclear how the  
 
 
Figure 1.4 Fluorescent microscope photomicrograph presenting stages of nephron 
formation ex vivo. Calbindin (green) staining of UB and laminin (red) staining of the 
basement membrane of developing nephron in cultured kidney: A) Renal vesicle; B) 
Comma-shape body; C) S-shape body; D) Early nephron. 
 
 
 
terminal nephron differentiation is regulated. However, a few steps of 
nephron formation have been identified:  
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 condensation of mesenchymal cells adjacent to the bud tips into 
aggregates;  
 cavitations of these aggregates to form the renal vesicles; 
 elongation to comma- and then S-shaped tubules;  
 the production of new epithelial cells and further elongation and 
maturation to form a functional nephron (Fig. 1.4) 
In general, during kidney development the ureteric bud forms the ureter 
and collecting duct system of the mature kidney whereas the metanephric 
mesenchyme gives rise to the nephrons from the renal corpuscle to the 
distal tubule (Saxen, 1987) (Fig. 1.2). 
 
1.2  Anatomy of the kidney  
Kidneys are bean-shape organs that are located symmetrically on both 
sides of the body in the retroperitoneal space (Fig. 1.1A). Kidneys are 
surrounded by connective tissue – the capsule, and have a few 
characteristic regions that can be easily distinguished on a coronal section 
(Fig.1.5B). The outer part is the cortex, which contains many capillaries 
and has reddish-brown colour appearance, whereas the inner part – the 
medulla is composed of renal pyramids separated by renal columns. Renal 
pyramids connect at the renal papilla to form a minor calyx. Minor calyces 
then merge to form a major calyx, and a few major calyces connect 
together to form the pelvis – which contains the entrance to the ureter. The 
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ureter connects the kidney with the bladder – an elastic sack that collects 
the urine and under pressure, allows it to drain by the urethra (Fox, 2008).  
 
 
Figure 1.5 Diagram showing location of human kidney (A) and its structure (B). 
Drawings prepared on the basis of Brenner 2000.  
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The kidney has two major units, which differ in their origin; the nephron, 
which develops from the metanephric mesenchyme, and the collecting 
duct, which develops from the ureteric bud. Both are surrounded by 
interstitial cells and loose extracellular matrix.  
 
1.2.1 Cell types of the nephron 
The smallest functional unit of the kidney is the nephron. It consists of the 
glomerulus, proximal convoluted tubule, proximal straight tubule, loop of 
Henle, which consists of thin descending limb, thin and thick  
ascending limbs, and the straight and convoluted distal tubule which is 
connected to the collecting duct (Fox, 2008; Valtin, 1995) (Fig.1.2). All 
parts of the nephron are characterized by different cell types that are 
specialized to participate in various functions. Apart from the large number 
of nephrons and blood vessel networks, kidneys also have a lymphatic and 
nerve system. 
The renal corpuscle is composed of the glomerulus and Bowman‟s capsule. 
The glomerulus is a capillary network that supplies the blood via the 
afferent arteriole and leads away filtered blood via the efferent arteriole. 
The glomerular capillaries are composed of endothelial cells which line the 
inner walls of all capillaries thus forming the glomerular basement 
membrane with overlying podocyte cells (Fig.1.6B). The podocytes 
represent the visceral layer of the glomerular capsule; whereas the parietal 
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layer of the glomerular capsule is formed by simple epithelial cells. 
Podocytes are the biggest cells within the renal corpuscle, and are 
characterised by their long cytoplasmic processes, which divide into many 
individual foot processes (Fig.1.7 C). The space between the capillaries is 
filled with mesangial cells, which build a glomerular matrix – a structural 
support for the glomerular capillaries. The space between the visceral and 
the parietal wall of the Bowman‟s capsule is forming a free area where the 
ultrafiltrate is collected (Brenner, 2000; Fox, 2008) (Fig. 1.7 B). 
At the urinary pole of the glomerulus, the proximal tubule of the nephron 
begins. It consists of two parts: convoluted and straight proximal tubules, 
which are divided onto three segments, S1, S2 and S3. The first segment 
(S1) includes two thirds of the convoluted tubule and cells are 
characterised by having a very tall brush border, many big mitochondria 
and many well-developed lysosomes. The second segment (S2) consists of 
the rest of the convoluted tubule and the initial part of the straight tubule. 
Cells of this segment possess a medium length brush-border, smaller 
mitochondria and numerous large lysosomes. The third segment (S3) 
includes the remaining part of the straight tubule. The brush border length 
in cells of this segment varies between species; however cells tend to have 
small and randomly distributed mitochondria and small lysosomes 
(Brenner, 2000).  In the kidney cross section, these tubules have a size 
similar to distal tubules but due to the brush border, the lumen may not be  
 
 34 
                       
Figure 1.6 Schematic structure of the glomerulus (A), schematic section through 
glomerular capillary (B) and interactions between podocytes (C). Drawings prepared 
on the basis of Brenner (2000). 
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visible or is very small in diameter and irregular in shape (Fig. 1.7 C). At 
the end of the proximal tubule, the thin descending limb of the loop of 
Henle begins the third part of the nephron.  
The epithelium of the thin descending and thin ascending limbs of the loop 
of Henle is flatter than in the proximal tubule and lacks microvilli. The 
epithelium of the thick ascending limb of the loop of Henle is thicker in 
comparison to the thin limbs and is more similar to distal tubules, and  
 
 
Figure 1.7 Localisation and structure of the different parts of the nephron.  
A) Schematic location of the nephron parts; B-F) haematoxylin and eosin staining of a 
cross section of the adult kidney: B – glomerulus, C – proximal tubule, D – hairpin of the 
loop of Henle, D‟ – thin limbs of the loop of Henle, E – distal tubule, E‟ – the macula 
densa cells in the distal tubule, F – collecting duct. 
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therefore, is sometimes considered as a part of the straight distal tubule 
(Brenner, 2000). In the cross section of the kidney it is possible to observe 
the hairpin of the loop of Henle as well as the easily distinguishable thin 
limbs of the loop of Henle, characterised by their very small diameter (Fig 
1.7 D and D‟, respectively).    
The distal tubule consists of the straight ascending tubule, the specialised 
region of the macula densa and the convoluted tubule. The straight tubule 
cells do not have microvilli but most cells possess one or two cilia. These 
cells have large elongated mitochondria and from the scanning electron 
microscopy, some cells have a rough surface pattern and some a smooth-
surface pattern (Brenner, 2000). The straight distal tubule ends at the 
specialised region of the macula densa, which is adjacent to the hilium of 
the glomerulus. Macula densa cells are taller than other cells of the distal 
tubule, and have an apically located nucleus (Fig. 1.7 E‟). At some distance 
behind the macula densa, the convoluted tubule begins. These cells are 
very similar to those of the straight distal tubule but are taller, have very 
small microvilli and long cilia as well as numerous mitochondria (Brenner, 
2000). The distal tubules have a similar diameter size as proximal tubules 
but the distal tubule lumen is clear and wide unlike in the proximal tubules 
(Fig. 1.7 E). The distal tubules constitute the last part of the nephron and 
connect to the collecting duct. 
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1.2.2 Cell types of the collecting duct 
The collecting ducts can be divided into three parts, depending on their 
location: the cortical collecting duct (CCD), which is located in the renal 
cortex, the outer medullary collecting duct (OMCD) located in the outer 
medulla and inner medullary collecting duct (IMCD) which is located in 
the inner medulla. These three segments consist only of two cell types: 
principal cells (light cells) and intercalated cells (dark cells), but the 
contribution of those cells differ in each segment. The principal cells have 
a light cytoplasm staining and fewer organelles whereas intercalated cells 
have more organelles and numerous cytoplasmic ribosomes which cause 
the cytoplasm to be more darkly stained. About one third of the CCD and 
OMCD is built by intercalated cells whereas in the IMCD, intercalated 
cells constitute only about 10% of all cells. As the duct extends, the 
diameter expands, from about 10μm at the beginning of the collecting duct 
to up to 50μm at the papillary tip (Brenner, 2000). The collecting duct has 
a distinctively wider diameter than the nephron tubules (Fig.1.7 F). 
 
1.3 Kidney functions 
The kidneys play an important role in maintaining the homeostasis of the 
organism by producing hormones regulating the blood pressure, volume of 
body fluids, performing selective reabsorption of important molecules and 
excreting toxins via selective secretion. During all these processes the body 
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metabolites are transferred into the urine. This liquid is first formed in the 
Bowman‟s capsule as an ultrafiltrate and undergoes modifications during 
the flow through different nephron parts and down the collecting duct to 
become urine. 
1.3.1 Renal corpuscle 
In the glomerulus, the difference in the diameter between the afferent 
arteriole (bigger diameter) and the efferent arteriole (smaller diameter), 
results in raised intraglomerular pressure, which causes many blood 
components to be filtered through the permselective vessels walls and enter 
Bowman‟s space to form the ultrafiltrate (Brenner, 2000). The capillary 
walls are generated by a triple filtration barrier, the fenestrae, glomerular 
basement membrane, and podocyte foot processes. The fenestrae are small 
gaps in the endothelial cell layer, which form a barrier for blood cells such 
as erythrocytes and leukocytes. The second filtration barrier is determined 
by the glomerular basement membrane which is a barrier for positively 
charged plasma macromolecules, and the third filtration barrier is provided 
by the podocyte foot processes which form a barrier for protein (Brenner, 
2000). Therefore, the ultrafiltrate is mainly composed of plasma water and 
its non-protein constituents (glucose, negatively charged micromolecules).  
Such liquid enters the proximal tubule. 
The role of the glomerulus does not end at ultrafiltrate production. Due to 
close contact of the glomerulus with its own distal tubule region of the 
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macula densa, there is a tubulo-glomerular feedback loop that regulates the 
blood pressure and water balance through the rennin-angiotensin-
aldosterone system (Valtin, 1995). Depending on the urate flow (low) 
through the distal tubule, the macula densa cells produce nitric oxide that 
induces granular cells of the glomerulus to produce renin (high).  Renin 
induces angiotensin production which stimulates the blood vessel walls to 
contract and increase the blood pressure. Moreover, angiotensin induces 
aldosterone production which increases the reabsorption of water and salts. 
This increases the volume of the body fluids which results in the increase 
of the blood pressure as well (Brenner, 2000; Valtin, 1995).    
 
1.3.2 Proximal tubule 
The first part of the proximal tubule, the convoluted proximal tubule, takes 
part in active and passive reabsorption of water, organic solutes such as 
glucose and amino acids, and electrolytes: Na
+
, K
+
, Ca
2+
, Cl
-
, HCO3
-
, PO4
3
, 
whereas the straight proximal tubule is mainly reabsorbing water and Na
+
 
ions. The transport of the aforementioned substances can be either active, 
taking place against the electrochemical potential gradient via Na
+
/K
+
 ATP 
pumps, Na
+
-cotransporters (glucose) and specialized transporters (glucose), 
or passive, taking place down the electrochemical potential gradient (urea). 
Small amounts of proteins that leaked into the ultrafiltrate at the 
 40 
glomerulus are reabsorbed by endocytosis (Brenner, 2000; Valtin, 1995) 
(Fig. 1.8). 
Another function of the proximal tubule is secretion of endo- and 
exogenous toxins (such as drugs in the body that form weak acids (anions) 
and weak bases (cations)), which could not be filtered at the glomerulus 
due to their being bound to proteins. The secretion mechanism involves 
active transport with use of specific transporters, usually related to Na
+
-
cotransporters (Brenner, 2000; Valtin, 1995).  
 
1.3.3 Loop of Henle 
The first part of the loop of Henle, the thin descending limb, is the only one 
permeable to water, and this is where the water is mainly reabsorbed. 
There is also secretion of urea, Na
+
 and Cl
-
 ions observed, and it is an 
effect of passive transport down the gradient. The thin ascending limb is 
passively reabsorbing Na
+
 and Cl
-
 ions, whereas the thick ascending limb 
is actively reabsorbing Na
+ 
ions through Na
+
/K
+ 
ATP pumps and  
Na:K:2Cl cotransporters, that allows the transport of one ion of Na
+ 
and K
+
 
each into the cell and 2 ions of Cl
-
 (Brenner, 2000; Valtin, 1995) (Fig.1.8). 
 
1.3.4 Distal tubule 
The distal tubule has two distinct regions in regard to water and sodium ion 
transport. The early distal tubule is characterized by passive transport 
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(reabsorption) of Na
+
 and Cl
-
. This part is, similarly to the most distal part 
of the loop of Henle, not permeable to water. In the convoluted part  
 
 
    
Figure 1.8 Schematic presenting functions of the nephron (red) and the collecting 
duct (green). The ultrafiltrate produced by the glomerulus is undergoing changes during 
the process of urine production. In the proximal tubule about 98% of the glucose is 
reabsorbed as well about 60% of the Na
+
 ions and quite high amounts of water and urea. In 
the proximal tubule, secretion of different metabolites takes place. In the loop of Henle the 
urea and Na
+
 and Cl
-
 ions are secreted to be reabsorbed in the later parts of the loop of 
Henle. In the late distal tubule the active reabsorption of Ca
2+
 and Mg
2+
 is taking place and 
vasopressin dependent (VD) reabsorption of water, the latter is similar to the action taken 
by collecting duct.   
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of the distal tubule the reabsorption of Na
+
 ions is passive, but this part is 
presenting active reabsorption of the Mg
2+
 and Ca
2+
 ions. The water 
reabsorption/secretion depends on the presence/absence of vasopressin, the 
antidiuretic hormone (ADH) secreted by the hypothalamus. This hormonal 
regulation of body fluids ensures the right water balance (Brenner, 2000; 
Valtin, 1995) (Fig.1.8).   
 
1.3.5   Collecting duct 
The collecting duct is similar in its functions to the late distal tubule. The 
principal cells are taking part in the passive reabsorption of Na
+
 and K
+
 
ions and H
+
 ions secretion. These cells of the collecting duct are also 
vasopressin sensitive to regulate the reabsorption/secretion of water 
depending on the actual fluid level in the body (Brenner, 2000; Valtin, 
1995) (Fig. 1.8). 
 
1.4 Stem cells in kidney regeneration  
Stem cells are unspecialised cells that have the ability to self-renew, and 
under the appropriate conditions, differentiate to generate a range of 
specialised cell types. Depending on their source, stem cells are classified 
as either adult stem cells or embryonic stem cells.   
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1.4.1 Adult stem cells 
Although adult stem cells (ASC) are present in many adult tissues: skin, 
hair follicle, corneal epithelium, respiratory system, dental pulp, digestive 
system, liver, salivary gland, kidney, mammary gland, prostate gland, 
endometrium, bone marrow, adipose tissue, pituitary gland, and brain  
(Diaz-Flores Jr. L., 2006), they are not very common and their location is 
restricted to specialized regions – the niches (Oliver, 2004). They are able 
to self-renew and keep their plasticity for long periods. Most adult stem 
cells are thought to be either unipotent, meaning that they can give rise to 
just one cell type, or multipotent, meaning they can give rise to a limited 
range of differentiated cell types. Within ASC, several types can be 
distinguished, including kidney stem cells (KSC) and bone marrow derived 
stem cells: mesenchymal stem cells (MSC) and hematopoietic stem cells 
(HSC), and amniotic fluid stem cells (AFSC).  
 
Kidney stem cells 
Localization of embryonic kidney progenitor cells within metanephroi 
(Oliver, 2002) gave hope to find adult kidney stem cells. Shortly 
afterwards, it was reported that adult stem cells were localized within the 
adult mouse kidney papilla and identified by BrdU staining. A population 
of these cells were able to divide and generate tubular epithelial cells in 
response to ischemic injury (Oliver, 2004). Adult kidney stem cells or so-
called multipotent renal progenitor cells were isolated from mouse kidney 
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and characterized by Gupta et al. (2006) as cells able to self-renew and 
expressing adult stem cell pluripotency markers: Oct4 and Pax2. These 
cells, supported by specific nephrogenic induction medium, were able to 
form cell aggregates in vitro. Undifferentiated cells injected into rat 
kidneys were able to integrate into injured tubules (Gupta, 2006). A tubular 
integration into rat embryonic kidneys ex vivo was obtained with use of 
BrdU positive cells isolated from adult rats‟ kidneys (Maeshima, 2006) and 
with Sca-1
+
Lin
-
 cells from adult mouse kidney (Dekel, 2006b). It was also 
possible to isolate human adult kidney stem cells using CD133 antibodies. 
These cells were Pax2 positive and underwent tubulogenesis following 
subcutaneous implantation into SCID mice (Bussolati, 2005). Following 
Bussolati‟s findings, Romagnani‟s group have isolated and characterised 
multipotent progenitor cells (CD133+CD24+) (Sagrinati, 2006), and 
demonstrated that these cells are able to regenerate injured podocytes and 
tubules (Ronconi, 2009). 
Although scientists have been successful in isolating adult kidney 
stem/progenitor cells and proved their potential to integrate into damaged 
kidney, most of these cells only integrate into tubules and form only 
tubular-like structures and only one type was shown to integrate into 
glomeruli (Ronconi, 2009). Nevertheless, KSC could be a good source of 
cells for stem cell therapies as they can be derived from the patient and 
hence the risk of graft rejection would be minimised. Moreover, there 
would be no need for administration of immunosuppressants. However, 
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KSC-based therapies might not be a feasible approach for many patients 
because if large proportion of renal tissue is already damaged, it might not 
be possible to isolate stem cells from biopsy samples. Furthermore, it is 
important to note that all of the human KSC lines that have been isolated to 
date have been derived from the unaffected areas of kidney containing 
malignant tumours. Therefore, it is possible that these KCS are actually 
tumour cells that have migrated from the main tumour mass. Therefore, 
other stem cell types are under investigation. 
 
Bone marrow-derived stem cells 
Adult bone marrow cells contain two populations of stem cells: 
mesenchymal stem cells (MSC) and hematopoietic stem cells (HSC). Both 
have been tested in the context of their potential to promote renal repair 
after injury. Renal repair was demonstrated after transplantation of mouse 
male bone marrow cells into mouse female kidneys; however it was not 
clear if the beneficial effect came from MSC or HSC (Poulsom, 2001). 
Later, it was shown that murine HSC (Rh
lo
Lin
-
Sca1
+
c-kit
+
 and CD45
+
 - 
hematopoietic marker) transplanted into mouse kidneys after 
ischemic/reperfusion injury can contribute to renal tubular regeneration 
(Lin, 2003) and possibly improve renal function by repopulation of 
glomerular podocytes in a mouse model of Alport Syndrome (Prodromidi, 
2006). However, in contrast with this study, Dekel showed HSC to have 
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only vasculogenic potential  and could not contribute to the formation of 
renal tubules (Dekel, 2006a).  
MSC (CD45
-
) were shown to promote tubular regeneration in acute renal 
failure (ARF) in a mouse model of cisplatin nephrotoxity (Morigi, 2004) 
and following the injection of hypertonic glycerol into muscle to induce 
rhabdomyolysis (Herrera, 2004). MSC were shown to protect animals from 
renal function impairment and prolong their lifespan (Morigi, 2010) probably 
by their paracrine effect, as they do not integrate into damaged tubules 
(Humphreys, 2008; Kunter, 2007).   
Bone marrow cells from transgenic rats carrying an EGFP cassette 
(enhanced green fluorescent protein) transplanted into rats with induced 
glomerulonephritis showed integration into host tissue: it was reported that 
60-70% of intraglomerularly integrated cells were of MSC origin (CD45
-
), 
while the remainder were of HSC (CD45
+
) origin. Therefore, MSC cells 
can also produce renal epithelial and glomerular mesanglial cells, but not 
podocyte cells (Ito, 2001). However, although in the short term post injury, 
MSC ameliorated renal functions, in the longer term, MSC that integrated 
into glomeruli maldifferentiated into adipocytes (Kunter, 2007). 
In one study, it has been shown that in the right environment, MSC do 
have the ability to be reprogrammed to generate renal cell types. Yokoo 
and co-workers showed that in a combination of whole-embryo culture 
followed by organ culture, human MSC (CD105
+
, CD166
+
, CD29
+
, CD44
+
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and CD14
-
, CD34
-
, CD45
-
) were able to generate functional nephrons 
when injected into a developing rat embryo ex vivo (Yokoo, 2005). 
The advantages of using mesenchymal stem cells are that these stem cells 
can be derived from patients, therefore minimizing the possibility of 
transplant immunorejection. However, although MSC were shown to 
generate all kidney cell types if introduced into the embryo at the site of the 
presumptive kidney (Yokoo, 2005) it would not be possible to perform this 
procedure with human embryos due to ethical issues. Moreover, although 
MSC promoted recovery from ARF, this seemed to be due to paracrine 
effects as they have limited integration abilities. Also, despite integration 
into glomeruli, these cells underwent maldifferentiation (Kunter, 2007) and 
therefore, although they could have the potential for promoting renal 
repair, they would not be able to replace lost nephrons, and would thus be 
of limited benefit in the treatment of chronic disease. 
 
Amniotic fluid stem cells 
A new stem cell source has been confirmed by the Hengstschlager group 
(Prusa, 2003), who have demonstrated that stem cells expressing Oct-4, a 
marker of embryonic stem cells and embryonic germ cells, could be 
isolated from amniotic fluid. Cells obtained from the amniotic cavity are 
heterogeneous; apart from showing Oct4 expression, they are also positive 
for mesenchymal stem cell markers  such as CD44, CD29, CD105, but are 
negative for hematopoietic stem cell markers CD45 and CD34 
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(Bossolasco, 2006; De Coppi, 2007; Tsai, 2004). AFSC have the capacity 
to differentiate into adipocytes, osteocytes, neuronal, myogenic, 
endothelial and hepatic cells (Bossolasco, 2006; De Coppi, 2007; Tsai, 
2004). More recently, it was shown that AFSC can integrate into kidney 
rudiments and differentiate into tubular cells (Perin, 2007). However, in 
this study, the authors showed expression of only one human kidney 
specific marker expression (GDNF) and two specific for tight junctions 
(ZO-1, Claudin) which can be found in any epithelium. Therefore, it would 
be interesting to analyse for the presence of other kidney specific markers: 
nephrin, podocin, aquaporin 1 and 2, synaptopodin, proximal and distal 
tubules markers. 
Although the potential of AFSC needs to be further investigated, they 
represent an interesting intermediate stage between embryonic stem cells 
(ESC) and lineage-restricted adult stem cells. These cells could overcome 
problems with ethical use of ESC, but also graft rejection in allogeneic 
transplantations, presenting an opportunity to build an AFSC bank to 
provide cells for autologous transplants. However, the heterogeneity of 
cells from amniocentesis is limiting the final number of AFSC to be 
isolated. 
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1.4.2 Embryonic stem cells 
Embryonic stem cells (ESC) are derived from the inner cell mass (ICM) of 
blastocyst at stage 4 to 5 days of the developing embryo. First, mouse ES 
cells were isolated in 1981 independently by Evans and Martin (Evans, 
1981; Martin, 1981), and human ESC were isolated in 1998 by Thomson 
(Thomson, 1998). Although both mouse and human ESC (hESC) are able 
to self-renew and show pluripotency, it is thought that they are not 
equivalent. For instance, there are differences in their growth requirements; 
mouse ESC (mESC) maintain pluripotency in the presence of mouse 
leukaemia inhibitory factor (LIF) whereas hESC do not respond to LIF and 
need to be cultured on mouse embryonic fibroblasts (MEFs) cells 
(Humphrey, 2004) or on special matrix (Koestenbauer, 2006; Stojkovic, 
2005). Furthermore, hESC culture conditions require supplementation with 
FGF (Xu, 2005), whereas this factor promotes mESC differentiation 
(Stavridis, 2003). Recently it was shown that hESC are likely to be at a 
later stage of development than mESC, more closely resembling mouse 
epiblast stem cells (mEpiSC). In support of this, it has been shown that the 
growth requirements and expression profile of mouse epiblast stem cells is 
very similar to that of hESC (Nichols, 2009a; Tesar, 2007). 
Unlike ASC, ESC are pluripotent, meaning that they are able to give rise to 
cells of all three germ layers of the embryo: mesoderm, endoderm and 
ectoderm, as well as the gametes following transplantation into the mouse 
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blastocyst (Nagy, 1993). They are also able to generate cells of the three 
germ layers in vitro when cultured as embryoid bodies (EBs) – a cellular 
aggregate that forms when ESC are cultured in suspension, the 
development of which resembles that of the early embryo. Furthermore, 
mESC are immortal cells that do not become senescent or lose their 
potential (Evans, 1981). It was also reported, that human ES cells form 
teratomas containing: gut epithelium, cartilage, bone, smooth muscle, 
neural epithelium nephron-like structures following subcutaneous injection 
of adult mice (Stojkovic, 2005; Thomson, 1998; Yamamoto, 2006). 
However, although ESC have the potential to form tumours, they are a 
good tool to investigate the potency of ES cells in vivo.  
The first study investigating the potential of mESC to develop kidney 
structures and integrate with host tissue involved injecting undifferentiated 
mESC into kidney rudiments ex vivo. Injected cells showed tubular 
integration with the host tissue, but with low efficiency (Steenhard, 2005). 
Therefore, in an attempt to improve the integration potential, subsequent 
studies used the EB culture system to differentiate the cells (Kim, 2005; 
Kramer, 2006; Yamamoto, 2006). mESC differentiated via EBs showed 
formation of ring-like structures which were positive for podocin, nephrin, 
podocalyxin and cytokeratin and tamm-horsfall glycoprotein (THP). This 
implied that these cells were differentiating into proximal and distal tubules 
of the nephrons; however, this was only investigated in vitro (Kramer, 
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2006). In a different study, following mESC differentiations using the EB 
system, cells were induced with a nephrogenic cocktail of retinoic acid, 
activin A and BMP4. Following stimulation with this nephrogenic cocktail, 
the majority of mESC contributed to tubular epithelia following injection 
into kidney rudiments ex vivo (Kim, 2005).  
Yamamoto and co-workers used the ability of mESC to form teratomas in 
order to investigate mESC potential to differentiate into renal tissue. 
Following EB differentiation, cells were disaggregated and injected 
subcutaneously to generate tumours. Following 14 and 28 days of growth, 
tumours were investigated for the presence of kidney markers such as 
Pax2, endo A cytokeratin and Ksp-cadherin, which confirmed renal fate of 
some cells of the tumour. However, many of the injected cells formed 
other cell types (Yamamoto, 2006). Work by Wilson‟s group showed 
integration of pre-differentiated mESC into the proximal tubules of the 
kidney rudiments in culture and kidneys of newborn mice in vivo. 
Similarly, this study used suspension culture to differentiate mESC to 
express markers such as Pax2, Wt-1, Wnt4 and cadh-11. By 
predifferentiating the cells prior to integration, it was possible to obtain 
renal differentiation of cells without tumour formation (Vigneau, 2007).  
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1.4.3 Induced pluripotent stem cells (iPSC) 
In the 2006 first report informing about possibility of generating induced 
pluripotent stem cells (iPSC) from mouse embryonic and adult fibroblast 
cells was published (Takahashi, 2006). These first somatic cells were 
induced to become pluripotent with use of four defined factors: Oct3/4, 
Sox2, c-Myc and Klf4. Although those iPSC showed morphology similar 
to ESC they were not identical as their genes profile was different from 
ESC and they did not shown full pluripotency due to being unable to form 
chimeras (Takahashi, 2006). Therefore further modifications were 
undertaken and instead of using only defined factors, endogenous Nanog 
(Okita, 2007; Wernig, 2007) or Oct4 (Wernig, 2007) were activated. Both, 
Nanog-iPSC and Oct4-iPSC showed ability to form embryoid bodies; 
tumours with ecto-, endo-, and meso-dermal cells structures; contributed 
into germ layers; formed chimeras and did not become senescent over 26 
passages. Their genes expression profile was highly comparable with ESC 
(Okita, 2007; Wernig, 2007). Also female iPSC displayed the same 
dynamics of X chromosome inactivation as female ESC (Maherali, 2007). 
Therefore, in iPSC (Nanog and Oct4) pluripotent state is maintained by 
endogenous pluripotency genes activation and iPSC show most if not all 
attributes of ESC. However, iPSC are very similar to ESC considering their 
behaviour and differentiation abilities, they are also easily accessible as can 
be derived from patients‟ skin fibroblast cells. This would significantly 
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reduce possibility of graft rejection. Nevertheless, the nephrogenic 
potential of iPSC has not yet been investigated.  
 
 
Table 2 Summary of in vitro, in vivo and ex vivo studies of ability of different stem 
cell types to show renal fate. 
  ? – not yet reported,  
 
Although the aforementioned studies show that stem cells have the 
potential to generate some renal specific cell types, at present, it is 
unknown if any of them are capable of generating the entire range of cell 
types necessary to constitute a functional nephron. Moreover, following 
transplantation into embryonic, neonatal kidneys or mouse models of 
kidney disease, it appears that all of the investigated cell types so far are 
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unable to generate the entire range of nephron cells. Therefore, although 
mESC derivatives showed good potential in regard of tubular cell 
differentiation and integration, it will be important to establish if they are 
capable of generating podocytes within the kidney environment. 
Furthermore, it will be important to establish if the ESC-derived renal cell 
types are functional. 
 
1.5  Cell labelling methods 
In regard of cell therapies it is very important to be able to identify a label 
that enables monitoring of cells following transplantation in in vivo studies. 
A number of labels are already well-established for the aforementioned 
purpose, and will be described here. 
1.5.1 GFP 
The most commonly used cell label is GFP (green fluorescent protein) or 
other fluorescent proteins such as RFP (red), YFP (yellow), BFP (blue). 
These fluorescent labels are most often delivered to cells using a knock-in 
strategy (Misteli, 1997): GFP is inserted under the control of a ubiquitously 
active promoter for ubiquitous expression (Sieberta, 2008) or GFP is 
inserted under the control of specifically active gene promoter (Fehling, 
2003) for regulated expression. This method allows for long term 
observations of cell/tissue movement and requires the generation of 
transgenic animals. Following appropriate selection, one can obtain 100% 
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efficiency of stable integration (Nagy, 2003), however, there are reports of 
GFP and RFP being toxic for cells (Strack, 2008; Taghizadeh, 2008), and 
the toxicity can depend on the gene insertion locus, protein concentration 
and/or cell type, and may lead to kidney defects in transgenic animals 
(Guo, 2007). Another method of delivery of fluorescent proteins to the 
cells is via lentiviral transfection. Viral vectors can integrate and stably 
express fluorescent proteins under the control of either viral or cellular 
promoters  (Blomer, 1997; Zhou, 2009). Although lentiviral transfection is 
rather simple, the use of primate viruses (Poeschla, 1998) and any other 
viruses raises safety issues for medical  applications. 
 
1.5.2   Vital stains 
Vital stains are used to label living cells in order to investigate their 
motility following transplantation ex vivo or in vivo. These labels include 
extracellular lipid dyes such as DiI, intracellular protein dyes such as 
vybrant dye (VD) and small nanocrystals – quantum dots (QDs). 
The lipophilic dye – DiI (red) binds to the outer layer of lipids in the cell 
membrane. It was used to label cells in culture (Ragnarson, 1992) and post-
mortem (von Bartheld, 1990). The strength of the dye strongly depends on 
the dye concentration and due to cell divisions, diminishes within a couple 
of days following labelling (Ragnarson, 1992). The DiI binds to the lipids 
in the outer layer of the plasma membrane, and due to membrane dynamics 
such as endocytosis, can be internalised by the cell. The dye can also be 
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transferred between the lipid bilayers of contacting cells (Razinkov, 1999; 
Zimmerberg, 1999).  
The protein dye – VD (CFDA SE – carboxyfluorescein diacetate, 
succinimidyl ester, Invitrogen) binds to intracellular proteins. It passively 
diffuses into the cells, when the cell membrane permeability was increased 
by DMSO. Similarly to DiI, the strength of VD depends on the dye 
concentration and cell type (Wang, 2005c). During cell divisions, the dye 
is transferred to all daughter cells, but is diluted by 50% with each division 
(Lyons, 2000).  
Another labelling method of living cells that allows for cell tracking is QD 
labelling. QDs are small nanocrystals that can be of many colours: green, 
red, yellow, different shades of blue (Lin, 2007), which are stably located 
in cytoplasmic vesicles (Rosen, 2007). Although QDs present high 
labelling efficiency, the label up-take and maintenance depends on the cell 
type (Lin, 2007; Rosen, 2007). QDs were showed to be resistant for 
photobleaching (Solanki, 2008) and therefore prolonging the imaging time. 
Moreover, QDs are up-taken by all cell types, but the coating can be 
modified with different ligands or antibodies, that would allow targeting 
specific cells (Gao, 2004; Gao, 2005; Kim, 2008; Koshman, 2008; Lidke, 
2004) and therefore presenting potential clinical use. However, due to 
toxicity of the QD core (CdSe) it is unlikely to happen.  
In spite of high efficiency of labelling, DiI, VD and QDs are diluted with 
every cell division (Parish, 1999) and therefore not suitable for labelling of 
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rapidly dividing cells (Lin, 2007; Rosen, 2007; Sechrist, 1989; von 
Bartheld, 1990; Wang, 1989). However, the longevity of each type of label 
can differ and should be investigated and optimised for the cell types and 
experimental settings used. 
 
1.6 Hypothesis  
Many stem cell types show potential for promoting renal repair and/or 
regeneration (see chapter 1.4); however, given the ability to generate 
derivatives of all three germ layers, it is likely that ESC have the greatest 
potential to generate all cell types of the nephron. Previous work has 
shown that if ESC are differentiated towards the renal lineage (identified 
by  expression of kidney markers: Pax2, Wt1, Wnt4 and cadherin11),  prior 
to transplantation into embryonic and neonatal kidney, they are able to 
integrate into kidney tubules without tumour formation (Vigneau, 2007).   
       
Fig.1.9 Schematic of the hypothesis investigated in the current study. Differentiation 
of mES cells into mesoderm should give better integration into mouse kidney rudiments 
than undifferentiated ES cells. 
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The study of kidney organogenesis revealed that kidneys develop form 
mesoderm (Saxen, 1987). Mesoderm is recognized as a Brachyury  
(T, Bry) expressing cells (a known mesodermal marker (Rivera-Perez, 
2005). Therefore, the hypothesis of the current study was that ESC already 
differentiated into mesoderm (to express Bry) thus will present a higher 
potential for kidney cell generation, than undifferentiated ESC. 
 
1.7 Aims 
The possibility of healing kidney diseases with stem cell therapy is 
becomming more feasible, and in the future, could be a useful alternative 
to dialysis and renal transplantations. Embryonic stem cells have the 
potential to generate all kinds of cell types of the body (Nagy, 1993), but 
on the other hand, these cells have tumourigenic potential (Yamamoto, 
2006). Nevertheless, Vigneau (2007) showed that the tumourigenic 
potential of embryonic stem cells could be reduced, or even eliminated by 
differentiating them into kidney linage. However, this study did not show 
intraglomerular integration and differentiation into podocytes. There is a 
lack of studies investigating the effect of exogenous cells on the host tissue 
and of functional studies, to prove that integrated cells actually function 
properly to their location. 
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The aim of this study was to investigate: 
 in the first instance, how the differentiation of embryonic stem 
cells into mesoderm, prior to injection into kidney rudiments, 
improves their ability to integrate with embryonic kidneys 
 if kidney progenitor cells, ESC or their derivatives can have a 
detrimental effect on kidney development ex vivo 
 if investigated cells, following integration, would still present a 
characteristic of undifferentiated cells 
 and finally, whether or not the cells display any functionality. 
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Chapter 2: Materials and methods 
2.1 Cell lines 
2.1.1 Embryonic stem cells 
The E14 mouse embryonic stem cell (mESC) line was originally derived 
from the inbred mouse strain 129/Ola in 1985 by Martin Hooper in 
Edinburgh, Scotland, UK. The E14.1a ESC line used here was obtained 
from the Mark Boyd Laboratory at the University of Liverpool.  
Mouse Bry-GFP knock-in ESC were given to our lab by Georges Lacaud 
(Paterson Institute for Cancer Research, Manchester).  All information 
about the construct can be found in the following paper: Fehling, et al., 
2003. Fig. 2.1 presents a construct map published in the aforementioned 
paper (Fehling, 2003). 
 
 
Figure 2.1 Construct of Bry-GFP cell line. EGFP was knocked into the Bry locus, 
into the first exon of the Bry gene (Fehling, 2003). 
 
2.1.2 Feeder cells 
Mouse embryonic fibroblast (MEF) cells were isolated from decapitated 
and eviscerated mouse embryos at embryonic day E11.5 – E12.5. MEFs 
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were isolated from mouse embryos at embryonic day E11.5 – E12.5. 
Embryos were decapitated and eviscerated in PBS
Ca+Mg+
. Eviscerated 
embryos were transferred onto fresh petri dish and minced into small 
pieces, which were then incubated for 20-30 min in 0.25% trypsin/EDTA 
solution at 37°C. Following incubation, the trypsin reaction was stopped 
with complete MEF medium (see 2.17 for protocols).  Cells were seeded at 
a density of 1 embryo per 10 cm culture dish (Corning Incorporated) and 
incubated at 37°C and 5%CO2. After 3-4 days cells were at ~90% 
confluence and were either frozen or used for feeder cell preparation. 
2.2 Cell freezing protocol 
The cell freezing protocol used in this work was as follows. Firstly, cells 
cultured on 3.5 cm dishes were washed 2x with 2 ml of PBS (Phosphate 
Buffered Saline) and cells were trypsinized as follows: 2 ml of 1x 
trypsin/EDTA (Sigma) solution was added to each dish. The cells were 
then transferred into an incubator at 37°C for 3-5 min. Following 
incubation, the trypsin reaction was terminated with 2 ml of 10% FCS 
(Foetal Calf Serum) DMEM medium (see 2.17 for protocol) and cells were 
transferred into a 15 ml conical tube and centrifuged at 100x g for 2.5 min.  
After spinning, the supernatant was discarded and cells were resuspended 
in 1 ml of freezing recovery medium (Invitrogen) per trypsinized dish. 
Then, 0.5 ml of resuspended cells was transferred into cryovials labelled 
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with cell type, passage number and date. Cryovials were then placed into a 
freezing chamber, filled with isopropanol, and placed in a -80°C freezer for 
overnight incubation. This allowed for slow decrease in temperature by 
1°C per hour. Following freezing, cells were transferred into liquid 
nitrogen container.  
2.3 Cell thawing protocol 
To thaw cells, the following protocol has been used in this work. The 
cryovials containing frozen cells were rapidly thawed by placing vials into 
a 37° C water bath. As soon as the cells thawed, they were transferred into 
a 15 ml conical tube and 2 ml of 10%FCS DMEM medium was added and 
the cells were centrifuged at 100x g for 2.5 min. Pelleted cells were then 
resuspended in appropriate medium, ESC medium for embryonic stem 
cells or MEF medium for MEF cells (see 2.17 for protocol). The cells were 
cultured in the incubator at 37°C and 5% (v/v) CO2. Medium was changed 
every other day. 
2.4 Gelatinization protocol 
To culture MEF cells or ES cells without MEF feeder layer, culture dishes 
were coated with 0.1% (w/v) gelatine solution in PBS (see 2.17 for 
protocol). 2 ml of 0.1% (w/v) gelatine was added to the cell culture dish 
and incubated at room temperature for at least 15 min. Following 
incubation, the dishes were washed 3x 5min with warm PBS. 
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2.5 Cell counting 
In order to count cells, cells were trypsinized as described in section 2.2 
and were collected in 15 ml falcon tube in 5ml of appropriate media. 10μl 
were collected from the cell suspension and mixed with 10μl of trypan blue 
(Sigma) in a 0.2ml tube (Eppendorf). 10μl of the cells solution was 
transferred onto hematocytometer (Hausser Scientific) and cells were 
observed down the microscope using 10x objective. Cells were counted in 
four squares and average number (A) of cells per square was calculated. 
Obtained average number of cells was multiplied by a chamber factor (10
4
) 
and trypan blue dilution factor (2) which gave the number of cells in 1 ml. 
Required number of cells was calculated using cross-multiplication 
formula and diluted in appropriate amount of medium.  
2.6 Cell culture 
2.6.1 MEF culture 
MEF (mouse embryonic fibroblast) cells were maintained in gelatinized 
tissue culture dishes in MEF medium (see 2.17 for protocol) in a 
humidified atmosphere at 37C with 5% (v/v) CO2 in air.  
 
2.6.2 Preparation of MEFs as a feeder layers 
MEF cells at passage 1 (P1) were thawed and seeded on a 10 cm dish 
(Corning Incorporated). After a few days, when cells were ~90% confluent 
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they were split 1:3 every 3 days on 10 cm gelatinized dishes until passage 
4 (P4). Confluent dishes of MEF cells at P4 were treated with Mitomycin 
C (2mg/ml, Sigma) to arrest cells from further mitotic divisions. To obtain 
a final concentration of Mitomycin C of 20μg/ml, 5 ml of MEF medium 
was left in the dish and 100 μl of Mitomycin C added. The dish was gently 
agitated to ensure that the Mitomycin C was evenly distributed and was 
incubated for 2-3 hours in humidified incubator at 37ºC and 5% (v/v) CO2 
in air. Following incubation with Mitomycin C, MEF cells were washed 
twice with 1xPBS (Invitrogen / Gibco) and trypsinized as described in 
section 2.2. Following trypsinization and centrifugation the supernatant 
was aspirated and the cell pellet resuspended in appropriate amount of 
freezing recovery cell medium (Invitrogen) to give a final cell density of 
2x10
6
 cells per 1 ml.  Cells were then placed in freezing vials (1 ml / vial) 
and frozen as described in section 2.2. When needed, vial(s) of inactivated 
MEF cells were thawed using the protocol described in section 2.3 and 
cells were typically split 1:3 on 3.5cm gelatinized dishes (Nunc). The 
dishes were gently agitated before replacing in the incubator. MEF cells 
were ready to use as a feeder for Bry-GFP cells after overnight (ON) 
incubation. 
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2.6.3 Routine ES culture 
E14 Bry-GFP mESC were maintained in gelatinized tissue culture dishes, 
coated with MEF feeder cells, in ESC medium (see 2.17 for protocol) in a 
humidified atmosphere at 37C with 5% (v/v) CO2 in air.  
Cells were typically cultured on MEFs feeders and split 1:4 every 3 to 4 
days. Cells were trypsinized as described in section 2.2. The supernatant 
was aspirated and the cell pellet resuspended in 6 ml ESC medium and 2 
ml of the cell suspension was transferred to each dish. The dishes were 
gently agitated before replacing in the incubator. Medium was changed 
every other day. 
 
2.7 Differentiation of mouse embryonic stem cells 
2.7.1 Monolayer differentiation protocol 
For differentiation of mESC in monolayer culture, Bry-GFP cells were 
cultured typically for a few passages on MEF feeder cells in ESC medium,  
then transferred onto 3.5cm gelatinized dishes (Nunc) for 2 passages (in 
order to deplete the number of MEF cells) before setting up a 
differentiation experiment. Following the second passage on gelatinized 
dishes, cells were trypsinized as described in section 2.2 and resuspended 
in ES monolayer differentiation medium; either 10% FCS DMEM or 10% 
FCS IMDM both supplemented with 2ng/ml Activin A (R&D Systems) 
and 0.25ng/ml BMP4 (R&D Systems) (see 2.17 for protocols) and plated 
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on 3.5cm dishes (Nunc) at 3 different densities: 500 cells cm
-2
, 1000 cells 
cm
-2
, 2500 cells cm
-2
, counted as described in section 2.5. Medium was 
changed on a daily basis.  
 
2.7.2 Suspension differentiation protocol 
For differentiation of mESC in suspension culture, Bry-GFP ESC were 
used to make embryoid bodies. For that purpose Bry-GFP cells were 
cultured typically for a few passages on MEF feeder cells in the ESC 
medium, then transferred onto 3.5cm gelatinized dishes (Nunc) for 2 
passages (in order to deplete number of MEF cells in EB culture) before 
setting up an embryoid body culture. During the first passage on gelatine 
cells were cultured in ESC medium, and during second passage, cells were 
cultured in ES/EB medium (see 2.17 for protocols).  Following the second 
passage on gelatinized dishes, cells were trypsinized as described in section 
2.2, and resuspended in the EB medium (see 2.17 for protocols). Cells 
were seeded onto non-adherent dishes that were treated with detergent, 
Pluronic (Sigma) to further reduce adhesion. Pluronic was prepared fresh 
before pouring onto dishes. 2 ml of the pluronic at a concentration of 
0.01% (w/v) in PBS was added to 3.5 cm petri dishes (Sarsted) and 
incubated at room temperature for at least 20 min. Following incubation, 
dishes were washed 3x 3min with 1x warm PBS and used immediately. 
Cells were counted as described in section 2.5 and seeded at different 
densities in suspension: low cell densities: 5x10
3
 cells ml
-1
, 25x10
3
 cells 
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ml
-1
, 50x10
3
 cells ml
-1
, 75x10
3
 cells ml
-1
, 1x10
5
 cells ml
-1
, and high cell 
densities: 25x10
4
 cells ml
-1
, 50x10
4
 cells ml
-1
, 75x10
4
 cells ml
-1
 and 1x10
6
 
cells ml
-1
. Onto each dish treated with Pluronic, 2 ml of cell suspension 
were added and kept in culture for up to 20 days. Culture medium was 
changed every 2 days and if necessary, EBs were transferred to new petri 
dishes prepared as described above. 
 
2.7.3 Preparation of embryoid bodies for FACS sorting 
EBs at day 4 or 6 of development were disaggregated using 1x trypsin 
(Sigma) in PBS (Invitrogen) solution. For that purpose, EBs were 
transferred into a 15 ml conical tube and allowed to settle under gravity. 
Medium was aspirated and EBs were washed with 1x PBS and 3 ml of 1x 
trypsin solution was added to the EBs pellet and incubated in 37°C (in the 
water bath) for 3-5 min. Following incubation EBs were vigorously 
pipetted and incubated for 10 min in 3 ml of 10%FCS DMEM medium to 
stop trypsin reaction, and again vigorously pipetted to give single cell 
suspension.  
In order to prepare cells for FACS sorting analysis, cells were centrifuged 
for 2.5 min at 100x g, following which, medium was discarded and 
replaced with 0.1% bovine serum albumin (BSA; Sigma) in  
PBS
Ca+ Mg+
 solution and vigorously pipetted to single cell suspension. Cells 
were counted as described in section 2.5 and diluted to obtain a final 
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concentration of 1x10
6
 cells ml
-1
. Such prepared cells were ready to be 
sorted. 
 
2.7.4 FACS sorting 
Firstly GFP-positive (GFP+) cells number was established by counting 
using BD Calibur FACS machine, and obtained data were analysed with 
WinMDI software.  
The FACS Ventage SE (BD Biosciences) was used to sort GFP+ and GFP- 
cells. Before sorting FACS machine was cleaned to ensure sterile 
conditions for sorting.  After alignments and calibrations conducted with 
fluorescent three colour beads (BD Biosciences), the FACS machine was 
ready to count cells. Before sorting, more optimisations were done to 
establish the best drop off point and align side streams to be smooth, after 
which FACS was ready to sort. First, a solution of negative control of non-
fluorescent cells (treated the same way as those to be sorted, but not 
transfected with GFP) was used to establish the level of cell auto 
fluorescence. Following this final alignment, cells prepared as described 
above (see section 2.6.3), were sorted into polystyrene tubes (Falcon) filled 
with 1ml 10%FCS DMEM medium to prevent cell adhesion to the tube 
walls. Sorted cells (GFP+ and GFP-) were kept in the incubator at 37°C 
until the required number of cells was sorted. FACS data obtained from 
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FACS Ventage SE machine were analysed with use of Cell Quest PRO 
software.  
2.7.5 Cytospin of cells 
EBs at day 14 of culture were disaggregated as described above (see 
section 2.6.3).  Cells were counted and density was adjusted to give a final 
concentration of 1x10
5
 cells ml
-1
 in PBS and cytospinned using Cytospin3 
(Shandon Scientific Limited). Glass slides were subbed prior to use (see 
section 2.12) and cells were fixed following the spin. 
 
2.8 Organ dissection 
2.8.1 Dissection of embryonic kidney rudiments 
Mouse embryos at embryonic day (E) 11.5 and 13.5 were dissected from 
timed mated CD1 mice (Charles River) as follows. Firstly, mice were 
sacrificed as stated in Schedule 1 procedure (Home Office Regulations) by 
cervical dislocation. The uterine horns were dissected at room temperature 
and placed into L-15 medium (Invitrogen / Gibco) supplemented with 1% 
(v/v) FCS and embryos were then removed from extraembryonic 
membranes and placed into the same medium on ice.  
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Figure 2.2 Kidney rudiment dissection from mouse embryos at embryonic day  
(E) 11.5. 
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Kidney rudiments were dissected using a stereoscopic microscope (LEICA 
MZFLIII) from the mouse embryos as follows. Firstly, the embryos were 
decapitated as stated in Schedule 1 procedure (Home Office Regulations).   
Following the decapitation all organs were removed starting from the heart 
and lungs through the liver and gut. The nephrogenic ridge of mesonephros 
and early developing metanephros could now be observed. Before 
dissecting the metanephros, the dorsal aorta was carefully removed. At 
E11.5 the kidney rudiments have a characteristic morphology (Fig. 2.2).  
Following dissection, the kidney rudiments were transferred onto isopore 
(1.2μm) membrane filters (Millipore) placed on a metal grid (Fig. 2.3) and 
filled with kidney culture medium (see section 2.17 for protocols) just 
below the level of metal grid.  
Kidney rudiments were then transferred and cultured in a humidified 
atmosphere at 37C with 5% (v/v) CO2 in air.  
                                  
 
Figure 2.3 Kidney rudiment culture conditions. 
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2.8.2 Dissection and disaggregation of neonatal kidney  
Neonatal mice were sacrificed using increasing concentrations of CO2 in 
air as described in Schedule 1 procedure of Home Office Regulations. The 
neonatal kidneys were dissected from 6-10 day old mice (CD1) (University 
of Liverpool) and transferred into 1x PBS (Invitrogen). 
The kidneys were disaggregated as follows: first, kidneys were cut into 
~1mm
2
 pieces and transferred into a 15 ml conical tube containing PBS. 
After the tissue fragments had settled at the bottom of the tube the PBS 
was aspirated and replaced with Hank‟s buffered saline solution (1x HBSS 
with Ca
2+
 and Mg
2+
) (Invitrogen ).  After the tissue fragments had settled at 
the bottom of the tube, the HBSS buffer was then removed and replaced 
with 5 ml of warm (37ºC) Collagenase I (Sigma) in HBSS buffer solution 
and incubated at 37ºC for 20 min. After incubation, the digested kidney 
tissue was aspirated into the syringe and passed through a 23-gauge needle 
twice. The procedure was repeated with a 26-gauge needle. Following 
disaggregation, the cell suspension was centrifuged at 100x g for 2.5 min. 
The supernatant was then aspirated and renal cells were resuspended in a 
kidney culture medium and placed into gelatinized cell culture dishes. The 
samples were incubated in a humidified atmosphere at 37C with 5% (v/v) 
CO2 in the air. The renal cells were fixed with 4% PFA for immunostaining 
after 24h of culture. 
 
 73 
2.9 Integration of cells into developing kidney 
Cell of interest (Bry
+
 cells sorted from EB day 4; Bry
-
 cells sorted from EB 
day 4; ESC, embryonic kidney cells) were labelled with Quantum Dots 
(Sigma) as described in chapter 2.9.1 and mixed with disaggregated 
embryonic kidneys. The cell integration method was developed in Davis 
Lab (University of Edinburgh) (Unbekandt, 2010) and a slightly modified 
version was used here. Embryonic kidneys were isolated from mouse 
embryos at E13.5 as described in chapter 2.8, collected in 1.5 ml 
microcentrifuge tubes, washed once with 1x PBS and trypsinized in 1x 
trypsin/EDTA solution for 5-7 min at 37°C. After 4 min of incubation 
kidneys were pipetted and left at 37°C for the remaining incubation time 
(until kidneys formed single cell suspension). The trypsin reaction was 
stopped using 10% FCS DMEM medium and cells were incubated at 37°C 
for 10 min. Cells were then pipetted and centrifuged at 1400x g for 1 min. 
The supernatant was discarded and pelleted cells resuspended in kidney 
culture medium (see chapter 2.17 for protocols).  
QDs-labelled cells and kidney cells were counted as describe n section 2.5 
and mixed in a ratio of 1:8 (one labelled cell for eight unlabelled kidney 
cells) in 0.5 ml microcentrifuge tubes (Fig. 2.4). Cells were centrifuged at 
1400x g for 3min, and pellets were transferred onto isopore membrane 
filters (Millipore) and cultured for up to 7 days as shown on figure 2.3, in a 
humidified incubator at 37°C and 5% CO2. For the first 24h of incubation a 
Rho kinase (ROCK) inhibitor (Y27632, 5mM, Sigma) was applied to 
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obtain final concentration of 5μl ml-1. Medium was changed every second 
day. Samples were collected for fixation in cold methanol and 
immunostaining after 3h (day0), 24h (day1), 48h (day2), 72h (day3), 120h 
(day5) or 168h (day7) of culture.  
 
 
 Figure 2.4 Preparation of nephrogenic chimeras.  
 
2.10 Cell labelling 
2.10.1 Quantum dots labelling 
Cells of interest were labelled with Quantum Dots (QDs) (Invitrogen, 
Qtracker® Cell Labelling Kit (Q25021MP)) in order to enable localization 
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of the cells within cultured kidney chimeras. Cells were labelled with QDs 
as recommended by supplier. Briefly, component A and component B of 
QDs (1μl of each component) were pipetted into a microcentrifuge tube 
and incubated for 5 min at room temperature. Following incubation, 200 μl 
of complete growth medium (kidney culture medium), was added to the 
QDs solution to obtain concentration of QDs at 10nM, and vortexed for 30 
sec. Such prepared QDs-medium was applied to cells growing in a 
monolayer (adherent cells) or to trypsinized cells (suspension cells) and 
incubated for 45-60 min in the incubator at 37°C and 5% CO2. Following 
incubation time, cells were washed 4x with complete growth medium and 
cultured for 1, 3 and 7 days.  
 
2.10.2 Vybrant dye labelling 
Cells of interest were labelled with Vybrant dye (Invitrogen, Vybrant® 
CFDA SE Cell Tracer Kit (V12883)) in order to compare the labelling 
efficiency and dye retention to quantum dots. Cells were labelled as 
recommended by supplier. Briefly, following the preparation of Vybrant 
dye (VD) stock by dissolving component A (VD) with component B 
(DMSO), 1μl of the stock was added to 1ml of prewarmed PBS (37°C) (to 
obtain a concentration of 10nM). Such prepared dye was added to the cells 
and incubated for a 15 min in the incubator at 37°C and 5% CO2. 
Following incubation with dye, cells were incubated for further 30 min at 
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37°C in the culture medium to ensure complete modification of the probe. 
Next, cells were seeded on the culture dishes at a density of 500 cells cm
-2
 
and cultured for 1, 3 and 7 days.  
2.10.3 Lentivirus transduction 
KSC clonal line H6 was transduced with a pHR-SFFV-GFP lentiviral-
derived vector constitutively expressing green fluorescent protein (GFP) 
under the control of spleen focus-forming virus (SFFV) promoter. On the 
day of transfection KSC-H6 cells were trypsinized and seeded into a fresh 
tissue culture dish, then 110l of lentivirus supernatant, was added to the 
culture medium (final volume 3ml). The cells were incubated with the 
supernatant for 6 hours at 37°C and 5% CO2. Following the incubation 
time the medium was completely replaced with fresh culture medium. The 
presence of H6 GFP-expressing cells (KSC-H6/GFP
+
) was verified by 
observing the cells under a Leica DMIL fluorescent microscope (Leica, 
Heidelberg, Germany) and by FACS (FACS Ventage SE; BD Biosciences) 
and was first found 96h post transduction. KSC-H6/GFP
+
 cells were 
transduced by E. Ranghini (University of Liverpool) and used to determine 
the transfer of QDs from KSC-H6/GFP
+
 cells to kidney GFP- cells.  
 
2.11 Functionality assay 
Cells used to form kidney chimeras were investigated for their 
functionality. This was achieved by investigating the function of the 
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organic anion transporters (OATs) of the proximal tubules. A slightly 
modified method of that described by Sweet (2006) and Rosines (2007) 
was used (Rosines, 2007; Sweet, 2006). Briefly, chimeras grown for 4, 5 
and 6 days in culture, were washed twice in 1x PBS
Ca+Mg+
 for 5 min. 
Following washes, samples were transferred into 1 μM 6-
carboxyfluorescein (6-CF) solution (Sigma) in PBS
Ca+Mg+
 and PNA 
rhodamine (Peanut Agglutinin Lectin, PNArh) (20μg/ml) (Vector Lab.) 
and incubated at 25°C for 1 hour in the dark. Control samples were 
incubated in OATs blocking solution composed of 2 mM probenecid 
(Sigma) in PBS
Ca+Mg+, 1 μM 6-CF and PNArh (20μg/ml).  Following 
incubation, samples were washed twice in ice-cold PBS
Ca+Mg+
 to remove 
background staining. In order to block further OAT function, samples were 
blocked in 8 mM probenecid in PBS
Ca+Mg+
 solution for 15 min. After 
blocking, samples were transferred onto glass slip and covered with 80% 
(v/v) glycerol and cover slip. Such prepared samples were immediately 
imaged using confocal fluorescent microscope (LEICA AOBS SP2).  
 
2.12 Subbing slides protocol 
Slides were soaked in 100% ethanol for 15 min, and then washed 5x in 
distilled water. Following final wash slides were transferred for 25 sec into 
subbing solution (see section 2.17 for protocols) consisting of 0.5% (w/v) 
gelatine and 0.05% (w/v) chromium potassium solution in distilled water. 
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After incubation slides were allowed to dry in a dust-free environment and 
were ready to use for collection of frozen tissues sections or cytospinned 
cells. 
2.13 Fixation 
2.13.1 Fixation of cells  
Embryonic stem cells and cytospinned cells were fixed in 4% (w/v) PFA 
(paraformaldehyde) (see section 2.17 for protocols) for 10 min in the dark 
at room temperature. Following fixation, samples were washed 3x 5 min in 
PBS and stored in PBS at 4°C until they were used for immunostaining. 
2.13.2 Fixation of embryoid bodies and sectioning 
Embryoid bodies (EB) were collected in a 15 ml conical tube and allowed 
to settle under gravity, the supernatant was discarded and EBs were fixed 
in 4% PFA in the dark at room temperature. The timing of fixation 
depended on the age of EBs (see Tab. 2.1). Following fixation, EBs were 
washed 3x 10 min in PBS and soaked in 15% (w/v) sucrose solution (see 
section 2.17 for protocols) for overnight incubation at 4°C. On the next 
day, the sucrose solution was aspirated and EBs were transferred into the 
middle of small freezing cubes (Polysciences Ltd.) containing embedding 
medium (Bright Instrument Company Ltd.), and frozen in cold isopentane 
(isopentane on dry ice). Following freezing, EBs were stored at -20°C until 
used for sectioning.  
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Frozen sections of 8-10µm were prepared using the cryostat set to -20°C 
(MICROM HM505 N). EBs sections were transferred to subbed slides (see 
section 2.12), and stored at -20°C until used for immunostaining. 
 
Table 2.1 Embryoid body fixation times. 
EBs age 
(days in culture) 
Fixation time 
(4% PFA incubation time) 
1-6 10 min 
7-12 15 min 
13-20 20 min 
 
 
2.13.3 Fixation of kidney rudiment and kidney chimeras 
Kidney rudiments and kidney chimeras were fixed in cold methanol at 
room temperature for 10 min and stored in fresh methanol at -20°C until 
ready for staining (max. 1 month) or washed immediately 3x 5 min in 
1xPBS and immunostained. Following long storage in methanol at  
-20°C, samples were washed in 1x PBS for 1-2 hours at room temperature 
prior to staining. 
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2.14 Immunostaining 
2.14.1 Haematoxylin and eosin staining 
Frozen sections were incubated in 1x PBS at room temperature for 15 min 
in order to remove mounting medium from the sample. Samples were 
placed in staining rack and submerged in a haematoxylin solution for 6 
min. After haematoxylin (Sigma) staining, samples were briefly washed in 
a bowl of tap water and immediately placed in acid-alcohol for 2 sec to 
differentiate. Following differentiation, samples were washed well (~5-10 
min) in tap water until blue colour. Next, samples were stained for 1 min in 
eosin solution (Sigma), briefly washed in tap water and dehydrated by 
short washes in alcohol solutions (see table 2.2). Following dehydration, 
samples were mounted with 80% glycerol (see section 2.17 for protocols) 
and mounted with cover slips. 
Table 2.2 Samples dehydration steps during H&E staining. 
 
Alcohol solutions Incubation time 
70% (1
st
) ethanol 20 sec 
70% (2
nd
) ethanol 20 sec 
90% ethanol 40 sec 
100% ethanol 40 sec 
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2.14.2 Lectin staining 
Following fixation and storage in methanol, and a 1h wash in PBS, 
samples were incubated 1h in TBS (Tris Buffered Saline) at room 
temperature. Following the washes, samples were incubated for 2h at room 
temperature with lectin (10μg/ml) in TBS solution. After the lectin 
staining, samples were washed twice in TBS and twice in PBS and the 
immunostaining protocol continued.  
2.14.3 Immunostaining of cells 
Following fixation, samples were incubated for 1 hour at room temperature 
in blocking solution, consisting of 0.1% (v/v) TritonX in PBS and 10% 
(v/v) serum (Sigma). The serum used in this study to block primary and 
secondary antibody was chicken or goat, depending on the organism in 
which the secondary antibody was raised. When possible, the serum used 
for blocking was from the species in which the secondary antibody was 
raised. After incubation time, primary antibody solutions were prepared, as 
follows: 1x PBS supplemented with 1% (v/v) appropriate serum, 0.1% 
(v/v) TritonX and antibody (see Table 2.3 for concentration); and left for 
overnight incubation at 4°C or 1.5 h at room temperature for Brachyury 
antibody, in a humidified chamber. 
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Table 2.3 List of primary antibodies used for immunostaining in this study 
 
 
Table 2.4 List of secondary antibodies used for immunostaining in this study 
 
 
Antigen Type Concentration Supplier 
Pax2 Rabbit  
polyclonal IgG 
1:200 Covance 
#PRB-276P 
Six2 Rabbit  
polyclonal IgG 
1:200 Proteintech Europe 
#11562-1-AP 
Bry Goat  
polyclonal IgG 
1:300 Santa Cruz 
#sc-17743 
Nanog Rabbit  
polyclonal IgG 
1:300 Abcam 
#ab 21603 
Laminin Rabbit  
polyclonal IgG 
1:1000 Sigma 
#L 9393 
Synaptopodin Mouse monoclonal 
IgG1 
1:4 Fitzgerald 
#BM 5086 
Wt1 Mouse monoclonal 
IgG1 
1:500 Upstate 
#05-753 
Calbindin Mouse monoclonal 
IgG1 
1:500 Abcam 
#ab 9481 
β-Catenin Mouse 
 monoclonal IgG1 
1:500 Santa Cruz 
#sc-7963 
Oct4 Mouse monoclonal 
IgG2b 
1:500 Santa Cruz 
#sc-9081 
Antibody Type Concentration Supplier 
Goat α Mouse IgG1 –350 1:800 Invitrogen 
Goat α Rabbit IgG – 350 1:800 Invitrogen 
Chicken α Rabbit IgG – 488 1:500 Invitrogen 
Chicken α Goat IgG – 488 1:500 Invitrogen 
Goat α Rabbit IgG – 488 1:500 Invitrogen 
Donkey α Goat IgG – 488 1:1000 Invitrogen 
Goat α Mouse IgG1 – 488 1:500 Invitrogen 
Goat α Mouse IgG2B – 488 1:1000 Invitrogen 
Goat α Rabbit IgG – 594 1:500 Invitrogen 
Goat α Rabbit IgG – 594 1:500 Invitrogen 
Goat  α Mouse IgG2B  – 594 1:2000 Invitrogen 
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Following incubation of the primary antibody, samples were washed off  
3x 5 min with 1xPBS and secondary antibody solutions were prepared as 
follows: 1xPBS supplemented with 1% (v/v) appropriate serum, 0.1% (v/v) 
TritonX, and appropriate secondary antibody (see Table 2.4 for 
concentration); and incubated for 2 hours at room temperature in dark in 
humidified chamber. After incubation the secondary antibody was washed 
2x 5 min in 1xPBS and samples were counter-stained with 1:100,000 
DAPI (4,6-diamino-2-phenylindole dihydrochloride) solution in 1xPBS  
for 5min in the dark at room temperature. The DAPI solution was washed 
1X in PBS and samples were covered with DAKO Fluorescent Mounting 
Medium (Dako Cytomation) and mounted with cover slips. All solutions of 
primary and secondary antibodies were centrifuged at 13400x g for 6 min 
before use to precipitate protein aggregates. 
 
2.14.4 Immunostaining of frozen sections 
The frozen sections, after being removed from -20°C freezer were left at 
room temperature for 5 min to defrost. Then slides were incubated at room 
temperature in 1x PBS until embedding solution was removed. Following 
incubation, samples were immunostained as described above. 
2.14.5 Immunostaining of kidney rudiments and kidney chimeras 
After fixation kidney rudiment and kidney chimeras were removed from  
-20°C freezer and placed into 1xPBS for 1-2 hours in order to wash off the 
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fixative. Following incubation, the immunostaining was performed as 
described above with a couple of minor changes: firstly, the secondary 
antibody incubation was performed overnight at 4°C; and secondly, DAPI 
staining time was prolonged up to 10 min. 
 
2.15 Molecular biology 
2.15.1 Primers 
Primers used in PCR reactions were individually designed for the 
respective genes of interest and ordered from Sigma in a quantity of 
0.025µmol. Details on primer sequence and product length are given in 
table 2.5. All primers were reconstituted in nuclease-free water and made 
up to a working concentration of 6.25pmol/µl for use in PCR reactions. All 
in house primers were sequenced by the Sequencing Service in School of 
Life Sciences (MSI/WTB Complex) at the University of Dundee. 
 
2.15.2 RNA extraction 
To harvest cells for RNA extraction, all cell culture medium was first 
aspirated from the culture dish and the cells were immediately collected in 
1ml of Trizol
®
 (Invitrogen) and transferred to a 1.5 ml microfuge tube. 
200µl of chloroform (Sigma) was then added and the tubes were shaken 
for 15 sec and centrifuged at 12,000x g for 15 min at 4°C. The upper 
aqueous phase, containing the RNA, was transferred into a new tube 
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containing 1ul of glycogen (working conc. 1μg/μl) (Boehringer Mannheim; 
stock conc. 20mg/ml) (to get a visible pellet when small amounts of RNA 
were being extracted), and an equal volume of isopropanol (Sigma) 
(approximately 500 µl) added and the solution mixed by inversion 6 times. 
After incubation at room temperature for 10 min, the precipitated RNA 
was pelleted by centrifugation at 7000x g for 10 min at 4ºC. All the 
following steps were performed on ice: the supernatant was discarded, the 
RNA pellet washed in 1ml of 75% (v/v) ethanol in nuclease free water 
(Sigma) and centrifuged again at 4400x g for 5min at 4ºC. The 75% (v/v) 
ethanol was then removed and the RNA pellet was allowed to air dry for a 
few minutes before being dissolved in 15 - 20µl nuclease-free water 
(Sigma) (depending on the size of the pellet).  
The quality of RNA after isolation was checked by running on an 
electrophoresis gels. Two distinguishable bands of rRNA subunits were 
visible in all cases, the higher band representing the 28S subunit and the 
lower band representing the 18S subunit (Fig. 2.5). Lack of smears on the 
gel that indicated that RNA was intact and had not degraded.  
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Table 2.5 List of primers used in this study 
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Figure 2.5 Electrophoresis gels of RNA isolated from EBs. A) short-term culture (1-8 
days) and long-term culture (2-22 days); B) GFP+ and GFP- cells after FACS sort. 
 
2.15.3 DNase treatment 
Before cDNA synthesis, RNA was treated with DNase I (1000U/ml) 
(Promega) to degrade any contaminating genomic DNA.  8 µl of RNA 
solution was transferred to a fresh 0.2 ml microfuge tube and 1 µl of 
DNase buffer (Promega) plus 1 µl of DNase I was added and incubated at 
37ºC for 30min. To stop the reaction, 1µl of STOP buffer (Promega) was 
added and the solution was incubated for a further 15min at 60ºC.   
 
2.15.4 cDNA synthesis 
For cDNA synthesis, 5 µl of DNase-treated RNA were mixed with 5μl of 
Sigma water (Sigma) and 2µl of random hexamers (100ng/µl) (ABgene), 
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incubated at 80ºC for 3 min to denature RNA secondary structure and any 
hexamer duplexes, then chilled on ice and pulse centrifuged to collect all 
the contents.  4 µl of 5x 1
st
 strand buffer (Invitrogen), 2 µl DTT (0.1 M) 
(Invitrogen) and 1 µl dNTP mix (10 mM) (Bioline) were then added, the 
final solution gently mixed by pipetting and incubated at 42ºC for 2 min to 
allow random hexamers to anneal to template RNA. 1µl of reverse 
transcriptase (SuperScript III) (Invitrogen) (200 U) was added and the 
reaction was incubated for 50 min at 42ºC for cDNA synthesis. The 
reaction was stopped by heat inactivation of the reverse transcriptase at 
65ºC for 10 min. The solution was then pulse centrifuged to collect all 
contents and the cDNA diluted with nuclease-free water to a final 
concentration of 200ng/μl. Amount of DNA was quantified using 
Nanodrop. 
 
2.15.5 Polymerase chain reaction 
PCR reactions were performed in a volume of 25μl comprising: 12.0 l of 
nuclease-free water (Sigma), 2.5 l PCR buffer (10x NH4 Reaction Buffer) 
(Bioline), 0.5 l MgCl2 (25mM stock) (Bioline), 0.5 l dNTP mix (10mM 
stock) (Bioline), 5.0 l cDNA solution (200ng/μl), 2.0 l forward primer 
(6.25pmol/l stock) (see Table 2.3), 2.0 l reverse primer (6.25pmol/l 
stock) (see Table 2.3), 0.5 l Taq DNA Polymerase (Bioline). The thermal 
cycler (GeneAmp PCR Systems 9700) was set as follows: 1 cycle of 95
o 
C 
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for 5min (denaturation), 36 cycles of 95
o
C for 6 sec (denaturation), 
annealing temp depends on a primers and was set for 30 sec – see table 2.3, 
and 72
o
C for 30 sec (elongation), followed by 1 cycle of 72
o
C for 5 min 
(final elongation) and were then held at 4ºC.  
 
2.15.6 Electrophoresis gels 
2% (w/v) agarose gels in TAE buffer (see chapter 2.15 for recipes) were 
used for electrophoresis. Following cooling the gel to ~60ºC, 5l of 
ethidium bromide was added to 120ml of TAE buffer before pouring the 
gel. The Bioline hyperladder IV was used as a DNA molecular weight 
marker (100 – 1000 bp bands).  
 
2.16 Statistical analysis 
For all statistical analysis the same numbers of samples (3) /pictures per 
sample (6-10) were analysed. Basic functions used were: average (ave), 
standard deviation (St.dev.), standard error (St. err.), percentage (%) and 
Student‟s t-test (tt). Error bars present on all graphs are calculated on the 
standard error basis.  
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2.17 List of protocols for solutions  
2.17.1 Cell/tissue culture media 
10%FCS DMEM 
 10% FCS (PAA Laboratory) 
 DMEM (Invitrogen) 
MEF medium 
 10% FCS (PAA Laboratory) 
 1% (v/v) 200mM L-glutamine (Invitrogen) 
 1% (v/v) non essential amino acids (Sigma) 
 1% (v/v) penicillin/streptomycin (Sigma) 
 0.01% (v/v) 50mM 2-mercaptoethanol (Invitrogen) 
 DMEM (Invitrogen) 
ESC medium 
 10% FCS (PAA Laboratories) 
 1% (v/v) 200mM L-glutamine (Invitrogen) 
 0.15% (v/v) 100mM monothioglycerol (Sigma) 
 1% (v/v) penicillin/streptomycin (Sigma) 
 1000U/ml LIF (Chemicon) 
 Advanced DMEM (Invitrogen) 
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ES monolayer differentiation medium 
 10% FCS (PAA Laboratories) 
 1% (v/v) 200mM L-glutamine (Invitrogen) 
 0.15% (v/v) 100mM monothioglycerol (Sigma) 
 1% (v/v) penicillin/streptomycin (Sigma) 
 DMEM or IMDM (Invitrogen) 
 2ng/ml Activin A (R&D Systems)  - added to the medium just 
before adding to the cells 
 0.25ng/ml BMP4 (R&D Systems) – added to the medium just 
before adding to the cells 
ES/EB medium 
 10% FCS (PAA Laboratories) 
 1% (v/v) 200mM L-glutamine (Invitrogen) 
 0.15% (v/v) 100mM monothioglycerol (Sigma) 
 1% (v/v) penicillin/streptomycin (Sigma) 
 1000U/ml LIF (Chemicon) 
 IMDM (Invitrogen) 
EB medium 
 15% FCS (PAA Laboratory) 
 1% (v/v) 200mM L-glutamine (Invitrogen) 
 0.45% (v/v) 100mM monothioglycerol (Sigma) 
 1% (v/v) Interleukin-Transferin-Selenium (Invitrogen) 
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 1% (v/v) penicillin/streptomycin (Sigma) 
 0.1% (v/v) 500mM ascorbic acid (Sigma) 
 IMDM (Invitrogen) 
Kidney culture medium 
 10% FCS (PAA Laboratory) 
 1% (v/v) 200mM L-glutamine (Invitrogen) 
 1% (v/v) penicillin/streptomycin (Sigma) 
 MEME (Invitrogen) 
2.17.2 Buffers and solutions 
Phosphate buffered saline (PBS)  10x 
From IHC world, 2009 (IHCworld, 2009) 
 80.0 g NaCl (Normapur) 
 2.0 g  KCl (BDH Chemical Ltd.) 
 14.4 g Na2HPO4 dibasic (AnalarR) 
 2.4 g KH2PO4 monobasic (AnalarR) 
 Up to 1L distilled H2O 
pH adjusted to 7.4 – 7.6 
Tris Buffered Saline (TBS)    10X 
From IHC world, 2009 
 61g Tris base (Sigma) 
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 90g NaCl (Novapur) 
 Up to 1L distilled water 
pH adjusted to 7.4-7.6 
0.1%BSA  
 1 ml 10% (w/v) BSA 
 100 ml PBSCa+Mg+ (Sigma) 
Sterilised before use 
0.1% (w/v) Gelatine 
 1 g porcine gelatine type A (Sigma) 
 1 L H2O 
Autoclaved before use 
4% (w/v) Paraformaldehyde (PFA) 
 4 g PFA (Sigma) 
 100 ml PBS 
pH adjusted to 7.4-7.6 
PFA should be weighted in the fume cupboard as it is toxic. 4% PFA 
should be stored up to 7 days in the dark at 4°C, then discarded. 
15% (w/v) Sucrose 
 15 g sucrose (Sigma) 
 100 ml PBS 
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Autoclaved before use 
80% (v/v) glycerol 
 80 ml glycerol (Sigma) 
 20 ml H2O 
Autoclave before use 
Subbing solution 
 2.5g  porcine gelatine type 1 (Sigma) 
 500 ml distilled water 
 0.25g CrKSO4x12H2O 
2.17.3 Molecular biology buffers 
Tris-acetate- EDTA (TAE) 50X 
From IHC world, 2009  
 242 g 40 mM Tris base (Sigma) 
 57.1 ml  20 mM glacial acetic acid (AnalarR) 
 100 ml 0.5M EDTA (Sigma) 
 up to 1L distilled H2O 
pH adjusted to 8.0 
2% agarose gel  
 2.4 g agarose (Bioline) 
 Up to 120 ml TAE 
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 5 μl ethidium bromide 
Gel loading buffer  6x 
 3 ml glycerol (Sigma) 
 25 mg bromophenol blue (Sigma) 
 10 ml of distilled  H2O  
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Chapter 3: Directing mesoderm differentiation 
3.1 Introduction  
In order to test the hypothesis that mESC differentiated towards the 
mesodermal lineage would have an increased ability to generate functional 
renal tissue, it was first necessary to optimise conditions for mESC 
differentiation. It is well known that kidneys develop from mesoderm, the 
germ layer between ectoderm and endoderm (Saxen, 1987). Mesoderm 
differentiation in the mouse embryo starts at embryonic day (E) E6.0-7.5 
during gastrulation (Rivera-Perez, 2005). During this stage, signaling 
centres (Spemann‟s organizer in amphibians or Hensen‟s node in birds and 
its equivalent in mammals – primitive streak) develop to regulate the 
gastrulation processes. Cells migrate through the primitive streak to reach 
their final location and fate (Gilbert, 2006; Tam, 1997). There are a few 
types of mesoderm, but the first is formed through cell ingression and gives 
rise to extraembryonic tissues. Later the primitive streak elongates to the 
distal end of the embryo and paraxial mesoderm (PM) emerges and is 
followed by intermediate (IM) and lateral plate mesoderm (LM) formation 
(Nagy, 2003; Rivera-Perez, 2005), which develop in this particular order 
(Tam, 1997). Each of these tissues has its own very specific marker(s): 
Tbx6 and Foxc1 for PM; Osr1 for IM; Foxf1 for LM. 
In situ hybridization (ISH) studies on gene expression profiles have shown 
that one of the first genes expressed in the nascent mesoderm is the pan-
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mesoderm marker brachyury (T, Bry). Its expression occurs at E5.5 in the 
proximal epiblast and later in the early primitive streak (E6.5) and 
deteriorates by day E7.5 (Chapman, 1996; Rivera-Perez, 2005).  
T expression is followed by expression of Foxc1, a gene which is highly 
expressed first by PM and later also by IM (Kume, 2000a; Sasaki, 1993) 
but at lower levels of expression. This signal is immediately followed by 
Tbx6, another PM marker. Tbx6 shares expression domains with T in the 
primitive streak and tail bud, but only Tbx6 is found in the mid and late 
primitive streak in the region of somitic (paraxial) mesoderm of the trunk 
(Chapman, 1996). Expression of Tbx6 is followed by expression of the IM 
marker Osr1 at E7.5. Osr1-/- mutants do not show any signs of 
metanephric kidney development, suggesting an important role during 
gastrulation and organogenesis of the kidney (Wang, 2005b). The LM 
marker, Foxf1, was found at day E8.5 of mouse development within the 
posterior primitive streak mesoderm, where it plays a role in mesenchyme 
migration (Malin, 2007). Foxf1 knock-out studies show its importance in 
the proper development of the embryonic and extraembryonic structures, 
as all Foxf1-/- embryos died by day E10 (Mahlapuu, 2001). 
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Table 3.1 In situ hybridisation studies identified timing of gene expression for 
different populations of mesoderm.  
E  M-T  PM-
FOXC1  
PM-
TBX6 
IM- 
OSR1  
LM-
FOXF1 
5.0       
5.5  +
1
      
6.0  +
1
      
6.5  +
1
  +
2 
   
7.0  +
1
  +
2
  +
1
    
7.5  +
1
  +
2
  +
1
  +
4
   
8.0   +
2
  +
1
  +
4
   
8.5   +
2,3
 +
1
  +
4
  +
5
  
9.0   +
2,3
  +
1
  +
4
  +
5
  
9.5   +
2,3
 +
1
  +
4
  +
5
  
E-embryonic day, M-mesoderm, PM-paraxial mesoderm, IM-intermediate mesoderm, 
LM-lateral plate mesoderm, T – brachyury, +1- Chapman et al. 1996; +2- Sasaki et al. 
1993; +
3
- Kume et al. 2000, +
4
 Wang et al. 2005-, +
5
 - Mahlapuu et al. 2001 
mESC are derived from 4 to 5-day-old blastocyst. They are pluripotent, 
meaning that they are able to give rise to all cell types of the body 
including germ cells (Nagy, 1993) and can self-renew in culture (Evans, 
1981; Martin, 1981). Self-renewal and mESC pluripotency are maintained 
in culture due to the presence of MEFs (mouse embryonic fibroblasts) 
and/or  by supplementation of media with LIF (leukaemia inhibitory 
factor) (Williams, 1988). During such conditions, mESC express 
pluripotency markers such as Oct4 and nanog. Upon LIF withdrawal from 
mESC in monolayer culture, the cells down-regulate expression of Oct4 
and nanog, and undergo a dramatic change in shape, from tightly packed 
rounded cells with high nucleus-to-cytoplasm ratio to flattened, spread 
cells with lower nucleus-to-cytoplasm ratio (Notariani, 2006). On the other 
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hand, LIF removal and change of culture conditions from monolayer to 
suspension (non-adherent dishes) allows for cell aggregation and embryoid 
body (EB) formation (Murray, 2004). EB development resembles normal 
mouse development and since the 1980s they have been used as a model 
system for studying the early stages of mouse embryo development 
(Robertson, 1987). The first cells that differentiate in EBs are those at the 
periphery, which down-regulate Oct4 and nanog and become primitive 
endoderm cells. The primitive endoderm cells deposit a basement 
membrane between themselves and the inner cells of the EB, and 
  
Figure 3.1 Schematic of the embryoid body development based on Murray and 
Edgar, 2000. 
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also give rise to parietal and visceral endoderm cells. Inner cells in contact 
with the basement membrane become polarised to form primitive 
ectoderm, which produces signals that cause the cells at their apical surface 
to undergo cell death, giving rise to a proamniotic-like cavity(Murray, 
2000). As the EB matures, the primitive ectoderm cells undergo a process 
that resembles gastrulation (Smyth, 1999), where cells delaminate from the 
primitive ectodermal epithelium and up-regulate T (Fujiwara, 2007) 
(Fig.3.1).  
Several protocols have been developed to differentiate mESC into 
mesoderm in culture. Some complex protocols involved the use of serum 
free medium and/or addition of different growth factors to cells in 
monolayer (Notariani, 2006; Yasunaga, 2005). The first protocol involved 
the use of SFO3 medium (Sanko Junyaku, Tokyo, Japan), which was not 
available for overseas customers, and supplemented with activin A 
(Yasunaga, 2005). A second protocol described in „Embryonic Stem Cells 
– practical approach‟ book required co-culture of mESC with a OP9 feeder 
cells monolayer and supplementation of media with VEGF and BMP4 
(Notariani, 2006). In the first protocol, mesoderm differentiation 
(recognised as a goosecoid positive (Gsc+) and negative for Sox17  
(Sox17-)), was a side product of the differentiation mESC into definitive 
endoderm (Gsc+ Sox17+), whereas, in the second protocol, mesoderm 
differentiation was a first step in the differentiation of mESC into 
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hemangioblasts. Other methods were more simple, involving EB formation 
in the presence of high concentration of foetal calf serum (FCS) (Fehling, 
2003; Johansson, 1995). Mesodermal differentiation of mESC was 
obtained in cells in suspension culture following 4-5 days in culture, in 
Iscove‟s Modified Dulbecco‟s Medium (IMDM) or Dulbecco‟s Modified 
Eagle‟s Medium (DMEM) supplemented with 15%FCS (Fehling, 2003; 
Johansson, 1995). In both cases the efficiency of mesodermal 
differentiation was high (~80%). When EBs were cultured in serum free 
chemically defined medium, they required additional supplementation of 
Activin A to support differentiation of dorsoanterior-like mesoderm or 
BMP4 to support posteroventral-like mesoderm (Johansson 1995). Activin 
A and BMP4 belong to the TGFβ superfamily, and are known to play 
important roles during in vivo development of the fruit fly (Drosophila 
melanogaster), amphibians (Xenopus laevis), birds (Gallus gallus 
domesticus) and mammals (Mus musculus) (Asashima, 1990; James, 
2005a; Kaufmann, 1996; Kingsley, 1994).   
The aim of my work was to first compare the efficiency of the previously 
published methods for generating mesoderm in the E14 mESC line, in 
order to establish which method generated the highest number of 
mesodermal cells and would be reproducible.  For that purpose, a 
brachyury-GFP (Bry-GFP) knock-in ESC line (Fehling, 2003) was used. 
The GFP was knocked-in to the first exon of the Bry gene locus rendering 
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one copy of the gene non-functional. These cells have been used 
previously to establish hemangioblast differentiation (Fehling, 2003) and 
hepatocyte differentiation (Kubo, 2004). 
This chapter will describe: 
 the optimisation of culture conditions that lead to efficient 
mesoderm differentiation  
 the purification of mesodermal cells (Bry-GFP+) from EBs 
 the characterisation of GFP+ and GFP- cells 
 the expression profile of key mesodermal  and MM-specific genes 
during EB development. 
  
3.2 Results 
 
In order to promote mesoderm differentiation from ESC, culture conditions 
were optimized and expression of the key pan-mesodermal gene – 
Brachyury (T, Bry) was investigated. To be able to follow cell 
differentiation in live cells, Bry-GFP cells (Fehling, 2003) were used. The 
GFP cassette knocked into the Brachyury locus causes cells to become 
fluorescent (green) when cells differentiate into mesoderm and express T. 
The Bry-GFP cells were cultured in both monolayer and suspension culture 
systems for optimisations of the conditions for mesodermal differentiation. 
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3.2.1 Directing mesoderm differentiation in monolayer culture 
Cell densities for the monolayer culture assay were: 500 cells cm
-2
, 1000 
cells cm
-2
, 2500 cells cm
-2
. Bry-GFP cells were seeded in 2 different 
media: 10% FCS DMEM (Dulbecco‟s Modified Eagle Medium) and 10% 
FCS IMDM and both were supplemented with Activin A (2ng ml
-1
) and 
BMP4 (0.25ng ml
-1
) (Johansson, 1995). Cells cultured at all three plating 
densities in 10% FCS DMEM detached from the culture dish by day 5 of 
culture (data not shown) whereas those cultured in IMDM supplemented 
with 10% FCS at 500 cells cm
-2 
started to change morphology and many no 
longer displayed the typical characteristics of undifferentiated mESC. 
Generally, the cells became more spread and the nuclear-to-cytoplasmic 
ratio decreased, with cells adopting an epithelial-like morphology (Fig.3.2). 
However, these conditions did not induce mesodermal differentiation, as 
no signs of GFP fluorescence were observed at any day of the experiment 
(data not shown). Moreover, immunostaining of these cells with T antibody 
showed lack of T protein and supported the result obtained with the GFP 
fluorescence. To verify that the cells had differentiated, immunostaining 
for the pluripotent markers Nanog and Oct4 was performed. The results 
showed that although a few cells were still positive for Nanog and Oct4, 
the majority were negative, showing that most of the cells had 
differentiated.  
In the developing embryo, T expression is under the control of Wnt/β-
catenin signalling, and thus the presence of nuclear β-catenin, is an early   
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Figure 3.2 Differentiation of mESC in monolayer culture system. Phase contrast 
pictures showing differentiation at day 3, 4 and 5 of culture at density of 500 cells cm-2  
in 10%FCS IMDM and visible changes in cell morphology (epithelial-like cells – 
yellow arrows); Scale bar 100μm. 
 
Figure 3.3 Fluorescent staining of BRY-GFP cells cultured for 5 days in 10%FCS 
IMDM at 500cells cm
-2
. A) Bry (green) and Nanog (red) fluorescent staining showing 
lack of Brachyury protein and persistence of some undifferentiated cells. Nuclei were 
counterstained with DAPI (blue). B) β-catenin (green) and Oct4 (red) fluorescent staining 
show presence of a few undifferentiated cells and absence of any cells with nuclear β-
catenin. β-catenin staining at cell-cell contacts show presence of cells with low nucleus to 
cytoplasm ratio which had differentiated, but not towards mesoderm. Nuclei 
counterstained with DAPI – blue. Scale bar: A –50μm; B – 100μm. 
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marker for nascent mesoderm (Lindsley, 2006). Therefore, 
immunostaining was performed to determine if the differentiated cells 
expressed nuclear β-catenin. The results showed, that β-catenin was 
located in the cell membrane rather than the nucleus, confirming that the 
cells had not differentiated towards the mesodermal lineage (Fig. 3.3). 
Cells seeded at densities 1000 cells cm
-2
 and 2500 cells cm
-2 
in 10% FCS 
IMDM medium grew in a multilayer, becoming overgrown by day 5 and 
were therefore not analysed further (data not shown). These results 
showed that using the culture conditions described above, the monolayer 
system was not effective in directing mesoderm differentiation as neither 
GFP expression was found, nor Brachyury protein. 
3.2.2 Directing mesoderm differentiation in suspension culture 
To determine the effect of cell density on mesoderm differentiation in EBs 
in suspension culture, two ranges of cell densities were tested. The low cell 
density range included the following seeding densities:  5x10
3
 cells ml
-1
, 
25x10
3
 cells ml
-1
, 50x10
3
 cells ml
-1
, 75x10
3
 cells ml
-1
, 10x10
4
 cells ml
-1
, 
and the high cell density range included the following seeding densities: 
25x10
4
 cells ml
-1
, 50x10
4
 cells ml
-1
, 75x10
4
 cells ml
-1
 and 1x10
6
 cells ml
-1
.  
EBs were also cultured in the following four media to determine which 
condition supported maximal mesodermal differentiation: 10% FCS 
DMEM, 15% FCS DMEM and 10% FCS IMDM, 15% FCS IMDM. Initial 
observations showed that in all media types, high cell densities (≥ 250K 
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cells ml
-1
) did not induce mesoderm differentiation over the time course of 
the experiment (8 days). Also, DMEM medium did not induce mesoderm 
differentiation as effectively as IMDM (Fig. 3.4), irrespective of the 
concentration of the FCS used (not shown).  
 
     
Figure 3.4 Difference in GFP fluorescence in EBs cultured 4 days in DMEM and 
IMDM medium. Cells differentiating in IMDM medium showed high GFP expression at 
day 4 in 15% FCS concentration at density of 75x10
3
 cells ml
-1 
in contrast to cells 
differentiating in DMEM which showed very low GFP expression at day 4 in 15% FCS 
concentration and 75x10
3
 cells ml
-1
. Scale bar – 100μm. 
 
 
Optimal conditions for GFP – brachyury expression 
During EB culture, only IMDM medium supported efficient mesoderm 
differentiation. At day 3 of culture in 15% FCS IMDM medium, EBs at all 
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lower densities (<100K cells ml
-1
), showed the first signs of GFP 
fluorescence, indicating Bry expression and mesoderm differentiation. EBs 
cultured in 10% FCS IMDM also showed signs of mesoderm 
differentiation, however, it was found that the higher the seeding cell 
density, the later GFP fluorescence occurred (Tab 3.2).  
To confirm that GFP expression in EBs reflected expression of T protein, 
day 4 EBs cultured in 15% FCS IMDM were immunostained for T protein. 
The results showed that many cells within the EBs expressed nuclear T 
(Fig.3.5). To determine the time-course of induction of T mRNA, semi-
quantitative RT-PCR was performed using RNA derived from ESC and 
EBs (day1 – day8) cultured at different densities in 10% and 15% FCS 
IMDM. The reference gene was Gapdh (glyceraldehyde 3-phosphate 
dehydrogenase). RT-PCR analysis showed good correspondence between 
T gene expression and GFP. In other words, T was found to show delayed 
expression in 10% FCS IMDM medium in comparison to 15% FCS 
IMDM medium, where at all cell seeding densities T was expressed at day 
3 of culture. Furthermore, in both concentrations of FCS, T expression was 
delayed at higher cell densities, and at the highest density used (250K ml
-1
) 
expression levels were dramatically reduced (Fig. 3.6).  
These results showed that suspension culture is a good and effective 
system to direct mesoderm differentiation. Analysis of GFP fluorescence 
together with RT-PCR results for T expression showed that 15% FCS 
IMDM medium induced efficient differentiation of mesoderm. In cells 
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Table 3.2 Summary of GFP expression in cells cultured in different conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thick √ means that GFP fluorescence was observed in >50% EBs; thick √ means that GFP 
fluorescence was observed in <50% EBs 
 
 
 
Figure 3.5 Photomicrograph of fluorescent staining of frozen section of EB at day 4 
of development. A) Presence of Brachyury (green) positive cells in EB; B) Control of 
staining where primary antibody was omitted. Scale bar – 50μm. 
EB day 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 
density 10%FCS IMDM 15%FCS IMDM 
5000   √ √ √ √     √ √ √    
25000   √ √ √ √     √ √ √ √   
50000    √ √      √ √ √ √   
75000    √ √      √ √ √ √   
100000    √ √ √      √ √ √   
density 10%FCS DMEM 15%FCS DMEM 
5000           √      
25000    √             
50000    √             
75000    √             
100000    √             
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cultured in low serum concentration Bry expression was delayed in higher 
seeding cell densities, while in high serum concentration cells in all 
densities showed T expression at day 3, meaning that there was no delay in 
differentiation irrespective of cell seeding density. Therefore, 15% FCS 
IMDM was chosen as an optimal condition to direct mesoderm 
differentiation. 
 
 
Figure 3.6 Semi-quantitative RT-PCR analysis of brachyury expression in EBs 
culture. A) EBs cultured in 10% FBS IMDM showed T expression at day 3 at the lowest 
seeding density and  in higher densities Bry expression was delayed to not be present in 
the 250K cells ml
-1
; B) housekeeping gene GAPDH levels for 10%FBS IMDM medium; 
C) EBs cultured in 15%FBS IMDM showed expression at day 3 in all seeding densities, 
but in higher (≥100K cells ml-1) Bry expression was at lower level; D) housekeeping gene 
GAPDH levels for 15%FCS IMDM medium. Experiment was performed three times; the 
results shown being representative of those observed in the other two biological replicates. 
EB – embryoid bodies, ES – embryonic stem cells, NTC – no template control. 
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 The morphology of the embryoid bodies  
The difference in GFP fluorescence between EBs cultured in IMDM and 
DMEM medium was shown above. Moreover, EBs cultured in DMEM 
medium showed different, to EB cultured in IMDM medium, morphology 
(Fig. 3.7). The DMEM EBs developed visible basement membrane 
(Reichert‟s membrane, Fig. 3.7 arrow) and plenty of primitive endodermal 
cells surrounding it, whereas EB cultured in IMDM medium did not 
develop basement membrane and primitive endodermal cells (Fig. 3.7).  
 
Figure 3.7 Differences in morphology of EBs cultured in DMEM and IMDM. Bright 
field photographs presenting A) high number of primitive endodermal cells (*) 
surrounding EB basement membrane (arrow) in EBs cultured in DMEM medium and B) 
lack of basement membrane and primitive endodermal cells in EBs cultured in IMDM 
medium. Scale bar – 100μm. 
 
 
Frozen sections of day 7 EBs cultured in 15% FCS IMDM were analysed 
morphologically and immunostained for laminin to detect the presence of 
basement membranes.  The results showed that only ~10% of EBs cultured 
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in 15% FCS IMDM developed a defined layer of peripheral extra-
embryonic endoderm with underlying basement membrane, primitive 
ectodermal epithelium and central cavity by day 7 of culture, whereas the 
majority of EBs appeared to be simple aggregates with no obvious 
structural features (Fig. 3.8). To investigate if the cells within the simple 
EBs were still undifferentiated, immunostaining was performed for the 
pluripotency marker, Oct4. The results showed that in day 7 simple EBs, 
although some Oct4+ cells were present in the centre of EB, the majority 
of outer cells had down-regulated Oct4, indicating that they had 
differentiated (Fig. 3.8B).  
 
Figure 3.8 Development of EBs in conditions optimized for mesoderm differentiation. 
A) By day 7, 10% of EBs developed laminin layer (green) between extraembryonic 
endoderm cells (yellow arrowheads) and primitive ectoderm epithelium. Cells that do not 
have contact with basement membrane undergo programmed cell death leading to cavity 
formation (Coucouvanis E., 1995). B) Majority of EBs stayed underdeveloped as no signs 
of basement membrane and/or polarised epithelium formation were seen. 
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These results may suggest that DMEM medium is optimal for endodermal 
cells differentiation, whereas IMDM is optimal for mesodermal 
differentiation as was shown by GFP expression (Fig.3.4). Therefore, the 
15% FCS IMDM medium was used in further part of this study as 
conditions optimal for mesodermal differentiation. 
 
3.2.3 The proportion of mesodermal cells in embryoid bodies cultured 
under optimal conditions 
To determine the proportion of GFP positive (Bry+) cells present in EB 
populations cultured in conditions optimal for mesodermal differentiation 
(15% FCS IMDM) and to establish the optimal seeding cell density, Bry-
GFP cells were used to generate EBs at seeding densities of 25x10
3
 cells 
ml
-1 
and 75x10
3
 cells ml
-1
. At day 4 and 6 of development EBs were 
dissociated into a single cell suspension and the proportion of GFP+ cells 
was analysed using Fluorescent Activated Cell Sorting (FACS). FACS 
results demonstrated that at both seeding densities, about 60% of the 
population was GFP+ at day 4 of development, but this dropped to around 
10% at day 6 (Fig. 3.9). The density of 75x10
3
 cells ml
-1
 was selected for 
future experiments to improve yield. Therefore, the established conditions 
to efficiently direct mesoderm differentiation of mESC were as follows: 
15% FCS IMDM medium and density of 75x10
3
 cells ml
-1 
in suspension 
culture for 4 days. 
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Figure 3.9 Percentage of GFP+ cells. A) E14.1 cells without GFP insertion cultured in 
the same conditions as BRY-GFP samples at random density; B) BRY-GFP cells 
cultured in 15%FCS IMDM at density of 25x10
3
 cells ml
-1
 showed ~60% GFP+ cells at 
day 4 of differentiation; C) GFP+ cells number dropped till 10% by day 6 of 
differentiation at density of 25x10
3
 cells ml
-1
; D) BRY-GFP cells cultured in 15%FCS 
IMDM at density of 75x10
3
 cells ml
-1
 showed ~60% of GFP+ cells at day 4 of 
differentiation; E) GFP+ cells number dropped till ~10% by day 6 of differentiation at 
density of 75x10
3
 cells ml
-1
. Experiment was performed two times, the results shown 
being representative of those observed in the other biological replicate. 
 
3.2.4 Gene expression profiles of GFP+ and GFP- cells 
The previous experiments established the optimal culture conditions for 
directing mesoderm differentiation, and showed that under these 
conditions, 60% of cells in day 4 EBs expressed the mesodermal marker T. 
For future work, it was necessary to isolate GFP+ cells from GFP- cells 
and establish their gene expression profiles. Cells cultured under optimal 
conditions formed embryoid bodies which were collected at day 4 of 
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development and sorted using FACS in order to obtain two populations: 
GFP+ (Bry+) cells (mesodermal cells) and GFP- (Bry-) cells (non-
mesodermal cells). In order to characterise these cell populations  
sqRT-PCR (semi-quantitative reverse transcriptase PCR) was performed to 
investigate the expression of various mesoderm, endoderm, ectoderm, 
kidney specific and pluripotency genes. Results showed that FACS sorting 
purity was about 80% (Fig. 3.10A).   
Therefore some GFP+ (Bry+) cells could be still found in GFP- (Bry-) 
fraction of cells and vice versa. Hence, it is necessary to analyse gene 
expression profile bearing in mind that there is a low level of 
contamination. 
The RT-PCR results showed that GFP+ cells expressed high levels of T, 
Foxc1 and Tbx6, and low level of Osr1 and Foxf1. T, Foxc1 and Tbx6 
expression was also detected in GFP- cells, but given that the expression 
levels of these genes was markedly lower than in GFP+ population, it is 
likely due to the presence of GFP+ cells in the GFP- cell fraction (Fig. 3.10 
B, green stars). GFP+ cells showed expression of most of the endodermal 
markers tested: strong expression of BMP4, Gata4 and Sox17, weak 
expression of AFP and lack of expression of Gata5. GFP- cells showed 
expression of BMP4, Gata4 and Sox17 but Gata4 and Sox17 expression 
could be due to presence of GFP+ cells within GFP- cells fraction (Fig. 
3.10 B, green stars), whereas BMP4 expression was at the same level as in 
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Figure 3.10 Gene expression profiles of GFP+ and GFP- cells. A) Histogram 
showing ~60% of the cells are GFP+ at day 4 EBs (blue), and purity (~80%)  of sorted 
populations of cells; GFP+ (green line) and GFP- (red line); B) gene expression profile 
of FACS sorted cells. Green stars indicate gene expression likely to be affected by 
GFP+ cells within GFP- cells fraction; orange stars indicate gene expression likely to be 
affected by GFP- cells within GFP+ cells fraction.  ES – undifferentiated mESC, GFP+ 
– GFP positive cells, GFP- – GFP negative cells, K – kidney at E13.5, NTC – no 
template control. GAPDH – reference gene. Experiment performed two times with 
similar results. 
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GFP+ cells. Therefore both populations (GFP+ and GFP-) showed similar 
expression of BMP4. The ectodermal marker Pax6 was expressed in GFP- 
cells at higher levels than in GFP+ cells; therefore, expression of Pax6 in 
GFP+ cells could be due to the presence of GFP- cells within the GFP+ 
population. A similar situation was observed with the kidney specific 
markers Wt1, where GFP- cells showed stronger expression than GFP+ 
cells (Fig. 3.10 B, orange stars). Of the other kidney specific genes tested, 
GDNF and Pax2 showed stronger expression by GFP+ cells, but levels of 
Pax2 were almost undetectable. Sall1 on the other hand, was expressed by 
both GFP+ and GFP- at the same level. Other investigated genes included 
the pluripotency marker, Oct4 and the epithelial marker, E-cadherin (E-
cadh), both of which showed similar levels of expression in the GFP+ and 
GFP- populations.  
 
3.2.5 Timing of expression of key mesodermal and kidney specific 
genes in embryoid bodies  
Gene expression profiling in the developing mouse embryo is usually 
investigated by using the very sensitive but difficult and time consuming 
method of in situ hybridisation (ISH). ISH allows the identification of 
regions of specific gene expression in very early mouse embryos, starting 
from E5.5. Table 3.1 (see page 80) summarises the results of various ISH 
studies of mesodermal marker genes, giving the timing of expression in the 
normal mouse embryo. These studies showed that the mesodermal marker, 
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Brachyury, is expressed in the early mouse embryo prior to gastrulation 
(Rivera-Perez, 2005). Mesoderm, identified by T expression, gives rise to 
three subpopulations: PM, IM and LM. Therefore, in the developing 
embryo, T expression is followed by PM marker expression – Foxc1 and 
Tbx6, which  is in turn followed by expression of the IM marker – Osr1, 
and finally, the LM marker Foxf1.(Chapman, 1996; Kume, 2000a; 
Mahlapuu, 2001; Sasaki, 1993; Wang, 2005a).To investigate if the timing 
of expression of the aforementioned mesodermal markers in developing 
EBs resembled that observed in the mouse embryo, sqRT-PCR was used to 
determine the expression levels of these key genes from day 2 to day 14 of 
EB development. EBs were cultured under the previously defined optimal 
culture conditions (15% FCS IMDM, 75K cells ml
-1
).  The results showed 
that the expression pattern of mesodermal genes in the developing EBs was 
similar to that of the normal mouse embryo. 
The RT-PCR showed expression of T at day 4 of culture, which was 
followed by expression of the PM markers, Tbx6 and Foxc1. Tbx6 
expression peaked at day 4 and then decreased and peaked again at day 12 
of culture, whereas Foxc1 expression was observed at day 4 and gradually 
increased to reach maximum expression at day 12 of culture. PM marker 
expression was followed by the IM marker, Osr1, which was first detected 
at day 8 of culture and gradually increased till the end of the experiment 
(day 14).  The LM marker, Foxf1, is the only exception to the similarity of 
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Figure 3.11 Semi quantitative RT-PCR of mesodermal markers expression profile. 
Electrophoresis gels presenting dynamics of expression of mesodermal markers: pan-
mesoderm – Bry, PM – Tbx6 and FoxC1, IM – Osr1, LM – FoxF1 and housekeeping gene 
GAPDH. EB – embryoid bodies, ES – embryonic stem cells, NTC – no template control. 
Experiment was performed two times with similar results.  
 
 
EB development in culture to the normal mouse. Foxf1 expression was 
detected at day 4 of culture, the same day as T and PM markers, but its 
expression decreased and peaked again at day 10 of culture (Fig. 3.11). 
Next, the expression of key kidney marker genes was detected in EBs 
cultured under optimal conditions. Low level of Pax2 expression was 
observed at day 6 but high level of expression was not observed until day 
14 of suspension culture (Fig.3.12), which followed the expression of Osr1 
(Fig. 3.11) and Wt1 expression was detected at all time points, including 
the undifferentiated mESC. There was an obvious decrease in Wt1 
expression at day 4 of culture (reproducible) which increased at day 6 and 
stayed high until the end of the experiment.  Both genes were found to be 
expressed at high levels at day 14 of EB differentiation (Fig. 3.12).  
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Figure 3.12 Semi-quantitative RT-PCR showing the expression profile of key kidney 
genes in developing EBs. Pax2 and Wt1 are the first markers to be co-expressed during 
kidney development by condensed metanephric mesenchyme (MM) and this 
electrophoresis gel showed strong Pax2 and Wt1 expression at day 14 of differentiation. 
Experiment performed two times with similar results. 
 
 
Both genes Pax2 and Wt1 are known to be co-expressed in condensed 
metanephric mesenchyme (MM) during kidney development (Moore, 
1999). Therefore, to investigate if any MM-like cells were present in 
developing EBs, dual immunostaining for Wt1 and Pax2 was performed on 
cytospinned cells of day 14 EBs to investigate if Pax2 and Wt1 were co-
expressed in any of the EB cells (fig. 3.13).    
The results showed that some of the EBs cells at day 14 of culture showed 
presence of both proteins, Pax2 and Wt1 (Fig 3.13 G, H), but with different 
locations within the cell. In other words, Pax2 was expressed in the nucleus 
of the cells whereas Wt1 was in the cytoplasm. Control staining, where 
primary antibody was omitted did not show any background staining (data 
not shown). 
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Figure 3.13 Immunofluorescent staining of Pax2 and Wt1. A-F) Pax2 (green) and Wt1 
(red) staining presenting: co-expression in developing mesonephros in vivo at E9.5 embryo 
(A, B); co-expression in metanephric mesenchyme in cultured kidney rudiments (C, D); 
expression in mouse brain in vivo at E9.5 embryos (E, F) counter stained with DAPI; G-H) 
Pax2 (red; yellow arrows) and Wt1 (green; white arrows) expression in some cytospinned 
cells of EBs at day 14 of differentiation. Experiment was performed two times with similar 
results. Scale bars: A, C, E – 150μm, B, D, F – 50μm, G, F – 10μm. 
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Although many mesodermal (Fig.3.11) and kidney specific (Fig. 3.12) 
genes were up-regulated in EBs cultured in optimal conditions, the 
pluripotency marker Oct4, has not been down-regulated and stayed 
expressed until the end of the experiment (day 22) (Fig.3.14).  
 
Figure 3.14 Semi-quantitative RT-PCR of pluripotency marker Oct4 expression 
profile in EBs. Oct4 expression during EBs culture remains high until day 22 of culture. 
Housekeeping gene GAPDH showed similar levels of expression in all samples. 
Experiment performed twice.  
 
 
3.3 Conclusion 
In this chapter, it has been shown that the optimal conditions to direct 
mesoderm differentiation from mESC is suspension cell culture in 
15%FCS IMDM medium using a cell density of 75x10
3
 ml
-1
. Under these 
conditions, the EB cells not only expressed the nascent mesodermal marker 
Bry, allowing for isolation of Bry+ (GFP+) cells, but also expressed 
markers of PM, IM and LM at a similar time course as that seen in the 
normal embryo.  
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3.3.1 Mesoderm differentiation 
Using a Bry-GFP mES cell line, it was demonstrated that mesoderm 
differentiation occurs more efficiently in EB culture rather than monolayer. 
Although Johannson and Wiles (1995) optimised amounts of Activin A 
and BMP4 very precisely (2ng/ml and 0.25ng/ml respectively) to induce 
mesoderm differentiation in serum free EB culture, in the current study it 
was found that these growth factors were unable to induce mesoderm 
differentiation in a monolayer culture system. The failure of mesoderm 
differentiation in the aforementioned condition is rather surprising because 
it has recently been shown that short-term BMP4 treatment can efficiently 
induce mesoderm differentiation in monolayer culture of human ESC 
(hESC) (Zhang, 2008).  However, it is important to bear in mind that there 
are several differences between mESC and hESC. Firstly, mESC are 
cultured in the presence of mouse leukaemia inhibitory factor (mLIF) 
whereas hESC do not respond to LIF and need to be cultured on mouse 
embryonic fibroblasts (MEF) (Humphrey, 2004; Thomson, 1998) or on 
special matrices in the presence of either MEF-conditioned medium, or 
FGF2, NT4 and activin (Baxter, 2009; Koestenbauer, 2006; Stojkovic, 
2005). Furthermore, whereas FGF signalling is required to maintain hESC 
in an undifferentiated state, it promotes the differentiation of mESC (Ying, 
2003). Recently it was suggested that hESC might be at slightly later stage 
developmentally than mESC, and more equivalent to mouse epiblast stem 
cells than mESC (Nichols, 2009b; Tesar, 2007). In support of this 
 123 
hypothesis, it was demonstrated that mouse epiblast stem cells have the 
same culture requirements as hESC; i.e., they do not respond to LIF and 
require FGF to maintain their self-renewal (Nichols, 2009b; Tesar, 2007). 
Therefore, given that mESC and hESC are probably not equivalent, it is 
not surprising that they require different culture conditions for mesoderm 
induction.   
As mesoderm differentiation in mESC monolayer was not successful, the 
EB culture system was optimised to promote maximal mesoderm 
differentiation. Although many studies used IMDM medium to induce 
mesoderm (Fehling, 2003; Johansson, 1995), it was not clearly stated what 
advantages IMDM had over DMEM. In the current study it was shown that 
only IMDM medium induced efficient mesoderm differentiation whereas 
DMEM was only partially successful. This might be due to very small but 
significant differences in the medium formulation. IMDM medium is 
supplemented with vitamin B12, which is normally involved in  cellular 
metabolism and regulates synthesis of nucleic acids (Stryer, 1995), and 
also contain HEPES buffer, which is known to regulate pH in the 
physiologically important range (pH= 7.0 – 7.4) (Baicu, 2002). Although 
the difference in pH between DMEM (pH= 8.0 – 8.4) and IMDM (pH= 7.0 
– 7.4) was not high, this could be the main factor influencing mESC 
differentiation. It has been shown previously that pH has an effect on cell 
differentiation (McAdams, 1996), and lower pH (~7.3) can significantly 
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increase the ability of mESC to form EBs (Chaudhry, 2009). Therefore, 
this could explain why IMDM with lower pH induced mesoderm 
differentiation more efficiently.  
Another finding of this study is that 15% FCS was more effective for 
promoting mesoderm differentiation than 10% FCS. This is probably due 
to growth factors present in the FCS. FCS is known to contain various 
growth factors, the concentration of which vary between different batches 
(Notariani, 2006). In FCS formulations, the presence of Activin A (Sakai, 
1992) and BMP4 (Kodaira, 2006) was shown, and it is known that both 
factors play an important role during fruit fly and vertebrate development 
(Asashima, 1990; James, 2005a; Kaufmann, 1996; Kingsley, 1994). 
Therefore, in higher serum concentration, there would be increased levels 
of growth factors, which were likely to have a positive impact on 
mesoderm differentiation. Another possibility is that mESC are 
producing/secreting inhibitors of BMP4, such as noggin (Gratsch, 2002), 
which is known to play inhibitory role in vivo (Tonegawa, 1998). If this 
were the case, it would explain a delay in T expression at higher cell 
seeding densities in low serum concentration (10% FCS). In other words, 
in low serum concentration, the level of growth factor inhibitors produced 
by mESC might be higher than the level of growth factors in the medium, 
and therefore in high cell seeding densities, this could lead to a the delay in 
mesoderm differentiation (T expression).  
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Previous work has shown that using optimal conditions, 80% of Bry-GFP 
cells were positive at day 4 of culture (seeding cell density – unknown) 
(Fehling, 2003). Although similar culture conditions were used in the 
current study, Fehling results could not be recapitulated in our lab, and the 
best GFP positive cell score was ~60%.  This could be due to the fact that 
the batch of FCS and MEFs used in the current study were different from 
those in the Fehling study. Nevertheless, the Fehling protocol was used in 
this study as an efficient and simple way to direct mesoderm 
differentiation.  
In normal mouse embryo development, after the basement membrane has 
been deposited between the extra-embryonic endoderm and primitive 
ectoderm epithelium (epiblast) and the pro-amniotic cavity has formed, the 
embryo undergoes gastrulation. At the onset of gastrulation, part of the 
basement membrane is degraded, allowing for cell migration through the 
primitive streak and mesoderm differentiation (Tam, 1997). In EBs, a 
gastrulation-like process also takes place, although it is much more chaotic 
than the tightly orchestrated process that occurs in the embryo. 
Interestingly, it has been shown that in EBs, the basement membrane 
inhibits gastrulation, as demonstrated by the fact that basement membrane-
deficient EBs show more extensive mesoderm formation than their wild-
type counterparts  (Fujiwara, 2007). In the current study, it was found that 
under optimal conditions for mesoderm differentiation, the majority of EBs 
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did not form a basement membrane. Taken into account the results of the 
Fujiwara study, it is possible that the absence of basement membrane in the 
majority of EBs might have played a role in promoting mesoderm 
differentiation. It is not clear why basement membrane deposition occurred 
at such low frequency in the current study, but it is possible that cell 
density might have played an important role. In the current study the initial 
seeding density was much lower than used in the Fujiwara work (75x10
3
 
and 25x10
4
, respectively). 
 
3.3.2 Characteristic of FACS sorted cells 
EBs cultured in optimised conditions, showed quick and efficient 
differentiation into mesoderm, recognised by GFP fluorescence and 
confirmed by RT-PCR. At day 4 of culture, EBs were dissociated and 
sorted to obtain two populations: GFP+ and GFP-. FACS sort showed 
~80% purity and therefore some GFP+ cells could be found in the GFP- 
cell fraction and vice versa.  
Gene profile analysis of both populations showed that GFP+ cells are Bry+ 
and therefore they are mesodermal cells, and apart from expression of the 
pan-mesodermal marker T, they also expressed other mesodermal genes 
(Tbx6, Foxc1, Foxf1, Osr1). GFP+ cells also expressed various endodermal 
markers (AFP, BMP4, Gata4, Sox17), suggesting that the GFP+ cell 
population is multipotent and can give rise to mesodermal and endodermal 
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lineages (Yasunaga, 2005). This gene expression profile is similar to what 
has been found in vivo and can be called a „salt and pepper‟ mix of 
endodermal and mesodermal gene expression, which has been observed in 
the pan-mesodermal region of the primitive streak (Nagy, 2003; Tam, 
1997). GFP+ cells showed expression of some kidney specific markers as 
Wt1 and GDNF, suggesting differentiation toward the kidney lineage. 
Therefore, GFP+ cells were shown to be cells with 
mesodermal/mesendodermal characteristics, with some signs of kidney 
lineage specification.   
The population of GFP- cells showed weak expression of some 
mesodermal and endodermal markers (Bry, Foxc1, Tbx6, Gata4 and 
Sox17), but this was probably due to the presence of GFP+ cells within the 
GFP- cells fraction, as showed by ~80% purity of the sort. GFP- cells 
showed stronger expression of Pax6, an ectodermal marker, than the GFP+ 
cell population, and therefore expression of Pax6 in GFP+ cells is probably 
due to presence of GFP- cells within the GFP+ cell fraction. Therefore, 
GFP- cells are likely to be of the origin of the third germ layer – ectoderm, 
which develops in EBs and in the embryo proper during mouse 
development (Tam, 1997).  
Both populations of cells, GFP+ and GFP-, showed high levels of Oct4 
expression, a known ESC pluripotency marker (Ovitt, 1998). Surprisingly, 
Oct4 was still present at high levels at day 22 of EB development (Fig. 
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3.14). One possible explanation is that the expression of Oct4 is due to the 
presence of pseudogenes or different splice variants of Oct4 which are 
expressed at different stages of development and might be recognised by 
the primers used, as was shown for hESC  (Atlasi, 2008; Liedtke, 2007).  
Whether it is true for mice remains to be tested, but the observations that 
Oct4 protein was down-regulated in the majority of EB cells by day 7 (Fig. 
3.8), suggests that at least during the later stage of EB development, there 
appears to be  little correlation between levels of Oct4 mRNA and protein.  
One possible reason for the persistence of Oct4 mRNA transcripts in later 
stages of EB development could be the high serum concentration (15% 
FCS) used: a recent study has shown persistence of Oct4 mRNA in EBs 
cultured in high serum conditions (Mansergh, 2009). However, the 
presence of real undifferentiated (pluripotent) cells in late EBs (EB day 20) 
could be investigated in two ways. First, would investigate the ability of 
dissociated EBs cells to give rise to ES cells (when seeded onto adherent 
dishes), and the second would investigate the ability of dissociated EBs to 
give rise to secondary EBs (when seeded onto non-adherent dishes), both 
confirming presence of pluripotent stem cells. 
3.3.3 Timing of expression of mesodermal genes in EBs is similar to 
that of the mouse embryo 
In order to be able to obtain kidney progenitor cells from mESC that would 
be able to give rise to kidney cells in an in vitro model system, it was 
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important to establish if mESC could differentiate towards the kidney 
lineage. It is well known that the kidney develops from mesoderm, which 
gives rise to other mesodermal lineages PM, IM, LM during mouse 
development and leads to kidney organogenesis (Saxen, 1987).  Therefore, 
the principle was to direct the differentiation of the cells, taking lead from 
normal mouse development (Keller, 2005), considering all stages of 
mesoderm induction and commitment to become kidney progenitors as a 
very important signal that builds cell history and determines their fate. 
Here, it was shown that conditions optimised for mesoderm differentiation 
allowed as well for other mesodermal types to differentiate, namely PM, 
IM and LM showing very high similarity in timing of gene expression 
between EB culture and mouse embryos.  Although minor differences in 
gene expression profile were noticed (Tbx6 expression at day 12 of culture, 
and Foxf1 expression at day 4 of culture) and remain unclear, they did not 
disturb EB development, leading to differentiation of beating cells by day 
12 of culture (data not shown). 
Another observation showed that some genes expressed by undifferentiated 
ESC, like Osr1 or Foxc1 are strongly down-regulated during the first two 
days of EB culture and become up-regulated at later time points (i.e., Osr1 
is up-regulated at day 8 and Foxc1 at day 4 of culture; Fig. 3.11). Possible 
reasons for this are: (i) differences in media used to maintain mESC in a 
pluripotent state  and to promote their differentiation; for instance, the 
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presence of LIF in medium to promote self-renewal might induce low level 
expression of various lineage-specific genes, because LIF is known to 
activate various signalling pathways, including Erk and STAT3 (Nichols, 
2009a; Silva, 2008); (ii) different culture conditions: adherent culture 
dishes to maintain pluripotency of mESC and non-adherent dishes for 
suspension EB culture to differentiate mESC. The transition from attached 
to suspension culture conditions can have a dramatic effect on cell-cell 
contact, cell cycle and finally, cell signalling (Burdon, 2002), which can 
have an impact on gene expression.  
As mesodermal genes were expressed in EBs in the same sequence as they 
are in embryos, it was interesting to see if optimised conditions led to 
differentiation of kidney progenitors. Suitable markers for identifying 
metanephric mesenchyme (MM) cells were Pax2 and Wt1, as these 
transcription factors are co-expressed in condensed MM, which is known 
to give rise to functional nephrons (Saxen, 1987). RT-PCR results showed 
expression of Pax2 and Wt1 at day 14 of EBs culture. Although both genes 
are expressed in organs other than the kidney; e.g., Pax2 is expressed in the 
developing central nervous system, eye (Bouchard, 2000; Pfeffer, 2002) 
and urogenital system (Dressler, 1990) and Wt1 is expressed by 
mesenchymal cells in the brain, heart, gonads and spleen (Hohenstein, 
2006; Niksic, 2004), they are only co-expressed in the metanephric 
mesenchyme of the developing kidney (Moore, 1999), which was 
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confirmed by performing a whole embryo immunostaining for Pax2 and 
Wt1. Therefore, expression of both genes would be a good identification of 
cells differentiating into MM cells. However, immunostaining of day 14 
EBs showed expression of both genes but they did not overlap. In other 
words, Pax2 expression was found in nucleus of some EB cells whereas 
Wt1 was expressed by the majority of the cells but was located in the 
cytoplasm (Niksic, 2004). Thus, it may be necessary to treat EBs at a 
certain point of culture (after day 10 when expression of IM marker Osr1 
occurs) with a nephrogenic cocktail of factors to induce renal progenitor 
differentiation (Kim, 2005).   
 
The described conditions of mesoderm differentiation (15%FCS IMDM ,  
75x10
3
 ml
-1
) were used in this study to efficiently differentiate mesoderm 
from mESC and sort these cells to obtain populations of GFP+ and GFP- 
cells using FACS. However, before investigating the nephrogenic potential 
of the sorted cells by incorporating those in developing mouse kidney 
rudiments ex vivo, it was first necessary to establish a method for labelling 
the mESC derivatives so that they could be distinguish from the host 
rudiment cells. Therefore, the next chapter describes a series of 
experiments that were undertaken to identify the most suitable cells 
labelling system.  
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Chapter 4: Cell tracking system 
4.1 Introduction 
It has been shown that mouse ESC can be efficiently differentiated into 
mesoderm-like cells via embryoid bodies. A key aim of this study is to 
compare the nephrogenic potential of both undifferentiated ESC and ESC-
derived mesoderm cells to that of embryonic kidney progenitor cells by 
incorporating the different cell types into mouse kidney rudiments ex vivo. 
However, in order to monitor the fate of the aforementioned cells 
following transplantation into the host tissue it is necessary to establish an 
appropriate method of cell labelling that does not adversely affect cell 
behaviour.  
There are several methods of cell labelling (see chapter 1.5), however, for 
the current study it was important that the following criteria were met: 
 Labelling should be a vital stain – it should be possible to label 
living cells without the need for fixation to visualise the stain, due 
to performance of the vital functionality assay on the kidney 
chimaera (chapter 6) 
 Short incubation time – it should be possible to introduce the label 
to living cells after a short incubation period, because the ESC-
derived mesodermal cells that will be used in later studies, will be 
isolated from day 4 EBs by FACS, and will need to be introduced 
into the kidney rudiment within a few hours of isolation. 
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 High efficiency of labelling – it should be possible to label the vast 
majority of cells in order for their future integration potential to 
be accurately quantified.  
 Low toxicity – the stain should not be toxic and should have no 
adverse effect on cell viability, in order to minimize cell death. 
 Long signal preservation – it should be possible to localize labelled 
cells after 7 days of culture, as this is the latest time point of the 
analysis.   
One of the most common methods of cell tracking; namely, labelling with 
green fluorescent protein (GFP), (either by knock-in or lentiviral 
transfection), is usually a permanent labelling method, where GFP can be 
ubiquitously expressed by precisely selected stable cells lines (Nagy, 
2003). However, GFP labelling requires cells to be cultured for prolonged 
periods following transfection with plasmid or lentiviral vectors, in order to 
allow sufficient time for the GFP to be expressed (Blomer, 1997; Nagy, 
2003; Zhou, 2009). For example, about 72h should be allowed for GFP 
expression to appear in cells transfected with lentiviral vector (personal 
consultation with S. Theocharatos, University of Liverpool). Therefore, the 
GFP labels do not fulfil the criteria of short incubation time and rapid 
signal appearance.  
The vital stains, DiI and Vybrant Dye (VD) bind to cell membranes. 
DiI is an extracellular lipid dye, whereas VD localises to intracellular 
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proteins (Wang, 1989).  However,  in previous studies, DiI was shown to 
flip-flop between the lipid monolayer of contacting cells 
 (Razinkov, 1999), and therefore was excluded from further analysis as 
there was concern it would cause difficulties in quantifying results, due to 
the possibility of the dye being transferred to host cells. Although VD 
fulfilled the criteria of short incubation, high efficiency of labelling and 
low toxicity, it was not clear how long the label would be retained in mES 
cells. It was also not clear how long cells retain Quantum Dots (QDs) – 
small fluorescent nanocrystals, which are up-taken by the cells and located 
in the vesicles in the cell cytoplasm (Rosen, 2007).  
Taking into account the selection criteria, GFP and DiI labelling were 
discounted for the reasons outlined above. The purpose of this chapter was 
therefore to establish if VD or QDs were suitable for labelling the mESC 
and their derivatives. Therefore this chapter will compare the efficiency, 
toxicity and signal preservation in cells labelled with VD and QDs. 
Furthermore, the optimal labelling method will be tested to determine the 
degree of transfer of label to the host cells. 
 
4.2 Results 
In order to investigate the nephrogenic potential of ESC and ESC-derived 
mesoderm (Bry+) cells, it was necessary to establish the most suitable 
labelling method. Due to the specific criteria for cell labelling required for 
the successful localisation of cells integrated with kidney rudiments ex 
 135 
vivo; the most promising vital stains appeared to be quantum dots (QDs) 
and vybrant dye (VD). Therefore, these two labels were tested to establish 
their intracellular retention time.   
 
4.2.1 Optimisation of labelling method 
In order to determine how long the signal was retained by the cells, 
undifferentiated mouse ESC were labelled according to the manufacturer‟s 
recommendations: either with 10nM QDs or 10nM VD concentration and 
seeded at low cell density (500 cells cm
-2
) (see chapter 2.9 – 2.10). Cells 
were fixed after 1, 3 and 7 days in culture and counter-stained with DAPI 
to visualise cell nuclei.  
The results showed that at day 1, both methods were highly efficient in cell 
labelling, as all cells in both cases were labelled with QDs or VD (Fig. 4.1 
and 4.2). However, at day 3 differences in label retention became apparent. 
QDs were observed in the majority of cells whereas VD labelling had 
become highly diluted and only very weak stain could be observed in a few 
cells. By day 7 of culture, although the population had undergone 
noticeable expansion, QDs were still visible in many cells whereas the VD 
stain was no longer detected in any of the cells (Fig. 4.1). 
Furthermore, apart for having poor retention, VD appeared to be more 
toxic than QDs: for instance, after the first 24h in culture, more cells 
labelled with QDs survived and formed colonies, whereas, many VD  
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Figure 4.1 Comparison of two cell labelling methods: quantum dots (QDs) and vital 
stain of vybrant dye (VD). A, C, E - mES cells labelled with 10μM concentration of QDs 
showed high efficiency of labelling at day 1 (A), day 3 (C) and dilution at day 7 (E); B, D, 
F – mES cells labelled with 10μM concentration of VD showed high efficiency of 
labelling at day 1 (B) and very high dilution of labelling at day 3 (D) and lack of labelling 
at day 7 (F). Scale bar: 50μm. 
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Figure 4.2 Localisation of Quantum Dots (QDs) in the cells. A) Photomicrograph of 
cells labelled with QDs (red), cell membrane stained with vybrant dye (green) and nuclear 
stain – DAPI (blue) presenting QDs aggregation; Scale bar – 10μm; B) Schematic 
localisation of QDs in the cell cytoplasm, very close to the cell nucleus. 
 
             
Figure 4.3 Schematic presentation of labelling dilution with cell divisions.  
A – Dilution and loss of Vybrant dye labelling during cells culture;  B – Aggregation of 
Quantum Dots in cells and their loss during cell culture.  
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labelled cells detached during the first 24h of culture (Fig. 4.1).  Another  
drawback of VD labelling was photobleaching: although cells labelled with 
VD were easily visible down the fluorescent microscope, the fluorescence 
rapidly bleached out during the imaging process, making it impossible to 
image the same area multiple times. 
 
 
Table 4.1 Comparison of cell labelling methods with QDs and VD 
+++ – all cells labelled; ++ – more labelled cells; + – more unlabelled cells; 
 - – lack of labelled cells; 
 
 
Dual labelling of cells with QDs and VD showed that after 1 day in culture, 
QDs are located in the cell cytoplasm of mESC, in the aggregates in the 
perinuclear space (Fig.4.2). A schematic comparison of VD and QDs 
behaviour in cultured cells is presented in Fig. 4.3; the VD label is lost 
during cell divisions and labelled cells can no longer be distinguish from 
unlabelled cells (day 7), whereas QDs are retained in some cells, and 
although many cells do not receive QDs during cell divisions, the primarily 
labelled cells, still maintained QDs (day 7).  
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To summarise, both investigated methods of vital labelling of cells, QDs 
and VD fulfilled the criteria of short incubation time: 1h for QDs and 
15min for VD; and high efficiency of labelling. However, VD showed 
slight cytotoxicity and weak signal retention (Tab. 4.1). Therefore, 
although the QDs labelling method was not perfect due to many cells 
lacking QDs after 7 days in culture, this was the optimal method as many 
cells retained QDs after 3 days in culture and some labelled cells could 
even be detected after a week. Furthermore, there was no obvious toxicity.  
 
4.2.2 Quantum dots do not transfer between cells 
Given that the QDs appeared to be the optimal labelling method, it was 
important to investigate if the QDs could transfer between cells; i.e., from 
labelled exogenous cells to unlabelled host cells, as a high rate of transfer 
would make it difficult to investigate the behaviour of exogenous cells in 
the chimaeric rudiments. Thus, to answer the question if QDs are located 
only in the labelled cells, and do not transfer between the cells during 
culture, a cloned cell line of kidney stem cells (KSC-H6)  
(C. Fuente Mora, University of Liverpool) transfected with GFP lentivirus 
(see chapter 2.9.3) (E. Ranghini, University of Liverpool) was used. These 
cells, KSC-H6/GFP, present stable expression of GFP, with minor changes 
in GFP intensity and were labelled with QDs according to the protocol and 
introduced into kidney rudiment cells. Following 3h (day 0), 1, 2 and 3  
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Figure 4.4 Quantum dots do not transfer between cells in the nephrogenic assay. A) 
FACS graph presenting KSC-H6/GFP being 100% GFP positive (green area), which is 
opposite to the nontransfected mES cells (violet line); B) Quantum dots inside a KSC-
H6/GFP cell after 1 days in culture; scale bar – 10μm C) KSC introduced into E13.5 
kidney cells show preservation of QDs in the cells up to day 3 in culture. Full arrowhead 
pointing onto GFP- cells that gained QDs, empty arrowheads pointing onto GFP+ cells 
that lost QDs; scale bars - 10μm.     
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Figure 4.5 Quantum dots do not transfer between the cells. Light grey columns are 
presenting high preservation of QDs in GFP positive cells (about 95% at day3) 
 (*- p<0.004) and dark grey columns are presenting lack of QDs transfer from GFP 
positive to GFP negative cells as there is no significant difference between the beginning 
and the end of the experiment (**- p>0.1); N=3 for each sample and error bar represents 
standard error. 
 
 
days in culture, samples were fixed, counter-stained with DAPI to visualise 
cell nuclei and analysed. 
The results showed that QDs were found in the cell cytoplasm of labelled 
cells (Fig. 4.4). QD labelled cells could be easily identified until day 3 of 
culture, although at this time point, some GFP positive cells (GFP+) had 
lost QDs (empty arrowhead) and some GFP negative cells (GFP-) had 
gained QDs (full arrowhead) (Fig. 4.4). Statistical analysis of QD loss by 
GFP+ cells and QD gain by GFP- host cells, showed that at day 0 of 
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culture, 99.1% of GFP+ cells were labelled with QDs, and only 1.8% of 
GFP- cells contained QDs. By day 3 of culture, 96% of GFP+ cells were 
still labelled with QDs, and only 2.5% of GFP- cells contained QDs (Fig. 
4.5). Although these numbers are small, QD loss by GFP+ cells showed a 
significant difference between the beginning and the end of the culture, 
whereas the percentage of GFP- cells labelled with QDs was not 
significantly different between the two time points. These results show that 
the extent of QD transfer to host cells is negligible and does not increase 
during the time course of the experiment. In fact, it is likely that the small 
increase in the number of GFP-QD+ cells is due to cell division of the 
kidney cells within the rudiment. 
 
4.3 Conclusion 
In this chapter it has been shown that the optimal method of labelling cells, 
best fulfilling the requirements of the current study, is QD labelling. This 
method showed high efficiency, lack of toxicity and long signal 
preservation as well as low transferability from labelled cells of interest to 
unlabelled cells. 
 
4.3.1 Quantum dots showed long signal maintenance and lack of 
photobleaching 
Signal maintenance by labelled cells was a very important issue for the 
current study. Although there are studies using signal/label disappearance 
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such as fluorescence recovery after photobleaching (FRAP), fluorescence 
loss in photobleaching (FLIP) or selective photobleaching to investigate 
protein dynamics (Goodwin, 2005), in the current study, it was important 
to preserve the signal for a minimum of 1 week without signs of 
photobleaching during imaging. The cells labelled with VD showed rapid 
signal loss and strong photobleaching during the cell imaging process, 
whereas in cells labelled with QDs, photobleaching was not observed, 
which allowed for extensive imaging of cells following the labelling 
(Rosen, 2007; Solanki, 2008) (see section 1.5). This photostability of QDs 
would be very useful in time lapse studies. QDs also showed longer signal 
preservation than VD. QDs in mESC presented signal preservation for up 
to 7 days but the number of labelled cells decreased dramatically, which is 
consistent with a previous report (Lin, 2007). A longer signal maintenance 
(by up to 6 weeks) could be obtained by labelling cells with large 
cytoplasm volume and  low proliferation rate, such as MSC (Rosen, 2007). 
The QDs used in the current study have already been shown to be mainly 
incorporated into cytoplasmic vesicles (endosomes) in the perinuclear 
space (Koshman, 2008; Rosen, 2007). This could be a potential problem, 
as endosomes during cell life can develop into exocytotic vesicles and 
remove QDs outside the cell, although it is worth noting that Rosen and co-
workers (2007) did not observe the release of QDs in their studies. 
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4.3.2 Quantum dots showed lack of toxicity to the labelled cells 
Previous studies have shown that the cytotoxicity of quantum dots was 
strongly dependent on the surface modifications (Hoshino, 2004), and 
while some modifications, such as silica coatings, have been found to be 
highly toxic (Derfus, 2004; Kirchner, 2005), other coatings, such as Zn/S, 
effectively reduced toxicity of QDs with CdSe cores (Kirchner, 2005). 
QDs used in the current study were shown on MSC to have no effect on 
cell viability, proliferation and differentiation abilities (Rosen, 2007). In 
the current study, the viability of QD-labelled cells was compared to VD-
labelled cells. Although there are no reports about VD cytotoxicity in the 
literature, in this study, higher cell death (high levels of cell debris, not 
shown) was observed during the first 24h of culture among mESC labelled 
with VD. The factor that may play a role in the decrease of cell viability is 
dimethyl sulphoxide (DMSO). It is used to deliver the dye into the cells 
(Invitrogen) by increasing the cell membrane permeability (Yu, 1994). 
This feature of DMSO may lead to cell membrane breakage and therefore 
cell death (Yu, 1994). As the incubation of VD took place at 37°C, an 
increased cell death could be observed as at high temperatures, the DMSO 
was shown to have a harmful effect on protein stability (Yu, 1994).  
 
4.3.3 Quantum dots show low transferability   
Another finding of the current study was negligible levels of transfer of 
QDs between cells. The number of adjacent cells labelled with QDs was 
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very low during the time of the nephrogenic assay: 1.8% and 2.6% at day 0 
and day 3 of culture, respectively, and did not show significance in 
increase. The initial number of adjacent GFP- cells labelled with QDs 
(1.8%) could be an effect of an insufficient number of washes in order to 
clean up the media from any free QDs. However, the number of washes 
performed in the current study was already greater than recommended by 
the supplier, and it was not advisable to increase this number, as it would 
decrease the yield of labelled cells.  It is unlikely that QDs, released from 
labelled cells, either as a result of exocytosis or cell death, could be taken 
up by neighbouring host cells, because following initial up-take, QDs form 
large aggregates which would probably be too big for non-phagocytotic 
cells to take up by pinocytosis. Furthermore, it is worth noting that the 
initial up-take of QDs is likely due to the presence of cell penetrating 
peptides (CPP) on their surface. In the acidic environment of the 
endosomes/lysosomes, it is envisaged that the CPPs would be removed by 
lysosomal enzymes (Kim, 2008; Thakur, 2005); making it unlikely that 
these particles could be taken up by adjacent cells.  
 
Despite a few disadvantages related to QD labelling; e.g., up-take and 
maintenance in cells may strongly depend on the cell type (Lin, 2007; 
Rosen, 2007), they have many advantages; e.g., photobleaching resistance, 
high fluorescent signal, non-toxicity and ability to be modified to target 
specific cells and cell organelles (Gao, 2004; Gao, 2005; Lidke, 2004). 
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Therefore, for their advantages QDs were chosen as the tracking method in 
the current study. The described conditions of cell labelling, which are as 
follows; ~1h incubation of ~1M cells in 10nM QD solution in suspension, 
were optimised to allow for medium-term cell tracking (~7 days) in the 
complex environment of the kidney rudiments. The aforementioned 
conditions were used to investigate the nephrogenic potential of mES cells 
and their derivatives in the subsequent part of this study. 
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Chapter 5: Nephrogenic potential of mouse ES cells 
and their derivatives 
5.1 Introduction 
Mouse embryonic stem cells (mESC) are derived from the inner cell mass 
(ICM) of the blastocyst at E3.5 to E4.5 (E – embryonic day). Mouse ESC 
were first isolated in 1981 independently by Evans and Martin (Evans, 
1981; Martin, 1981), and they were shown to be pluripotent, meaning that 
they are able to give rise to cells of all three germ layers of the embryo: 
mesoderm, endoderm and ectoderm, as well as the gametes following 
transplantation into mouse blastocyst (Nagy, 1993). They are also able to 
generate cells of the three germ layers in vitro when cultured as embryoid 
bodies. Furthermore, ESC in culture are immortal and do not become 
senescent or lose their potential (Evans, 1981). It was also reported, that 
ESC form teratomas containing: gut epithelium, cartilage, bone, smooth 
muscle, neural epithelium and nephron-like structures following 
subcutaneous injection of adult mice (Stojkovic, 2005; Thomson, 1998; 
Yamamoto, 2006). Although ESC have the potential to form tumours, they 
are a suitable tool to investigate the potency of ESC in vitro. 
The first study investigating the potential of mESC to generate kidney 
structures and integrate with host tissue involved injecting undifferentiated 
ESC into mouse E12.5 kidney rudiments ex vivo (Steenhard, 2005). 
Injected cells appeared to show integration into developing tubules of the 
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host; however the tubules that ESC formed within the rudiment were 
derived solely from ESC and there was no contribution from host rudiment 
cells. This raised the question of whether the ES-derived tubules were in 
fact non-renal tubular structures (Steenhard, 2005). This is an important 
issue because it has been well documented that that mESC/hESC readily 
form a range of non-renal cell types following subcutaneous injection 
(Thomson, 1998; Yamamoto, 2006), and transplantation under the kidney 
capsule of adult mice (Stojkovic, 2005). Following the Steenhard 2005 
study, various groups have investigated the ability of mESC to generate 
renal cell types using the embryoid body system (Kim, 2005; Kramer, 
2006; Yamamoto, 2006) (see summary in Table 5.1). Kramer and co-
workers showed that following differentiation in embryoid bodies, ESC 
formed ring-like structures positive for podocin, nephrin, podocalyxin and 
cytokeratin suggesting that the cells had differentiated into podocyte-like 
cells and some cells were THP (tamm-horsfall glycoprotein) positive 
suggesting their differentiation into distal tubule cells of the nephrons 
(Kramer, 2006). Using a nephrogenic cocktail of retinoic acid, activin A 
and BMP7, Dressler‟s group achieved nearly 100% integration of ESC into 
the tubular epithelium, of developing mouse kidney rudiments ex vivo, but 
it was not clear from this study if the tubules were metanephric 
mesenchyme or ureteric bud origin. Furthermore, the cells were unable to 
integrate into the glomerular tufts (Kim, 2005). The potential of mESC to 
form renal cells was also investigated by injecting subcutaneously into 
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adult mice to generate tumours (Yamamoto, 2006).  Following 14 to 28 
days of in vivo development, some of the mESC had differentiated tubular 
epithelium and avascular glomeruli. Moreover, the tubules and nephrons 
were shown  to be positive for Pax2, cytokeratin and Ksp-cadherin 
confirming their renal fate (Yamamoto, 2006). However, teratomas are 
known to consist of developing structures of different origins, such as 
meso-, endo- and ectodermal (Stojkovic, 2005; Thomson, 1998), and 
therefore many non-renal cell types are present. Wilson‟s  group (Vigneau, 
2007) have shown that mESC can integrate into proximal tubules 
following transplantation into kidney rudiments ex vivo and neonatal mice 
in vivo.  In this study, prior to transplantation, mESC were pre-
differentiated using the EB culture system and were found to express renal 
markers such as Pax2, Wt1, Wnt4 and cadh-11. In addition to integrating 
successfully with proximal tubules, the pre-differentiated mESC did not 
form tumours following in vivo transplantation (Vigneau, 2007).  
Taken together, the aforementioned studies show that mESC can integrate 
into developing renal structures, but it is not yet clear how this ability to 
integrate compares with that of the renal progenitor cells themselves; nor is 
it clear if the mESC or their derivatives have any detrimental effect on the 
developing kidneys, and the persistence of undifferentiated mESC 
following transplantation has not been thoroughly investigated. 
Furthermore, although mESC – derived mesodermal cells have potential to 
generate some renal cell types following transplantation into embryonic or 
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neonatal kidneys (Kim, 2005; Vigneau, 2007); it appears that they are 
unable to generate podocytes. However, the lack of podocyte 
differentiation could be due to the experimental protocols used. For 
instance, in all studies performed to date, the mESC were transplanted into 
the intact host tissue as a bolus injection, which could make it difficult for 
the cells to integrate into structures that had already differentiated. 
 
Table 5.1 Summary of experiments investigating nephrogenic potential of mESC. 
 
 
Therefore, the aims of this chapter were to: 
 Compare the integrative potential of mESC, mESC-derived 
mesoderm, mESC-derived ectoderm and kidney progenitors into 
mouse kidney rudiments. 
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 Ascertain if these cells types had any detrimental effect on kidney 
development. 
 Determine if the mESC and their derivatives can generate renal-
specific cell types such as podocytes, proximal tubules and 
ureteric bud cells. 
 Determine if any undifferentiated mESC are present at various time 
points following transplantation into rudiments and ex vivo 
culture. 
 
5.2 Results 
In order to achieve all aforementioned goals, it was important to select an 
appropriate cell incorporation method. Therefore, in the current study, use 
was made of a novel rudiment culture method recently established in the 
Davies laboratory (Unbekandt, 2010), which has been shown to facilitate 
the integration of exogenous cells into the kidney rudiments. This method 
involves disaggregating the rudiment; incorporating the stem cells and 
allowing the chimaeric rudiment to re-aggregate and undergo 
morphogenesis. 
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5.2.1 Optimisation of conditions of cell integration with kidney 
rudiments 
The method of creating kidney chimaeras required the kidney rudiments to 
be disaggregated into single cell suspension, mixed with labelled cells of 
interest, pelleted and plated onto a filter membrane. In the original method 
(Unbekandt, 2010), E11.5 kidney rudiments were used; however, the 
number of cells present in the E11.5 rudiment is quite low, necessitating 
the use of large number of embryos. Therefore, to improve yield, older 
kidney rudiments, from E13.5 mouse embryos were used. Therefore, the 
ability of E13.5 kidney rudiments to re-aggregate and reform kidney 
structures was investigated, and the optimal ratio of disaggregated 
rudiment cells to exogenous cells was established.   
The results demonstrated that E13.5 kidney rudiments that were 
disaggregated to a single cell suspension could re-aggregate and undergo 
normal development, reforming kidney structures by day 3 of culture (Fig. 
5.1). To establish the optimal ratio of labelled to unlabelled cells in the 
kidney chimaeras, E13.5 disaggregated kidney rudiments were labelled 
with quantum dots (QDs) and mixed with unlabelled disaggregated kidney 
rudiments in the following ratios: 1:8, 1:20 and 1:50. Results showed that 
the ratios of 1:20 and 1:50 were too low; as few labelled cells could be 
observed following the 3 day culture period (data not shown). However, 
using the ratio 1:8, many labelled cells could be observed both at the initial 
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time point, where they were found to be evenly distributed within the 
chimaera, following a 3 day culture period (Fig.5.2).  
 
Figure 5.1 Kidney chimaera formation. Wt1 (green), Laminin (blue), staining of kidney 
chimera pellet at day 0, presenting random distribution of cells within the pellet without 
any structures (A); and after 3 days in culture, presenting tubule-like (t) and glomeruli-like 
structures (g) formation (B). Scale bars: A) 30μm, B) 60μm. 
 
 
Therefore, in subsequent experiments, chimaeras were always made as 
follows: 20000 QD-labelled cells per 160000 unlabelled kidney cells, so 
that the total number of cells per chimera at day 0 was ~180000.  
These results showed that older embryonic kidneys derived from E13.5 
mouse embryos, can efficiently re-aggregate and re-differentiate to form 
kidney structures, and established that the optimal ratio of unlabelled to 
labelled cells is 1:8.  
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Figure 5.2 Ratio 1:8 of QDs labelled cells to unlabelled kidney rudiment cells.  
Wt1 (green) and laminin (blue) staining of chimaeras at day 0 of culture presenting lack of 
any structures and even distribution of QDs (red) labelled cells (A); and at day 3 of culture 
where kidney structures can be observe with QDs labelled cells incorporated into kidney 
structures (B); Scale bars: A – 30μm, B – 60μm. 
 
5.2.2 Growth and development of rudiment chimaeras 
To investigate the ability of mESC and their derivatives to generate renal 
cell types, the following chimaeras were formed: 
 Undifferentiated mESC mixed with the kidney rudiment cells that 
will be called „ES chimaera‟ in further parts of this work. 
 mESC - derived Bry+ cells (i.e., mesoderm cells) mixed with 
kidney rudiment cells that will be called „Bry+ chimaera‟. 
 mESC - derived Bry- cells (i.e., non-mesodermal cells) mixed with 
kidney rudiment cells that will be called „Bry- chimaera‟. 
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 Kidney rudiment cells mixed with kidney rudiment cells used as a 
positive control of development and integration that will be called 
„kidney chimaera‟. 
These chimaeras were stained for markers of kidney-specific cell types, 
where Wt1 positive cells represented early glomeruli, synaptopodin 
positive cells represented mature podocytes, Six2 positive cells represented 
condensing MM, calbindin positive cells represented UB, LTA (Lotus 
tetragonolobus lectin) represented proximal tubules, and laminin positive 
regions presented basement membrane. 
The results showed that following 3 days of culture, there were noticeable 
differences in sizes of the different types of chimaeras. The surface area of 
each chimaera was either round or ellipse in shape and therefore either the 
formula for the surface area of a disc or an ellipse was used. For each 
chimaera type three samples were measured, the mean was calculated and 
the t test was performed to investigate the size difference significance.  
The biggest chimaeras were formed by the positive control kidney 
chimaeras (4.4 +/- 0.1 mm
2
), followed by the ES chimaeras (3.5 +/- 0.08 
mm
2
), Bry+ chimaeras (2.5 +/- 0.2 mm
2
) and finally, the Bry- chimaeras 
(1.4 +/- 0.4 mm
2
) (Fig. 5.3). The kidney chimaera was shown to be 
significantly (p<0.003) bigger than the other three chimaera types of ES, 
Bry+ and Bry-, whereas no significant (p<0.07) difference between Bry+  
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Figure 5.3 Chimaera surface areas. A) Chimaera surface area visualised by Wt1 
immunostaining, demonstrating formation of glomeruli-like structures (white dashed line 
and yellow arrows). Scale bar – 500μm; B) Graph presenting chimaera size ratios; N=3 for 
each sample and error bar represents standard error; * - p<0.003, ** - p<0.07. 
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and Bry- chimaeras was observed. Immunostaining of the chimaeras for 
Wt1 showed that in three of the chimaera types: kidney, ES and Bry+, 
developing kidney structures were observed (glomerular-like structures 
indicated by the intense Wt1 staining), whereas no staining was observed 
in Bry- chimaeras indicating that no structures had formed (Fig. 5.3). 
Considering the fact that Bry- chimaeras did not develop normally, they 
were excluded from further analyses. 
As the cells introduced into the kidney environment seemed to have an 
impact on chimaera growth, further analysis was undertaken to compare 
the number developing nephrons in the different types of chimaeras. 
Results showed that the average number of glomerular-like structures per 
mm
2
 in kidney, ES and Bry+ chimaeras was 25, 50 and 30 respectively 
(Fig.5.4). Therefore, kidney and Bry+ chimaeras developed a similar 
number of glomeruli while ESC formed twice the number of glomeruli. 
Moreover, ES chimaeras formed very small glomeruli, which were about 
one fourth of the size of the glomeruli that developed in the kidney and 
Bry+ chimaeras. Immunostaining showed that cells expressing high levels 
of Wt1, characteristic of maturing podocytes, had differentiated in the 
kidney and Bry+ chimaeras, whereas these cells were not observed in the 
ES chimaeras (Fig.5.4). 
In order to investigate if the glomeruli in ES chimaeras were able to 
increase in size and mature with time, the culture period was extended to 7 
days, following which, the chimaeras were fixed and co-stained with 
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synaptopodin and laminin. The comparison of sizes and maturity of 
nephrons between kidney, ES and Bry+ chimaeras at day 7 of culture, 
showed that glomeruli of the ES chimaeras were still smaller (similar to 
day 3 results) in comparison to kidney and Bry+ glomeruli, but showed 
expression of synaptopodin (Fig. 5.6), which is a sign of their maturity. 
However, synaptopodin expression in ES chimaeras was noticeably less 
than in kidney and Bry+ chimaeras, indicating that ESC had a negative 
impact on nephron maturation. 
All types of chimaera showed development similar to the one observed in 
intact kidneys, with minor differences. Firstly, the Wt1 and laminin 
immunostaining showed that ES chimaeras had smaller glomeruli-like 
structures, in comparison to kidney and Bry+ chimaeras (Fig. 5.4 and 5.5). 
Secondly, the Six2 and calbindin immunostaining revealed that in all 
chimaera types the condensing MM was present. However, in the ES 
chimaera, the Six2 positive cells were present along the entire ureteric bud 
structure, and not only at the UB tip (Fig. 5.7). Thirdly, all chimaera types 
presented proximal tubule development (LTA staining); however, the 
number of proximal tubules appeared to be reduced in the ES chimaeras 
(Fig. 5.8). 
Therefore, exogenous cell types have an effect on rudiment chimaera 
growth and development. The most obvious effect on chimaera growth 
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Figure 5.4 Glomerular size and number differ between chimaeras. A) Number of 
glomerular-like structures formed during three-day culture by kidney, ES and Bry+ cells in 
respect of area; B) Size of glomerular-like structures formed by kidney, ES and Bry+ 
chimearas; C) Comparison of glomerular-like structures formed in the kidney chimaeras 
(a), ES chimaeras (b) and Bry+ chimaeras (c), identified by Wt1 (green) immunostaining; 
Note that kidney and Bry+ chimaeras showed development of podocyte-like cells (yellow 
arrow in a and c), whereas glomerular-like structures in ES chimaeras are very numerous 
but immature, with no evidence of podocyte differentiation ; * - p<0.001, N=3, error bar 
represents standard error; Scale bar – 50μm. 
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Figure 5.5 Confocal photomicrograph of MM condensation and nephron 
development in kidney, ES and Bry+ chimaeras by day 3 of culture. Wt1 (green) and 
laminin (blue) immunostaining of intact kidney (A), kidney chimaera (B), ES chimaera 
(C), and Bry+ chimaera (D), presenting abilities of all chimaera types to condense MM 
and develop nephrons. Photograph in left upper corner of A presents secondary antibody 
(Goat α Mouse IgG1 (488) and Goat α Rabbit (350)) control staining (where the primary 
antibody was omitted), and applies to all stainings presented in this chapter. Scale bar – 
75μm.  
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Figure 5.6 Presence of mature podocytes in glomeruli in kidney, ES and Bry+ 
chimaeras by day 7 of culture. Synaptopodin (green) and laminin (blue) immunostaining 
of intact kidney (A), kidney chimaera (B), ES chimaera (C) and Bry+ chimaera (D). ES 
chimera developed mature glomeruli (synaptopodin positive) but were much smaller in 
comparison to kidney and Bry+ chimaeras. Photograph in left upper corner of A presents 
secondary antibody (Goat α Mouse IgG1 (488) and Goat α Rabbit (350)) control staining 
(where the primary antibody was omitted), and applies to all stainings presented in this 
chapter. Scale bar – 75μm.  
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Figure 5.7 Confocal photomicrograph of condensing MM in kidney, ES and Bry+ 
chimaeras by day 3 of culture. Six2 (green) and calbindin (blue) immunostaining of 
intact kidney (A), kidney chimaera (B), ES chimaera (C) and Bry+ chimaera (D) 
presenting abilities of all chimaera types to develop ureteric bud structures (calbindin 
positive) and condensed MM (Six2 positive). Photograph in left upper corner of A 
presents secondary antibody (Chicken α Rabbit IgG (488) and Goat α Mouse IgG1 (350)) 
control staining (where the primary antibody was omitted), and applies to all stainings 
presented in this chapter. Scale bar – 75μm.  
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Figure 5.8 Confocal photomicrograph of proximal tubules development in kidney ES 
and Bry+ chimaeras by day 5 of culture. LTA (green) and laminin (blue) 
immunostaining of intact kidney (A), kidney chimaera (B), ES chimaera (C) and Bry+ 
chimaera (D) presenting abilities of all chimaera types to develop proximal tubules. 
Photograph in left upper corner of A presents LTA lectin and secondary antibody (Goat α 
Rabbit IgG (350)) control staining (where the LTA and primary antibody was omitted), 
and applies to all stainings presented in this chapter. Scale bar – 75μm.  
 
 
 
 
 
 
 
 164 
had the non-mesodermal (Bry-) cells, which prevented the kidney 
structures from re-aggregating and re-formatting. Another cell type that 
induced abnormal rudiment chimaeras development was ESC. The ES 
chimaeras developed numerous but small glomerular-like structures and 
formed noticeably fewer proximal tubules. Importantly, ESC – derived 
mesoderm (Bry+), showed lack of negative impact on rudiment chimaera 
development. Although, the Bry+ chimaeras were significantly smaller 
than kidney chimaeras (positive control) they showed most normal 
development in regard of proximal tubule development and glomeruli 
number and size, although the later were slightly bigger than observed in 
the intact kidney. 
 
5.2.3 Integration abilities of mESC and their derivatives 
To establish the regions of the developing kidneys into which the 
exogenous cells integrated, the cells were labelled with QDs prior to 
chimaera formation. The different regions of the developing kidney were 
identified, in chimaeras cultured for 3 days, as follows (Fig.5.9): 
 Developing glomeruli were identified as aggregates of cells with 
intense staining for Wt1 surrounded by basement membrane. 
 Developing tubules (of both UB and MM origin) were identified as 
regions not expressing Wt1 surrounded by basement membrane. 
 The stroma was identified as a region not expressing Wt1 that were 
not surrounded by basement membrane. 
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Figure 5.9 Kidney structures developed during three-day culture. Wt1 (green) and 
laminin (blue) immunostaining presenting tubules of both MM and UB origin, developing 
glomeruli, surrounded by basement membrane and stroma cells.   
 
 
The cells of interest, i.e. kidney, ESC and Bry+ cells were easy to identify 
due to red QD labelling (see chapter 4). Counting of labelled cells in each 
of the three regions was performed on confocal images taken under a 40X 
oil objective. For each type of chimaera, three separate experiments were 
performed and analysed. 
The labelled cells showed the following integration pattern: 
 kidney cells: stroma (68.6% +/- 10), tubules (26.0% +/- 8.7),  
glomeruli (5.3% +/- 1.4). 
 ESC: stroma (32.2% +/- 2.0), tubules (66.5% +/- 2.2), glomeruli 
(1.2% +/- 0.5). 
 Bry+ cells: stroma (75.5% +/- 1.8), tubules (20.6% +/- 1.8), 
glomeruli (4.1% +/- 0.5). 
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The results showed that kidney cells (positive control) and Bry+ cells 
showed a very similar integration pattern, whereas ESC presented a 
significantly different integration potential. In other words, kidney cells 
and Bry+ cells integrated mainly into stroma, whereas ESC integrated 
mainly into tubules. Figures 5.10 and 5.11 present the integration of 
labelled cells within the kidney structures of chimaeras at day 3 of culture 
and the percentage of cells integrated within described structures, 
respectively.  
To establish if the exogenous cells integrated into MM- or UB – derived 
tubules, staining was performed for the proximal tubule marker, Lotus 
tetragonolobus, a lectin that  stains the brush border of proximal tubule 
cells (Kim, 2005; Steenhard, 2005), and for the UB marker, calbindin. 
Statistical analysis of cell integration into proximal tubules versus ureteric 
bud was performed on confocal images taken under the magnification of 
100X. For each sample six images were analysed, from two independent 
experiments.   
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Figure 5.10 Confocal photomicrographs of integration of labelled cells within 
chimaera structures following 3 days in culture. A & B) labelled kidney cells integrated 
into glomerular-like structure (A) and tubules (B) in kidney chimaeras; C & D) labelled 
ESC integrated into glomerular-like structures (C) and tubules (D) in ES chimaeras; E & 
F) labelled Bry+ cells integrated into glomerular-like structures (E) and tubules (F) in 
Bry+ chimaeras; g – glomerular-like structure, t – tubule-like structure. Scale bar – 20μm. 
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Figure 5.11 Integration potential of kidney cells, embryonic stem (ES) cells and 
mesoderm-like cells (Bry+) into different regions of the developing kidney. Kidney 
cells and Bry+ cells showed similar integration pattern whereas ES cells showed 
significantly different integration potential. ES – embryonic stem cells; N=3 for each 
sample and error bar represents standard error; * - p< 0.05, ** < 0.01. 
 
 
The results showed that all investigated cell types; kidney, ESC and Bry+ 
cells, integrated into both MM- and UB-derived tubules (Fig.5.12). 
However, statistical analysis revealed that in all investigated cells types, 
more cells integrated into the collecting duct tubules than into proximal 
tubules. Moreover, significantly (p<0.05) lower numbers of ESC 
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Figure 5.12 Confocal photomicrograph showing differentiation of exogenous cell  to 
proximal tubules cells (A) following 5 days in culture and ureteric bud cells (B) 
following 3 day in culture, within rudiment chimaeras. Labelled kidney cells (A‟), ESC 
(A‟‟) and Bry+ cells (A‟‟‟) integrated into proximal tubule of the nephron and into ureteric 
bud, B‟ – kidney cells, B‟‟ – ESC, B‟‟‟ – Bry+ cells; Yellow arrows indicate QD- labelled 
cells; Scale bar – 20μm. 
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Figure 5.13 Relative integration of cells into tubules of both: MM and UB origins. 
Percentage of cells integrated into proximal tubules (bottom column); ureteric bud (middle 
column) and not integrated – undifferentiated cells (upper column). ESC showed 
significantly lower integration into proximal tubules than kidney and Bry+ cells and 
showed significantly more undifferentiated cells not integrated into any structures. N=6 for 
each sample, * - p<0.05, ** - p<0.001.   
 
 
integrated into the proximal tubules in comparison to the kidney and Bry+ 
cells, and more importantly the ESC showed a significant (p<0.001) 
number of cells (>40%) not integrated into proximal tubules neither UB 
structures, which were later identified as still undifferentiated cells clusters 
surrounded by basement membrane (see chapter 5.2.4), whereas in Bry+ 
chimaeras, Bry+ cells presented only 1% of these undifferentiated cells 
(Fig. 5.13). 
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The results demonstrated that mES-derived mesoderm (Bry+) cells 
integrated into the kidney structures in a similar manner as kidney 
progenitor cells (positive control) into stroma, tubules of MM and UB 
origin, and glomerular-like structures, whereas undifferentiated mESC 
showed integration mainly into tubule-like structures. mESC integrated 
into proximal tubules and collecting duct, but a large number of ESC 
(>40%) were not integrated into tubular structures but remain in 
undifferentiated state.  
 
5.2.4 Differentiation potential of mES cells and their derivatives 
To investigate the differentiation / nephrogenic potential of mESC and 
their derivatives (Bry+ cells), exogenous cell types were labelled with QD 
(see chapter 4) and used to generate ES and Bry+ chimaeras. These 
chimaeras were stained for markers of kidney-specific cell types, where 
Wt1 positive cells and synaptopodin positive cells represented mature 
podocytes, Six2 positive cells represented condensing MM, and calbindin 
positive cells represented UB tubules. The expression of the 
aforementioned markers was investigated in exogenous cells before they 
were used to generate chimaeras.    
The results showed that neither ESC nor Bry+ cells showed expression of 
any of the aforementioned renal markers, Wt1, synaptopodin, Six2 or  
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Fig. 5.14 Expression of kidney specific genes: calbindin, Six2, Wt1 and Synaptopodin 
by kidney, ESC and Bry+ cells (cultured for 24h after dissociation/FACs sort) prior 
to chimaeras formation. A, D, G, J)  Kidney (E13.5) cells presented expression of 
Calbindin (A) ,Six2 (D), Wt1 (G) and Synaptopodin (J); B, E, H, K) ES cells showed lack 
of expression of calbindin (B), Six2 (E), Wt1 (H) and Synaptopodin (K); C, F, I, L) Bry+ 
cells showed lack of expression of Calbindin (C), Six2 (F), Wt1 (I) and Synaptopodin (L); 
Scale bar 50μm; Experiment performed twice. 
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Figure 5.15 Control staining where primary antibody was omitted, on kidney cells 
cultured for 24h after dissociation, showed light background. A) Goat anti mouse 
IgG1 antibody; B) Goat anti rabbit IgG antibody. Scale bar – 50m; Experiment performed 
twice. 
 
 
calbindin prior to generating chimaeras in comparison to kidney cells 
(positive control) (Fig. 5.14). The negative control of the experiment, 
where primary antibody was omitted, showed light background staining 
(Fig. 5.15). However, after integration, QD-labelled Bry+ cells showed 
expression of Wt1, synaptopodin, Six2 and calbindin (Fig. 5.16), when 
integrated into appropriate renal structures. This was very similar to the 
positive control of kidney chimaeras. Undifferentiated ESC showed up-
regulation of calbindin, but very few were found to up-regulate Wt1, and 
all failed to show up-regulation of synaptopodin and Six2 (Fig. 5.16).  The 
negative controls for all previously mentioned staining on chimaeras, 
where primary antibody was omitted, showed lack of unspecific staining 
(Fig.5.5-5.8). 
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Figure 5.16 Confocal photomicrographs presenting up-regulation of kidney specific 
markers by integrated exogenous cells. A) Wt1 (green) and laminin (blue) staining 
present QD-labelled cells of kidney (A‟) and Bry+ (A‟‟‟) that integrated into glomeruli-
like structures and up-regulated Wt1, while ES cells (A‟‟) did not up-regulate Wt1; B) 
Synaptopodin (green) and laminin (blue) staining present QD labelled cells of kidney (B‟) 
and Bry+ (B‟‟‟) that integrated into glomeruli-like structures and formed podocyte-like 
cells, whereas ES cells (B‟‟) did not up-regulate synaptopodin and were not found in the 
podocyte-like cells; C) calbindin (blue) staining present QD-labelled cells of kidney (C‟), 
ES (C‟‟), Bry+ (C‟‟‟) cells that integrated into ureteric bud structures up-regulated 
calbindin (blue); Six2 (green) staining show  QD-labelled cells of kidney (C‟) and Bry+ 
(C‟‟‟) that were present in condensed MM and up-regulated Six2 (green), while only ES 
(C‟‟) cells did not show up-regulation of Six2 as none of labelled cell was found in the 
condensed MM region. Scale bar – 20μm. Yellow arrows pointing onto integrated cell that 
have up-regulated Wt1 (A), synaptopodin (B), and Six2 (C). 
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The results demonstrated that Bry+ cells after integration into kidney 
structures, showed up-regulation of all important kidney markers of 
podocytes (Wt1 and synaptopodin), condensing MM (Six2), and UB 
tubules (calbindin), whereas undifferentiated ES cells showed convincing 
up-regulation of calbindin only. 
 
 5.2.5 Investigating the presence of undifferentiated (Oct4 positive) 
ESC in rudiment chimaeras 
Although expression of organ specific markers is an important process 
after cell integration, the opposite important process that will demonstrate 
cell profile changes is down-regulation of expression of markers specific 
for pluripotency, for example the marker gene Oct4.  
Therefore, Oct4 expression was investigated in cells before generating 
chimaeras and in the chimaeras after 3, 5 and 8 days in culture. Results 
showed that ESC and Bry+ cells presented Oct4 expression prior to 
chimaera formation as well as at day 0 of culture.  
ESC showed a tendency to continue Oct4 expression as long as day 8 of 
chimera culture. During the first 3 days of culture, cells seemed to clump 
together, and formed laminin surrounded colonies within the chimera. By 
day 5 of culture, ESC colonies enlarged in size and were found mainly in 
the outer area of the chimera. At day 8 of culture, ESC colonies decreased 
in size, but still remained in the outer area of the chimera forming big 
clusters. 
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Figure 5.17 Oct4 expression in the ES cells and Bry+ cells before making chimaeras 
and after 3 hours in culture (day0). A-C) Oct4 (red) and DAPI (blue) staining of 
cytospinned cells; ES cells (A), Bry+ cells after FACS sort (B) and control of Oct4 
staining where the primary antibody was omitted (C); D-E) Oct4 (green) and laminin 
(blue) staining of chimeras; expression of Oct4 in chimaeras of ESC (D), and Bry+ cells 
(E); F) Oct4 (green) and calbindin (blue) staining of kidney chimera; control of Oct4 
staining in the kidney chimera (F). Scale bar: A-C – 50μm, and D-F – 30μm.  
 
 
Bry+ cells expressed Oct4 straight after FACS sort and at day 0 of chimera 
culture, although not in all cells (Fig. 5.17). However, the number of Oct4 
positive cells became highly reduced by day 8 of chimera culture. Bry+ 
chimaeras showed only a few Oct4 positive cells at day 3 and 5 of culture 
(couple of small colonies composed of 4-12 cells) which decreased even  
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Figure 5.18 Confocal photomicrograph demonstrating the Oct4 positive cells 
presence in ES and Bry+ chimaeras. Oct4 (green) and laminin (blue) immunostaining of 
ES and Bry+ chimaeras at day 3, 5 and 8 of culture. A-F) presence of Oct4 positive cells in 
ES chimaeras at day 3 (A, D), day 5 (B, E), and day 8 (C, F) of culture.  
G-L) presence of Oct4 positive cells in Bry+ chimaeras at day 3 (G, J), day 5 (H, K) and 
day 8 (I, L) of culture. Scale bars: A-C and G-I – 60μm; D-F and J-L – 20μm. Experiment 
was performed twice. 
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Figure 5.19 Confocal photomicrograph demonstrating presence of Oct4 positive cells 
in ES and Bry+ chimaeras. Oct4 (green) and calbindin (blue) staining of ES and Bry+ 
chimaeras at day 3, 5, and 8 of culture. A-F) presence of Oct4 positive cells in ES chimera 
at day 3 (A, D), day 5 (B, E), and day 8 (C, F) of culture; G-L) presence of Oct4 positive 
cells in Bry+ chimera at day 3 (G, J), day 5 (H, K) and day 8 (I, L) of culture. Scale bars: 
A-C and G-I – 60μm; D-F and J-L – 20μm. Experiment was performed twice. 
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more in size and number by day 8 of chimera culture (Fig. 5.18 and Fig. 
5.19).  
Therefore, the elaborated results demonstrated, that mESC – derived 
mesoderm cells (Bry+) have successfully and rapidly down-regulated the 
pluripotency marker Oct4, in Bry+ chimaeras by day 8 of culture, although 
a few small colonies still could be observed. However, in ES chimaeras 
Oct4 positive cells increased in number during the 8 days of culture 
demonstrating failure of ESC in rapid down-regulation of this pluripotency 
marker. 
 
5.3 Conclusion 
In this chapter, it has been demonstrated that exogenous cell types have an 
effect on kidney growth and development. On the one hand, the non-
mesodermal cells were shown to have a strong detrimental effect on kidney 
growth, whereas ESC had an effect on normal kidney development. On the 
other hand, Bry+ cells were shown to have an impact on kidney growth but 
not on the development.  Mesoderm-like cells (Bry+) were shown to have 
a very similar integration profile to positive control (kidney progenitor 
cells) as well as the ability to up-regulate kidney specific markers (Wt1, 
Six2, calbindin, synaptopodin) and down-regulate the pluripotency marker 
Oct4. 
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5.3.1 Embryonic kidney rudiments are able to re-form kidney structures 
after disaggregation at embryonic day 13.5 
Saxen‟s well established method of intact mouse kidney rudiment ex vivo 
culture (Saxen, 1987) is suitable to investigate kidney developmental 
processes such as ureteric bud branching morphogenesis, metanephric 
mesenchyme condensation and nephron formation, whereas on the other 
hand, it is not suitable to investigate the behaviour of exogenous cells 
introduced to the organ culture system. The majority of cells injected into 
intact kidneys, remain at the injection site, as the kidney is very compact 
and organized organ and therefore it is difficult for injected cells to migrate 
away from the injection site (Steenhard, 2005). It is also possible that cells 
find it difficult to integrate into structures already delineated by the 
basement membrane and therefore form their own tubular structures not 
mixed with the host (Steenhard, 2005), which due to their morphology are 
characterized as a proximal tubules. This could be due to BMP7 produced 
by the podocytes of the host that induces proximal tubule growth and 
development (Kazama, 2008). Therefore, to solve the aforementioned 
limitations of metanephric organ culture, a novel method was employed, 
which used dissociated kidney cells to form kidney chimaeras (Unbekandt, 
2010). This method was used in the current study to introduce exogenous 
cells into the embryonic kidney environment and investigate their 
nephrogenic potential. Although culture conditions were optimised for 
E11.5 kidneys in Unbekandt‟s method, in the current study it was shown 
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that E13.5 kidneys are also able to re-aggregate after dissociation into 
single cell suspension, and re-form appropriate kidney structures. In this 
system, no nephron to nephron or bud to bud connections were observed, 
which is consistent with Unbekandt‟s study (Unbekandt, 2010). 
In the current study, the kidney chimaera formed about 25 glomeruli-like 
structures per mm
2
 by day 3 of culture, and a previous report demonstrated 
the same number of glomerular-like structures by day 7 of culture 
(Unbekandt, 2010). This could be an effect of using older embryonic 
kidneys, E13.5 in the current study and not E11.5, which possibly develop 
more rapidly than younger kidneys; as well as more cells used at the 
beginning of the experiment, i.e. 180K and not 80K cells. 
 
5.3.2 The effect of exogenous cells on development of rudiment 
chimaeras  
Embryonic kidneys were shown to be able to re-form kidney structures in 
vitro following dissociation into single cell suspension. However, 
introduction of different exogenous cell types had an impact on the 
chimaera growth, development and structure formation. As expected, 
chimaeras made only from kidney cells developed normally and served as 
a positive control for all experiments investigating the effect of exogenous 
cells on kidney development, and the nephrogenic potential of mESC and 
their derivatives.  
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mES-derived mesoderm cells (Bry+) chimaeras showed a similar number 
of glomerular-like structures of similar morphology to kidney chimaeras: 
large glomeruli with a visible podocyte-like cell layer. In contrast, ES 
chimaeras formed numerous small underdeveloped glomerular-like 
structures. This is probably due to the comparable gene expression profile 
between Bry+ cells and E13.5 kidney cells, especially the mesodermal 
genes (Foxc1 and Osr1) and kidney marker (GDNF) (see chapter 3); 
whereas mESC did not show expression of the aforementioned genes. 
Despite the lack of integration of mESC into glomerular-like structures, 
they influenced their development. It is known, that elevated levels of 
FGF7 can increase the number of nephrons in intact kidney cultures by 
about 50%, and moreover, prolonged exposure to exogenous FGF7 can 
partially inhibit nephron maturation (Qiao, 1999). Although there is 
minimal information concerning FGF7 expression by mESC in the 
literature, it must not be excluded that mESC express FGF7 and therefore 
elicit a similar phenotype of the many immature nephrons in culture 
conditions used in the current study.    
In contrast to the results of Vigneau and co-workers (Vigneau, 2007), Bry- 
cells not only did not incorporate into collecting duct structures but had a 
negative impact on the total kidney development, so that no structures 
could be observed. The discrepancy between Vigneau and the current 
study could be due to a different cell differentiation method used. Vigneau 
added activin A into the embryoid body culture medium, whereas in the 
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current study only high FCS concentration was used.  Therefore, the Bry- 
cells obtained in the current study could differ from those obtained by 
Vigneau, in their potential.  
The negative effect of Bry- cells on chimaera development could possibly 
be due to: 
 Sequestration of signalling molecules. 
 Inhibition of signalling pathways important for kidney 
development.  
 Overexpression of growth factors. 
GDNF is a signalling molecule that is crucial for kidney development. 
Numerous transcription factors, for example: Pax2, Pax8, Six1, Six2, Sall1, 
Eya1 and the Hox11 paralogous are playing important roles in inducing 
MM cells to secrete GDNF (Boyle, 2006; Sajithlal, 2005; Takasato, 2004; 
Wellik, 2002; Xu, 2003). Once secreted, GDNF binds to its receptor c-Ret, 
localized on the surface of the UB, where it induces UB branching 
morphogenesis by activating the Wnt pathway (Vize, 2003). Apart from 
many transcription factors (for example, Slit2, Robo2) that can inhibit 
GDNF secretion (Grieshammer, 2004), there are molecules that have a 
high affinity for GDNF and would be able to sequestrate it (Parkash, 
2008). Therefore, a possible explanation for the negative impact of Bry- 
cells on chimaera development could be due to either direct sequestration 
of GDNF by Bry- cells or by secretion of heparin sulphates, which could 
 184 
bind to GDNF and/or c-Ret and block them and therefore prevent their 
interactions and nephrogenesis induction. However, it is also possible that 
the negative action of Bry- cells can take place in the later stages of kidney 
development. For instance, after binding to c-Ret, GDNF activates the 
Wnt/β-catenin pathway during kidney development (Park, 2007; Vize, 
2003). This pathway can be inhibited by Wnt antagonists: e.g., the sFRP 
class which bind to Wnt ligands or by the Dkk class that bind to a 
component of the Wnt receptor (Kawano, 2003). Therefore, if Bry- cells 
are expressing any of the Wnt antagonists they could prevent 
nephrogenesis in the chimaera rudiment. 
Another possibility is high expression of factors such as BMP4 (a member 
of the transforming growth factor-β (TGF-β) family), which in vivo is 
known as a ureteric bud inhibitor that prevents multiple ureters from 
forming (Ichikawa, 2002). However, the similar levels of BMP4 
expression in Bry- cells to Bry+ cells and mESC (see chapter 3) suggests 
that this factor is not responsible for inhibiting nephrogenesis in Bry- 
chimaeras. Nevertheless, another member of the TGF-β family, BMP7, 
could be involved in inhibiting Bry- chimaera growth. BMP7 was 
demonstrated as an important survival factor for metanephric mesenchyme 
in culture, which can efficiently inhibit nephrogenesis and promote 
expansion of stromal progenitor cells in vitro (Dudley, 1999). Moreover, 
the stromal cells were shown to inhibit nephrogenesis (Yang, 2002). Thus, 
if Bry- cells express high levels of BMP7, they could induce stromal fate in 
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the kidney metanephric mesenchymal cells and therefore decrease Wt1 
expression in the chimaeras as it was observed in the current study.  
All three discussed possibilities are feasible explanations of the detrimental 
effect of Bry- cells in kidney rudiment development, although they may act 
independently or in combination. 
 
5.3.3 mES-derived mesoderm and kidney progenitors show similar 
nephrogenic potential 
The results presented have showed that in kidney chimaeras, the majority 
of labelled kidney cells integrated into renal stroma, fewer cells into 
tubules and even less into the glomerular-like structures. In the current 
work, the renal stroma is characterized as cells that are Wt1 negative and 
not surrounded by the laminin positive basement membrane. In this way, 
the renal stroma contained both: cells being a real stroma precursor (Six2 
negative and Wt1 negative) that inhibit glomerulogenesis (Yang, 2002), 
and cells of condensed metanephric mesenchyme (Six2 positive), which 
form the condensed MM cup and represent the cells that are committed to 
develop into nephrons (Kobayashi, 2008). A key goal in stem cell-based 
renal therapies would be to have a stem cell that was able to integrate into 
glomerular-like structures as well as being able to undergo tubular 
integration (Vigneau, 2007). Importantly, the current study suggests that 
cells integrated into the renal stroma are able to become part of the 
nephrons, including glomerular-like structures, during development.   
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mES-derived mesoderm cells (Bry+) integrated in a similar pattern to 
kidney cells, mainly into stroma, which may be due to similar gene 
expression profile, especially the expression of paraxial mesodermal gene 
Foxc1. It was recently shown that paraxial mesodermal cells contribute to 
the renal stroma during kidney development (Guillaume, 2009) and 
therefore, expression of Foxc1 may have a significant impact on cell 
integration. Moreover, many of these cells (Bry+) were calbindin positive 
indicating their integration and differentiation into ureteric bud cells. Bry+ 
cells were also Six2, Wt1, and synaptopodin positive, indicating 
differentiation into condensing MM cells, early and late (mature) 
glomeruli, respectively. Furthermore, Bry+ cells and also integrated into 
proximal tubules, as evidenced by LTA binding thereby proving their 
nephrogenic potential.  
In contrast, undifferentiated ESC which lack the expression of Foxc1, 
showed integration mainly into tubules. Immunostaining for calbindin and 
LTA confirmed integration of ESC with ureteric bud tubules (calbindin 
positive) and much less into proximal tubules of the nephron (LTA 
positive). This is in agreement with previously presented data (Steenhard, 
2005), although different methods of cell integration with kidney 
rudiments were used. Moreover, ESC did not integrate into glomerular-like 
structures. A possible explanation for this finding may be the kidney 
microenvironment, which provides specific signals to exogenous cells, 
which can be properly recognised by ESC derived mesoderm (Bry+) but 
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possibly not by the undifferentiated ESC. This might be due to the fact that 
kidney develops from mesoderm and therefore, mESC – derived 
mesoderm cells (Bry+) are already committed to read signals sent by 
kidney cells, whereas undifferentiated ESC need to first differentiate into 
mesoderm within the kidney environment to be able to differentiate into 
kidney specific cells. Therefore, the differentiation of mESC into kidney 
specific cells occurs at low frequency. 
 
5.3.4 Undifferentiated ES cells failed to down-regulate Oct4 expression 
Undifferentiated ESC, unlike Bry+ cells, failed to up-regulate kidney 
specific markers (Six2, Wt1, synaptopodin) and down-regulate the 
pluripotency marker (Oct4). Undifferentiated ESC showed expression of 
Oct4 until day 8 of culture and there was a visible increase of Oct4 positive 
cell “colonies”. This observation is consistent with the previous report by 
Steenhard (2005), who demonstrated that ESC constituted about 5% of the 
total kidney area by day 5 of in vitro culture. However, this report did not 
investigate if ESC remained in an undifferentiated state, whereas in the 
current study, failure of mESC in down-regulating Oct4 was demonstrated. 
It is known that for mESC to remain in an undifferentiated and pluripotent 
state, supplementation of the culture medium with leukaemia inhibitory 
factor (LIF) is required (Williams, 1988). UB cells within kidney 
rudiments were shown to express LIF (Yoshino, 2003), and therefore, the 
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signals for mESC to stay undifferentiated after ES chimaera generation can 
originate from kidney cells and cause delay in ESC differentiation. 
The immunostaining of chimaeras showed many Oct4 positive cells within 
ES chimaeras and only a few within Bry+ chimaeras. These observations 
are in agreement with statistical analysis performed in the current study, 
which demonstrated, that about 40% of cells within ES chimaeras are not 
integrated into any kidney structure in comparison to only 1% in Bry+ 
chimaeras at day 3 of culture.   
 
The aim of this work was to determine if ESC and their derivatives are able 
to respond to developmental signals obtained from the microenvironment 
of the kidney and to investigate their abilities to incorporate into kidney 
structures. Based on the presented analysis it was concluded that 
undifferentiated ESC did not incorporate into kidney structures, but rather 
stayed in an undifferentiated state. Only mES-derived mesoderm cells 
(Bry+) can efficiently, not only integrate with kidney structures, but as well 
up-regulate key kidney specific markers. More importantly, Bry+ cells 
showed down-regulation of the pluripotency marker Oct4, and therefore 
could be a potential source of cells for cell therapies. Although integration 
into kidney structures and up-regulation of kidney specific markers is an 
important attribute of Bry+ cells, it is also essential to investigate if 
incorporated cells are able to display kidney functions. The latter will be 
investigated in the following chapter. 
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Chapter 6: ESC derived mesodermal cells display 
normal kidney functionality 
6.1 Introduction 
The main kidney functions are to regulate the level of water and salts in the 
blood, and to produce hormones that regulate the blood pressure and retain 
the homeostasis of the organism. Maintenance of homeostasis is via 
selective reabsorption of important molecules such as glucose, water and 
amino acids, and active secretion of toxins of endo- and exogenous origin, 
including clinically important compounds such as antibiotics or other drugs 
(Brenner, 2000; El-Sheik, 2008). Such actions take place in the proximal 
tubule of the nephron although the distal tubule is more active in water 
reabsorption (Brenner, 2000). The basolateral and apical (brush border) 
membrane of the proximal tubule is filled with organic anion (OA) and 
organic cation (OC) transporters (Sweet, 2001). The organic anion 
transporters (OATs) belong to the solute carrier family that play an 
important role in anionic drug transport throughout the body and have been 
identified in fish (Sweet, 1999), mouse (Kobayashi, 2005b), rat (Sweet, 
2006), rabbit (Makhuli, 1995) and human (Kimura, 2002).  
The active up-take of organic anions from the renal plasma (interstitial 
renal fluid) is mediated by exchange with other intracellular anions, i.e.  
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Figure 6.1 Schematic of the organic anion transport mechanism in proximal tubule 
cells. On the basolateral membrane of the proximal tubule cells, organic anions (OA-) are 
taken up from the interstitial fluid and transported to the apical membrane (brush border 
membrane) where OA are secreted into the proximal tubule lumen. On the basal 
membrane, the OA transport indirectly depends on the Na+ gradient. The ATPase Na+/K+ 
channel is pumping Na+ outside the cells (interstitium), where it is used as a co-transporter 
in the Na+/DC (dicarboxylate) co-transport channel. Dicarboxylates (DC) (i.e. α-
ketoglutarate), which are pumped into the cell by Na+/DC channels, are used by organic 
anion transporters (OAT) to carry OA  into the cell. On the apical membrane OA are 
transported outside the cells, but the exact molecules taking part in this exchange process 
are unknown. Drawing prepared on the basis of: Brenner 2000, Sweet 2001, Sweet 2003 
and El-Sheik 2008. 
 
 
 
 
 191 
α-ketoglutarate, and depends directly or indirectly on Na+ gradients (El-
Sheik, 2008; Russel, 2002; Sweet, 2003). The transport through the 
proximal tubule cell from the basolateral to apical membrane is probably 
mediated by the microtubules (Masereeuw, 2001; Russel, 2002), whereas 
the transport out, into the proximal tubule lumen is similar to the 
basolateral membrane mechanisms; however, the anions taking part in that 
exchange have not yet been identified (Fig. 6.1) (El-Sheik, 2008; Russel, 
2002; Sweet, 2001; Sweet, 2003). The basolateral up-take of OA is more 
efficient than the apical transport, and therefore there is an accumulation of 
OA in the proximal tubule cell cytoplasm (Masereeuw, 2001). 
Knowledge of the mechanism of action of organic anion transporters has 
led to the identification of OAT inhibitors such as probenecid  
(4-(dipropylsulfamoyl)benzoic acid) (El-Sheik, 2008; Hsyu, 1988).   
Probenecid binds to the OA binding site of the transporter and thus inhibits 
OA transport by preventing the OATs from undergoing the conformational 
change required for OA transport (Tahara, 2006). Probenecid treatment 
results in decreased excretion of drugs from the body, and can therefore 
help to elevate antibiotic concentration in the blood, enabling lower doses 
to be administered (Butler, 2005).  
The functionality of OATs can be investigated in living cells using 
fluorescent anionic dyes such as lucifer yellow or carboxyfluorescein, 
(Cole, 1991; Sweet, 2006). Importantly, vital staining with 
carboxyfluorescein has shown that proximal tubule cells derived from 
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induced rat metanephric mesenchyme ex vivo express functional OATs 
(Sweet, 2006).  
Although previous studies have shown that mESC and mESC – derived 
mesoderm can generate proximal tubule cells following integration into 
kidney rudiments ex vivo (Steenhard, 2005) and neonatal kidney in vivo 
(Vigneau, 2007), it remains to be established if these cells display normal 
functionality.  
Therefore, the aim of this chapter was to investigate if proximal tubule 
cells generated from mESC and mESC – derived mesoderm cells displayed 
normal proximal tubule OAT function. To this end, the vital dye staining 
method established by Sweet (2006) to investigate function in rat kidney 
rudiments, was modified and optimised for use in intact mouse kidney 
rudiments. Following optimisation in intact rudiments, the assay was 
applied to kidney, ES and Bry+ rudiment chimaeras. In brief, this involved 
incubating the rudiments in the presence of carboxyfluorescein, and 
screening the exogenous cells for their ability to transport the anionic dye 
from the extracellular space into the cytoplasm and finally, into the lumen 
of the proximal tubule. 
 
6.2 Results 
The results will focus on optimising the kidney functionality assay and 
investigating the OAT function in proximal tubules generated by 
exogenous cells. 
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6.2.1 Optimisation of kidney functionality assay 
The assay to investigate OAT function in kidney rudiments had been first 
established using rat kidneys dissected at E13.5, which is equivalent to 
mouse E11.5. Sweet and co-workers showed that kidneys cultured ex vivo 
begin to function after 7-9 days in culture (Sweet, 2006). In the current 
study, before investigating the functionality of the ESC and their 
derivatives in the rudiment chimaeras, it was first necessary to establish the 
time point when functioning proximal tubule cells differentiated in intact 
mouse kidney rudiment during ex vivo culture.  
To enable tubule recognition and help identify the position of the proximal 
tubules, samples were incubated in the presence of peanut agglutinin lectin 
(PNA)-rhodamine (red), which labelled tubules of metanephric and 
ureteric bud origin, and early glomeruli within the kidney and chimaera 
rudiments (supra-vital staining). Results showed that intact mouse 
embryonic kidneys, dissected from mouse embryos at E13.5, demonstrated 
functionality – by active up-take of 6-carboxyfluorescein (6-CF), following 
3 days in culture. While, at day 3, only a couple of actively transporting 
tubules were observed, by day 5 of ex vivo culture, many tubules displayed 
activity. In control samples, accumulation of 6-CF was efficiently inhibited 
by addition of probenecid into the incubation solution (Fig. 6.2 and Fig. 
6.3). 
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Figure 6.2 Timing of on-set of proximal tubule cell function in kidney rudiments 
cultured ex vivo. PNA lectin (red) and 6-CF (green) staining presenting OATs function 
blocked with probenecid (A ,C, E, F) at day 2 (A), day 3 (C), day 4 (E) and day 5 (F) of ex 
vivo culture; and active 6-CF uptake by proximal tubules (B, D, F, H) at day 2 (B), day3 
(D) day 4 (F) and day 5 (H). Proximal tubules showed active uptake of 6-CF at day 3 and 
increased activity by day 5 of culture.  
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Figure 6.3 Proximal tubule functions. PNA lectin (red) and 6-CF (green) staining 
presenting effectiveness of probenecid inhibitory functions (A, C, E, G) and 6-CF up-take 
by proximal tubule cells (B, D, F, H) at day 2 (A ,B), day 3 (C, D), day 4 (E, F) and day 5 
(G, H) of ex vivo culture.  
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The results demonstrated that intact mouse E13.5 kidney rudiments began 
to develop functional proximal tubule cells following 3 day of ex vivo 
culture. By day 5, extensive proximal tubule cell differentiation was 
observed, as evidenced by the fact that all renal tubules displayed up-take 
of 6-CF.   
 
6.2.2 Investigating the functionality of proximal tubule cells derived 
from exogenous cells in mouse rudiment chimaeras  
The intact kidney rudiments showed functionality at day 3 of culture and 
after. The kidney, ES and Bry+ chimaeras, presented very obvious 
functionality after 4 days in culture (data not shown). Earlier time points 
(day 2 and day 3) of the samples could not be analysed because of weak 
adherence and their detachment from the filter membrane. This made the 
analysis not possible due to sample loss.  Therefore, for the reasons 
mentioned above, day 5 was chosen to investigate the ability of the 
kidney, ES and Bry+ chimeras to display proximal tubule cells 
functionality. The active transport of 6-CF in the chimaeras was compared 
to that in the intact kidney (positive control of the staining), as well as to 
chimaeras with probenecid (negative controls).  
 
 
 197 
            
Figure 6.4 Confocal photomicrographs presenting functionality of intact kidney 
rudiment and the different rudiment chimaeras at day 5 of culture (next page). 
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Figure 6.4 Confocal photomicrographs presenting functionality of intact kidney 
rudiment and the different rudiment chimaeras at day 5 of culture. PNA lectin (red) 
and 6-CF (green) staining presenting effective proximal tubules transport inhibition with 
probenecid (A,C,E,G) in the intact kidney rudiment (A), kidney chimaera (C), ES 
chimaera (E) and Bry+ chimaera (G); and proximal tubule transport of 6-CF (B,D,F,H) by 
intact kidney rudiment (B), kidney chimaera (D), ES chimaera (F) and Bry+ chimaera (H). 
Scale bar – 150μm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Confocal photomicrographs presenting OAT function in integrated 
exogenous cells in rudiment chimaeras cultured for 5 days. PNA lectin (red) and 6-CF 
(green) staining presenting effective proximal tubules transport inhibition with probenecid 
(A,C,F,I) in the intact kidney rudiment (A), kidney chimaera (C), ES chimaera (F) and 
Bry+ chimaera (I); and proximal tubule transport of 6-CF (B,D,G,J) by intact kidney 
rudiment (B), kidney chimaera (D), ES chimaera (G) and Bry+ chimaera (J); E, H, K – 
higher power photomicrographs of functional tubules with  
QD-labelled cells of kidney (E), ES (H) and Bry+ (K). White arrows are pointing to QD-
labelled cells that have integrated with proximal tubule and show active up-take of 6-CF, 
yellow arrows are pointing to QD-labelled cells that have not integrated into proximal 
tubules. Scale bar – 20μm.  
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Figure 6.5 Confocal photomicrographs presenting OAT function in integrated 
exogenous cells in rudiment chimaeras cultured for 5 days (previous page). 
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The results showed that all chimaera types: kidney, ES and Bry+, were 
able to transport 6-CF, indicating that functioning proximal tubule cells 
were present. This active up-take of 6-CF was similar to that observed in 
the intact kidney although less proximal tubule staining was observed in 
ES chimaeras, probably due to the fact that fewer proximal tubules develop 
in these chimaeras (see chapter 5, Fig. 5.8). In all investigated chimaeras, 
the 6-CF up-take was effectively blocked by probenecid, confirming that 6-
CF up-take was OAT dependent (Fig. 6.4). Since all chimaeras showed 
proximal tubule cell activity, it was important to study if the exogenous 
cells (i.e., kidney progenitors, ES, Bry+ cells) were able to generate 
functional proximal tubule cells within the rudiment chimaera. Quantum 
dot-labelled kidney progenitor and Bry+ cells were found to integrate into 
the proximal tubules and demonstrated active transport of 6-CF (green 
label), whereas ESC did not show functionality (Fig. 6.5).  
Therefore, the functionality of all types of chimaeras: kidney, ES and Bry+ 
was presented.  Bry+ cells, similarly to kidney cells (positive control), 
showed transport and accumulation of 6-CF when incorporated into 
proximal tubules, unlike undifferentiated ESC.  
 
 
6.3 Conclusion 
In this chapter it has been demonstrated that mouse embryonic kidneys 
show functionality after 3 days in culture, indicated by active up-take of 6-
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CF into proximal tubules. Moreover, the chimaeras of kidney, ESC and 
Bry+ cells presented similar functionality as intact kidney although there 
were fewer functioning tubules in the ES chimaeras. Detailed analysis 
showed that mES-derived mesoderm cells (Bry+) display normal OAT 
function following integration into the proximal tubules of the developing 
rudiment, indicating that the Bry+ cells are able to generate functioning 
proximal tubule cells. ESC, on the other hand, did not generate any cells 
with OAT function. 
 
6.3.1 Mouse embryonic kidney rudiments (E13.5) show functionality 
after 3 days in culture 
Using a well-established method of intact kidney culture (Saxen, 1987), it 
was shown here that mouse embryonic kidney rudiments dissected at 
E13.5, showed active 6-CF up-take in proximal tubules, similarly to that 
observed in rat kidney rudiments ex vivo (Sweet, 2006). The accumulation 
of 6-CF began on the third day of ex vivo culture, which is much earlier 
than was observed in rat kidneys (7 days). This difference in timing is 
probably due to the fact that the mouse rudiments in the current study were 
more mature than the rat rudiments used by Sweet and co-workers. It is 
known that OATs start to be expressed in the developing kidney between 
day E14 and E16 of normal mouse development and the level of their 
expression rises as kidney organogenesis proceeds (Sweet, 2001). It was 
found here that mouse embryonic kidneys dissected at E13.5 showed 
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functionality after 3 days in culture (E13.5+3), which is comparable to the 
timing observed in vivo (Sweet, 2001).  
 
6.3.2 Kidney dissociation does not affect kidney function 
In the current study (see chapter 5), and that of Unbekandt (2010) it has 
already been shown that dissociated kidney rudiments have the ability to 
re-aggregate and re-form kidney structures like glomeruli, nephron tubules 
and collecting duct tubules, and show normal expression of kidney 
markers. However, in this chapter it is shown for the first time that the 
proximal tubules that form following re-aggregation, display normal 
functionality. Furthermore, the onset of the functionality appeared similar 
in intact and re-aggregated rudiments.  The possible support for cells to re-
aggregate and re-sort appropriately can be a ROCK inhibitor applied to the 
culture, which could act via supporting cell survival. It has been shown that 
ROCK inhibitor can support hESC survival after dissociation (Watanabe, 
2007) and following cryopreservation (Li, 2008). It has been also shown to 
take part in lumen formation in epithelial tubules (Ferrari, 2008). 
Therefore, the ROCK inhibitor could help epithelial cells to survive in the 
first 24h following removal from their epithelial sheet and underlying 
basement membrane, thus enabling them to reform a tubular epithelium.  
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6.3.3 ESC derived mesodermal cells display proximal tubular cells 
function 
In the previous chapter it was demonstrated using LTA staining, that all 
investigated cells: kidney, ESC and Bry+, integrated into proximal tubules 
of the nephron. However, in this chapter, it was presented that only kidney 
(positive control) and Bry+ cells showed functionality, by active up-take of 
6-CF. It is known that the proximal tubule is divided into three segments 
that differ in their functions. Segment S1 is responsible mainly for selective 
reabsorption (e.g., glucose and amino acids), S2 for secretion (i.e. 
metabolites), and S3 for postsecretory reabsorption (mainly water) 
(Brenner, 2000). The OATs are distributed along the entire proximal 
tubule, although there are some significant changes between the segments. 
The highest concentration of OATs is found in the S2 segment 
(Masereeuw, 2001). Therefore, it is possible that the ESC did not generate 
proximal tubule cells with secretory function because they only integrated 
into the S1 and/or S3 segments of the proximal tubules. The other 
possibility is that ESC which integrated into proximal tubules (see chapter 
5, Fig. 5.12) started to differentiate into proximal tubule cells and express 
OATs, but still on a very low level that was not enough for 6-CF transport 
at the time point of the experiment. 
The proximal tubule cells have secretory functions that have been 
investigated in the metanephric kidney rudiment culture and rudiment 
chimaeras as presented in this chapter. They present as well selective 
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reabsorption functions which are difficult to investigate due to lack of 
vasculature in the metanephric kidney rudiment culture and therefore lack 
of ultrafiltrate flow. However, the reabsorption function of the proximal 
tubule cells generated by exogenous cells could be investigated in an in 
vivo system. For example, following injection of exogenous cells into 
neonatal mice and their integration (Vigneau, 2007), the fluorescently 
labelled myoglobin (Gburek, 2003) could be administered. This would 
induce kidney injury, as myoglobin destroys proximal tubule cells via 
binding to megalin (Gburek, 2003), and therefore would determine if QD-
labelled cells of exogenous origin, become fluorescently labelled and thus 
represents the same reabsorption functions as kidney cells.  
 
In the previous chapter it was demonstrated that ESC – derived mesoderm 
(Bry+) cells up-regulated key kidney markes when integrated into 
appropriate kidney structures, and down-regulated the pluripotency marker 
Oct4. In this chapter, the ability of Bry+ cells to generate proximal tubule 
cells with secretory functions was clearly demonstrated by active transport 
and accumulation of 6-CF within the QD-labelled cells.  
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Chapter 7: General discussion 
In this study the hypothesis that the differentiation of mESCs into 
mesoderm would significantly improve their ability to integrate into the 
embryonic kidney was confirmed. Moreover, following successful 
integration, the mesodermal cells rapidly down-regulated the pluripotency 
marker Oct4, suggesting that they would be less tumourigenic than 
undifferentiated precursors. Furthermore, functionality studies indicated 
that mesodermal cells could generate proximal tubule cells with 
functioning transporters following incorporation into the kidney rudiment 
ex vivo. Taken together, this study showed that ES-derived mesodermal 
cells behaved similarly to kidney progenitor cells in regard to integration 
and functionality ex vivo, and could be considered as a serious candidate 
for future stem cell therapy.  
 
Mesoderm differentiation 
The first step in this study was to optimise conditions for directing 
mesodermal differentiation from mESC. Cells used for this purpose, had 
GFP knocked into the Brachyury locus and became green if differentiated 
into mesoderm (Fehling, 2003). Two different conditions for mesodermal 
differentiation were investigated: the monolayer system and the suspension 
system. In spite of supplementing the media with growth factors: activin A 
(2ng/ml) and BMP4 (0.25ng/ml) (Johansson, 1995), mesoderm 
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differentiation was not induced in the monolayer system. It was reported 
for hESC that high, short-term BMP4 dose (25ng/ml) can induce 
mesoderm differentiation in 2-dimension culture (Zhang, 2008). Therefore, 
one of the reasons, why mESC did not become induced to differentiate into 
mesoderm in monolayer, could be due to the difference in dose and time of 
treatment with BMP4. In the current study the BMP4 dose was 100x lower 
and time of treatment 5x longer than suggested for hESC. On the other 
hand, the fact that hESC are more similar in their properties and growth 
requirements to mouse epiblast stem cells rather than mESC (Nichols, 
2009b; Tesar, 2007), might explain why the mesoderm induction in these 
two populations is different; for instance in hESC, mesoderm 
differentiation is maximal at the 2
nd
 day of induction, whereas in mouse 
EBs, mesoderm differentiation is maximal at day 4.  
High serum concentrations in the media for suspension differentiation of 
mESC (3-dimension model) (Fehling, 2003) was sufficient for mesoderm 
differentiation and high numbers of GFP/Bry positive cells (>60%) could 
be identified and sorted by FACS. However, while only 10% of EBs 
deposited basement membrane and developed a polarised primitive 
ectoderm layer, most of EBs showed high mesoderm differentiation. 
Previous studies on laminin deficient (LamC1
-
/-) mESC-derived EBs 
showed that while the basement membrane was required for polarisation of 
the epiblast to form the primitive ectoderm epithelium, it was not required 
for undifferentiated mESC in the centre of the EB to differentiate to form 
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epiblast, as evidenced by expression of FGF5 (Murray, 2000).  Moreover, 
a more recent study has shown that there is an increased level of Bry 
expression in LamC1
-
/- EBs (Fujiwara, 2007), indicating that basement 
membrane deposition inhibits mesoderm differentiation. Therefore, it is not 
surprising that high numbers of EBs lacking basement membrane gave rise 
to high numbers of Bry+ cells; however, it is not clear which compound of 
the media (IMDM) or serum (FCS) could have such a significant effect on 
laminin deposition in those EBs. Furthermore, the effect of cell density 
could also play an important role. 
 
Nephrogenic potential of ESC and their derivatives 
The next step was to investigate the nephrogenic potential of GFP+, GFP-, 
and undifferentiated ESC and compare it to that of the kidney progenitor 
cells. However, to be able to recognize the cells of interest from the kidney 
rudiment cells following their integration, it was necessary to label the 
exogenous cells. The label fulfilling the criteria of this study, such as short 
incubation time, rapid signal appearance, low toxicity, long signal 
preservation, photobleaching resistance and lack of label transfer between 
the contacting cells was QDs labelling (Lin, 2007; Rosen, 2007). For cell 
integration, a method of kidney rudiment disaggregation, incorporation of 
exogenous cell types and re-aggregation of the chimaeric rudiment was 
used (Unbekandt, 2010).  
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The integration experiments investigated the behaviour of four cell types; 
namely ESC, ES-derived mesoderm (GFP/Bry+), ES-derived ectoderm 
(GFP/Bry-) and kidney progenitor cells (positive control of the 
experiments). The ES-derived ectodermal cells had a detrimental effect on 
the growth and development of the chimaera as discussed in chapter 5, 
whereas ES-derived mesodermal cells showed a similar integration pattern 
and kidney marker expression profile to kidney progenitor cells. The 
difference in the behaviour of those two cell types, Bry- and Bry+, could 
be most likely due to different lineage commitment which developed 
during the cell differentiation process; i.e., commitment to ectodermal 
lineage or mesodermal lineage. This is well known from normal mouse 
development (Rivera-Perez, 2005; Tam, 1997) and therefore similar cell 
behaviour can be expected in in vitro differentiation. Therefore, the ES-
derived mesoderm cells have the potential to become kidney cells and 
hence are competent to read signals sent by the kidney microenvironment, 
whereas ES-derived ectoderm cells are committed to become neural cells 
or surface ectoderm and therefore are not competent to respond to signals 
sent by the kidney cells.  For the same reasons, the undifferentiated ESC 
did not really integrate: it seemed that although ESCs are pluripotent, the 
microenvironment of the kidney appeared to be too advanced to enable 
them to integrate, and many of the ESCs remained undifferentiated. This is 
possibly due to the fact that UB cells express leukaemia inhibitory factor 
(LIF) (Yoshino, 2003). In the developing kidney, the normal role of LIF is 
 209 
to promote condensation of the MM, but LIF also promotes the self-
renewal of ESC and inhibits their differentiation (Williams, 1988). 
Previous studies showed that although ES-derived mesodermal cells could 
integrate into neonatal mouse kidneys in vivo, they only gave rise to 
proximal tubule cells and did not generate glomerular, distal tubular cells 
or ureteric bud derivatives (Vigneau, 2007). In contrast, the current study 
showed that ES-derived mesodermal cells were able to integrate into 
ureteric bud, proximal tubules and glomeruli (podocytes) (Tab.7.1).  
 
Tab. 7.1 Comparison of findings by Vigneau et al. and current study. 
 
 
 
 
The capacity of these cells to integrate and develop distal tubule cells and 
other cells of the glomerulus (mesangial cells) have not been investigated, 
and therefore the possibility that the aforementioned cell type (Bry+) could 
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generate these cells must not be excluded and should be investigated. Very 
contradictory results were obtained as well in the case of ES-derived 
ectoderm cells (Bry-), which were showed by Wilson‟s group to integrate 
into distal tubules and UB structures (Vigneau, 2007), whereas in the 
current study, Bry- cells had a negative effect on kidney rudiment growth. 
These dissimilarities could arise as an effect of the different differentiation 
methods used. It is known that activin A is inducing the dorsoanterior-like 
mesoderm, whereas BMP4 induces the posteroventral-like mesoderm 
(Johansson, 1995), and the latter was reported to support intermediate 
mesoderm induction (James, 2005a). Therefore supplementation of the 
media with only activin A (Vigneau, 2007) might have induced only one 
type of mesoderm, whereas the use of FCS (current study),  which contains 
both activin A and BMP4 (Kodaira, 2006; Sakai, 1992), induced both 
mesoderm types, and supported intermediate mesoderm differentiation, 
which is known to give rise to kidney. This could influence the ability of 
cells to integrate into kidney structures. The other factor that could 
influence the difference in the results is the integration method used. Bolus 
injection of cells into intact kidney rudiment/neonatal kidney (Vigneau, 
2007) can limit the motility of  exogenous cells as well as adversely affect 
the rudiment. The method of kidney disaggregation (Unbekandt, 2010), 
used in the current study, allowed the inhibitory effect of intact epithelium 
borders on the integration of exogenous cells to be minimised (removal of 
basement membranes) and permitted improved cell integration (e.g. into 
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glomeruli). On the other hand, due to disaggregation, kidney cells became 
more sensitive to the effect of exogenous cells and therefore, the negative 
effect of Bry- cells could be observed.     
 
Kidney functions 
Properly organized kidney structures (i.e., nephrons beginning with 
glomerulus and connecting to the collecting duct), should display 
appropriate kidney functions. Investigation of cell functionality is very 
important, as cells differentiated towards specific lineage and expressing 
tissue-specific markers, may not display normal tissue functions (Sipione, 
2004). Therefore, the next step was to investigate if ES-derived 
mesodermal cells which integrated into kidney structures were able to 
function. This thesis is the first to report that ES-derived mesodermal cells 
display proximal tubule cell secretory function ex vivo. 
Due to the fact that kidney rudiment chimaeras do not have a blood supply, 
some kidney functions, such as reabsorption, cannot be investigated ex 
vivo. However, future experiments could address this by using a rudiment 
transplantation assay, where the kidney rudiments are injected under the 
kidney capsule of neonatal or adult rodents (Hammerman, 2007; Rogers, 
1998). Kidney primordia transplants were shown to be provided with a 
blood supply from the host and in some cases improved renal function, 
following one-sided nephrectomy (Hammerman, 2007; Rogers, 1998). 
Therefore, similar results could be expected to take place in the case of 
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rudiment chimaera transplants, hence allowing for investigation of the 
contribution of exogenous cells to glomerular filtration with administration 
of FITC-dextrans (Woolf, 1990), and to proximal tubule reabsorption, by 
administration of FITC-myoglobin (Gburek, 2003).  
 
Future directions 
In regard of stem cell based therapies, results contained herein, suggest that 
undifferentiated ESC, although pluripotent, would not be a good source of 
stem cells to be used directly in kidney failure patients. Firstly, due to the 
fact that ESC showed weak integration with kidney rudiments and 
secondly, and more importantly, due to their failure to down-regulate Oct4. 
This raises important questions about safety in terms of use of the 
undifferentiated ESC in cell therapies. It was shown that Oct4 is expressed 
in human tissue cancers (Jones, 2004; Karoubi, 2009) and the significance 
of Oct4 in tumour diagnosis is growing (Teng, 2005), and therefore cells 
increasing the risk of cancerogenesis would have to be rejected from 
therapies (Stojkovic, 2005; Thomson, 1998; Yamamoto, 2006).  
In the current study, differentiation of ESC into the first stage of kidney 
development (mesoderm), showed significant improvement in the ability 
of cells to integrate into kidney rudiments and down-regulate Oct4. 
Furthermore, these cells showed proximal tubule functions ex vivo. 
Therefore, this kind of cell differentiation is bearing great hope for stem 
cell-based therapies. However, there is a risk, that these cells can be 
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rejected by the patient. Therefore, another source of cells - induced 
pluripotent stem cells (iPSC) can help to overcome this problem. iPSC can 
be derived from patients‟ fibroblast, and reprogrammed to become 
pluripotent (Okita, 2007; Takahashi, 2006; Wernig, 2007). Such cells could 
be differentiated towards the kidney lineage and then used to treat kidney 
failure in patients, at the same time, minimising the risk of graft rejection. 
Although the use of ESC and iPSC derivatives in human patients raises 
safety concerns because of the risk of undifferentiated cells being 
transplanted and the associated risk of tumour formation, it is worth noting 
that clinical trials using hESC to treat age related macular degeneration 
(AGM) are due to take place soon in the UK (Coffey, 2009; Vugler, 2008). 
If these initial trials are successful and the patients do not experience 
adverse effects, it is likely that other ESC-based therapies will be 
developed for various other diseases, including renal disease.  
Although the ex vivo model used here has shown the potential of mESC-
derived mesoderm for generating functional renal cells, the real 
nephrogenic potential of all appropriate cells can be truly investigated only 
in animal models of kidney diseases, such as glomerulosclerosis, 
glomerulonephritis, rhabdomyolysis or pigmented nephropathy (Gburek, 
2003; Gburek, 2002; Nordstrand, 1998; Sugimoto, 2007). Animal studies 
should focus on investigating kidney morphology and functional 
improvement following stem cells injection as well as preventing 
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progression of chronic renal failure. This would allow evaluating the cells 
real potential use in stem cell-based therapies.  
In conclusion, differentiation of ESC into mesoderm improved the ability 
of these cells to integrate into the developing kidney rudiment ex vivo. ES-
derived mesodermal cells showed integration into kidney structures, kidney 
marker up-regulation and proximal tubule cell functions which was similar 
to that of kidney progenitor cells. These cells down-regulated the 
expression of the pluripotency marker, Oct4, and in this regard reduced the 
potential risk of tumourogenesis. All these attributes of ES-derived 
mesodermal cells makes them very attractive for future stem cell therapy 
for kidney disease. 
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